BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy8662
(260 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|2F91|A Chain A, 1.2a Resolution Structure Of A Crayfish Trypsin Complexed
With A Peptide Inhibitor, Sgti
Length = 237
Score = 119 bits (297), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 53/109 (48%), Positives = 75/109 (68%)
Query: 150 IVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGD 209
IVTGWG +GG+T D L +V VP++S+ +C+ + I +M+CAG P+G KDSCQGD
Sbjct: 129 IVTGWGTTSEGGNTPDVLQKVTVPLVSDEDCRADYGADEILDSMICAGVPEGGKDSCQGD 188
Query: 210 SGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNTI 258
SGGPL ++ ++ G+VSWG GCA+ YPGVY V+ ++ WIK N +
Sbjct: 189 SGGPLAASDTGSTYLAGIVSWGYGCARPGYPGVYTEVSYHVDWIKANAV 237
Score = 35.4 bits (80), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 17/50 (34%), Positives = 29/50 (58%), Gaps = 8/50 (16%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRF------YCGATLINNLYVLTAAHCVH 130
IVGG + ++P+ L +++ F +CGA++ N Y +TA HCV+
Sbjct: 1 IVGGTDATLGEFPYQ--LSFQETFIGFSFHFCGASIYNENYAITAGHCVY 48
>pdb|1FXY|A Chain A, Coagulation Factor Xa-Trypsin Chimera Inhibited With
D-Phe-Pro-Arg- Chloromethylketone
Length = 228
Score = 117 bits (292), Expect = 8e-27, Method: Compositional matrix adjust.
Identities = 75/227 (33%), Positives = 109/227 (48%), Gaps = 63/227 (27%)
Query: 87 IVGGQVTYVHQYPWMALLMYKK-RFYCGATLINNLYVLTAAHCVHQGLG----------- 134
IVGG + PW ALL+ ++ +CG T+++ Y+LTAAHC++Q
Sbjct: 1 IVGGYNCKDGEVPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTE 60
Query: 135 ----------IWVTIRGKSFSNKT-----------------------------------G 149
+ V I+ F+ +T
Sbjct: 61 QEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPASLPTAPPATGTKC 120
Query: 150 IVTGWG-VQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG G D L ++ P+LS A+C+ +Y +IT NM C G+ +G KDSCQG
Sbjct: 121 LISGWGNTASSGADYPDELQCLDAPVLSQAKCE-ASYPGKITSNMFCVGFLEGGKDSCQG 179
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
DSGGP+ + + GVVSWG+GCAQ+N PGVY +V Y+ WIKN
Sbjct: 180 DSGGPVVCNGQ----LQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKN 222
>pdb|2F83|A Chain A, Crystal Structure At 2.9 Angstroms Resolution Of Human
Plasma Coagulation Factor Xi Zymogen
Length = 625
Score = 115 bits (287), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 52/107 (48%), Positives = 71/107 (66%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
VTGWG +K +TL + ++P+++N EC+K ++IT M+CAGY +G KD+C+GDS
Sbjct: 516 VTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDS 575
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
GGPL + V H+VG+ SWGEGCAQ PGVY V Y+ WI T
Sbjct: 576 GGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKT 622
Score = 41.2 bits (95), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 20/50 (40%), Positives = 29/50 (58%), Gaps = 3/50 (6%)
Query: 84 KTRIVGGQVTYVHQYPWMALLMYK---KRFYCGATLINNLYVLTAAHCVH 130
K RIVGG + ++PW L +R CG ++I N ++LTAAHC +
Sbjct: 385 KPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFY 434
>pdb|1ZLR|A Chain A, Factor Xi Catalytic Domain Complexed With
2-Guanidino-1-(4-(4,4,5,5-
Tetramethyl-1,3,2-Dioxaborolan-2-Yl)phenyl)ethyl
Nicotinate
Length = 237
Score = 114 bits (285), Expect = 6e-26, Method: Compositional matrix adjust.
Identities = 52/107 (48%), Positives = 71/107 (66%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
VTGWG +K +TL + ++P+++N EC+K ++IT M+CAGY +G KD+C+GDS
Sbjct: 129 VTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDS 188
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
GGPL + V H+VG+ SWGEGCAQ PGVY V Y+ WI T
Sbjct: 189 GGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKT 235
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 27/47 (57%), Gaps = 3/47 (6%)
Query: 87 IVGGQVTYVHQYPWMALLMYK---KRFYCGATLINNLYVLTAAHCVH 130
IVGG + ++PW L +R CG ++I N ++LTAAHC +
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFY 47
>pdb|1ZHR|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine
(S434a-T475a-C482s-K437a Mutant)
pdb|1ZPB|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 4-Methyl-Pentanoic Acid {1-[4-
Guanidino-1-(Thiazole-2-Carbonyl)-Butylcarbamoyl]-2-
Methyl- Propyl}-Amide
pdb|1ZPC|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
2-[2-(3-Chloro-Phenyl)-2-Hydroxy-
Acetylamino]-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]- 3-Methyl-Butyramide
pdb|2FDA|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Coagulation Factor Xia In Complex With
Alpha-Ketothiazole Arginine Derived Ligand
pdb|1ZMJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With 4-(Guanidinomethyl)-Phenylboronic Acid
pdb|1ZML|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With (R)-1-(4-(4-(Hydroxymethyl)-1,3,2-
Dioxaborolan-2-Yl)phenethyl)guanidine
pdb|1ZMN|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
(R)-1-(4-(4-(Hydroxymethyl)-1,3,
2-Dioxaborolan-2-Yl)phenyl)guanidine
pdb|1ZOM|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With A Peptidomimetic Inhibitor
pdb|1ZSJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
N-(7-Carbamimidoyl-Naphthalen-1-
Yl)-3-Hydroxy-2-Methyl-Benzamide
pdb|1ZSK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
6-Carbamimidoyl-4-(3-Hydroxy-2-
Methyl-Benzoylamino)-Naphthalene-2-Carboxylic Acid
Methyl Ester
pdb|1ZTJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Benzylamino-2-
Methylsulfanyl-6-Oxo-6h-Pyrimidin-1-Yl)-N-[4-Guanidino-
1- (Thiazole-2-Carbonyl)-Butyl]-Acetamide
pdb|1ZTK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Amino-6-Oxo-2-M-Tolyl-6h-
Pyrimidin-1-Yl)-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]-Acetamide
pdb|1ZTL|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With N-[4-Guanidino-1-(Thiazole-2-
Carbonyl)-Butyl]-2-{6-Oxo-5-[(Quinolin-8-Ylmethyl)-
Amino]- 2-M-Tolyl-6h-Pyrimidin-1-Yl}-Acetamide
Length = 238
Score = 114 bits (285), Expect = 6e-26, Method: Compositional matrix adjust.
Identities = 52/107 (48%), Positives = 71/107 (66%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
VTGWG +K +TL + ++P+++N EC+K ++IT M+CAGY +G KD+C+GDS
Sbjct: 129 VTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDS 188
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
GGPL + V H+VG+ SWGEGCAQ PGVY V Y+ WI T
Sbjct: 189 GGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKT 235
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 27/47 (57%), Gaps = 3/47 (6%)
Query: 87 IVGGQVTYVHQYPWMALLMYK---KRFYCGATLINNLYVLTAAHCVH 130
IVGG + ++PW L +R CG ++I N ++LTAAHC +
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFY 47
>pdb|1XXD|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXD|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXF|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
pdb|1XXF|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
Length = 238
Score = 114 bits (285), Expect = 6e-26, Method: Compositional matrix adjust.
Identities = 52/107 (48%), Positives = 71/107 (66%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
VTGWG +K +TL + ++P+++N EC+K ++IT M+CAGY +G KD+C+GDS
Sbjct: 129 VTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDS 188
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
GGPL + V H+VG+ SWGEGCAQ PGVY V Y+ WI T
Sbjct: 189 GGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKT 235
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 27/47 (57%), Gaps = 3/47 (6%)
Query: 87 IVGGQVTYVHQYPWMALLMYK---KRFYCGATLINNLYVLTAAHCVH 130
IVGG + ++PW L +R CG ++I N ++LTAAHC +
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFY 47
>pdb|1ZJD|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Kunitz Protease Inhibitor
Domain Of Protease Nexin Ii
Length = 237
Score = 114 bits (285), Expect = 6e-26, Method: Compositional matrix adjust.
Identities = 52/107 (48%), Positives = 71/107 (66%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
VTGWG +K +TL + ++P+++N EC+K ++IT M+CAGY +G KD+C+GDS
Sbjct: 129 VTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDS 188
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
GGPL + V H+VG+ SWGEGCAQ PGVY V Y+ WI T
Sbjct: 189 GGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKT 235
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 27/47 (57%), Gaps = 3/47 (6%)
Query: 87 IVGGQVTYVHQYPWMALLMYK---KRFYCGATLINNLYVLTAAHCVH 130
IVGG + ++PW L +R CG ++I N ++LTAAHC +
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFY 47
>pdb|1ZPZ|A Chain A, Factor Xi Catalytic Domain Complexed With N-((R)-1-(4-
Bromophenyl)ethyl)urea-Asn-Val-Arg-Alpha-Ketothiazole
pdb|1ZRK|A Chain A, Factor Xi Complexed With 3-Hydroxypropyl 3-(7-
Amidinonaphthalene-1-Carboxamido)benzenesulfonate
pdb|1ZSL|A Chain A, Factor Xi Complexed With A Pyrimidinone Inhibitor
Length = 238
Score = 114 bits (285), Expect = 6e-26, Method: Compositional matrix adjust.
Identities = 52/107 (48%), Positives = 71/107 (66%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
VTGWG +K +TL + ++P+++N EC+K ++IT M+CAGY +G KD+C+GDS
Sbjct: 129 VTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDS 188
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
GGPL + V H+VG+ SWGEGCAQ PGVY V Y+ WI T
Sbjct: 189 GGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKT 235
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 27/47 (57%), Gaps = 3/47 (6%)
Query: 87 IVGGQVTYVHQYPWMALLMYK---KRFYCGATLINNLYVLTAAHCVH 130
IVGG + ++PW L +R CG ++I N ++LTAAHC +
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFY 47
>pdb|3SOR|A Chain A, Factor Xia In Complex With A Clorophenyl-tetrazole
Inhibitor
pdb|3SOS|A Chain A, Benzothiazinone Inhibitor In Complex With Fxia
Length = 238
Score = 114 bits (285), Expect = 6e-26, Method: Compositional matrix adjust.
Identities = 52/107 (48%), Positives = 71/107 (66%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
VTGWG +K +TL + ++P+++N EC+K ++IT M+CAGY +G KD+C+GDS
Sbjct: 129 VTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDS 188
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
GGPL + V H+VG+ SWGEGCAQ PGVY V Y+ WI T
Sbjct: 189 GGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKT 235
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 27/47 (57%), Gaps = 3/47 (6%)
Query: 87 IVGGQVTYVHQYPWMALLMYK---KRFYCGATLINNLYVLTAAHCVH 130
IVGG + ++PW L +R CG ++I N ++LTAAHC +
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFY 47
>pdb|1ZHM|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Coagulation Factor Xia In Complex With Benzamidine
(s434a- T475a-k437 Mutant)
Length = 238
Score = 114 bits (285), Expect = 6e-26, Method: Compositional matrix adjust.
Identities = 52/107 (48%), Positives = 71/107 (66%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
VTGWG +K +TL + ++P+++N EC+K ++IT M+CAGY +G KD+C+GDS
Sbjct: 129 VTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDS 188
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
GGPL + V H+VG+ SWGEGCAQ PGVY V Y+ WI T
Sbjct: 189 GGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKT 235
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 27/47 (57%), Gaps = 3/47 (6%)
Query: 87 IVGGQVTYVHQYPWMALLMYK---KRFYCGATLINNLYVLTAAHCVH 130
IVGG + ++PW L +R CG ++I N ++LTAAHC +
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFY 47
>pdb|1XX9|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
pdb|1XX9|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
Length = 238
Score = 114 bits (284), Expect = 6e-26, Method: Compositional matrix adjust.
Identities = 52/107 (48%), Positives = 71/107 (66%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
VTGWG +K +TL + ++P+++N EC+K ++IT M+CAGY +G KD+C+GDS
Sbjct: 129 VTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDS 188
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
GGPL + V H+VG+ SWGEGCAQ PGVY V Y+ WI T
Sbjct: 189 GGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKT 235
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 27/47 (57%), Gaps = 3/47 (6%)
Query: 87 IVGGQVTYVHQYPWMALLMYK---KRFYCGATLINNLYVLTAAHCVH 130
IVGG + ++PW L +R CG ++I N ++LTAAHC +
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFY 47
>pdb|3BG8|A Chain A, Crystal Structure Of Factor Xia In Complex With
Clavatadine A
Length = 238
Score = 114 bits (284), Expect = 6e-26, Method: Compositional matrix adjust.
Identities = 52/107 (48%), Positives = 71/107 (66%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
VTGWG +K +TL + ++P+++N EC+K ++IT M+CAGY +G KD+C+GDS
Sbjct: 129 VTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDS 188
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
GGPL + V H+VG+ SWGEGCAQ PGVY V Y+ WI T
Sbjct: 189 GGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKT 235
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 27/47 (57%), Gaps = 3/47 (6%)
Query: 87 IVGGQVTYVHQYPWMALLMYK---KRFYCGATLINNLYVLTAAHCVH 130
IVGG + ++PW L +R CG ++I N ++LTAAHC +
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFY 47
>pdb|2ANY|A Chain A, Expression, Crystallization And The Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 113 bits (283), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 50/107 (46%), Positives = 71/107 (66%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
VTGWG K+ G + L +V +P+++N EC+K + +IT M+CAGY +G KD+C+GDS
Sbjct: 129 VTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDS 188
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
GGPL + + +VG+ SWGEGCA+ PGVY +V Y+ WI T
Sbjct: 189 GGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKT 235
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 20/45 (44%), Positives = 27/45 (60%), Gaps = 3/45 (6%)
Query: 87 IVGGQVTYVHQYPWMALLMYK---KRFYCGATLINNLYVLTAAHC 128
IVGG + ++PW L K +R CG +LI + +VLTAAHC
Sbjct: 1 IVGGTESSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHC 45
>pdb|2ANW|A Chain A, Expression, Crystallization And Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 113 bits (282), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 50/107 (46%), Positives = 71/107 (66%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
VTGWG K+ G + L +V +P+++N EC+K + +IT M+CAGY +G KD+C+GDS
Sbjct: 129 VTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDS 188
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
GGPL + + +VG+ SWGEGCA+ PGVY +V Y+ WI T
Sbjct: 189 GGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKT 235
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 20/45 (44%), Positives = 27/45 (60%), Gaps = 3/45 (6%)
Query: 87 IVGGQVTYVHQYPWMALLMYK---KRFYCGATLINNLYVLTAAHC 128
IVGG + ++PW L K +R CG +LI + +VLTAAHC
Sbjct: 1 IVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHC 45
>pdb|1ZHP|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine (S434a-T475a-K505
Mutant)
Length = 238
Score = 112 bits (279), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 51/107 (47%), Positives = 70/107 (65%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
VTGWG + +TL + ++P+++N EC+K ++IT M+CAGY +G KD+C+GDS
Sbjct: 129 VTGWGYRALRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDS 188
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
GGPL + V H+VG+ SWGEGCAQ PGVY V Y+ WI T
Sbjct: 189 GGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKT 235
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 27/47 (57%), Gaps = 3/47 (6%)
Query: 87 IVGGQVTYVHQYPWMALLMYK---KRFYCGATLINNLYVLTAAHCVH 130
IVGG + ++PW L +R CG ++I N ++LTAAHC +
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFY 47
>pdb|3VEQ|B Chain B, A Binary Complex Betwwen Bovine Pancreatic Trypsin And A
Engineered Mutant Trypsin Inhibitor
Length = 223
Score = 109 bits (273), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 55/106 (51%), Positives = 75/106 (70%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ CK +AY +IT NM CAGY +G KDSCQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCK-SAYPGQITSNMFCAGYLEGGKDSCQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ A + + G+VSWG GCAQ+N PGVY +V Y++WIK
Sbjct: 176 DSGGPVVCAGK----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 35.0 bits (79), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|1F0T|A Chain A, Bovine Trypsin Complexed With Rpr131247
pdb|1F0U|A Chain A, Bovine Trypsin Complexed With Rpr128515
pdb|1EZX|C Chain C, Crystal Structure Of A Serpin:protease Complex
pdb|1LQE|A Chain A, Crystal Structure Of Trypsin In Complex With 79.
pdb|1UTN|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTO|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-ray Structures And Association Constant Measurements
pdb|1UTP|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTQ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|2BY5|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY6|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY7|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY8|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY9|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BYA|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
Length = 243
Score = 108 bits (271), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 54/106 (50%), Positives = 75/106 (70%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ CK +AY +IT NM CAGY +G KDSCQG
Sbjct: 137 LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCK-SAYPGQITSNMFCAGYLEGGKDSCQG 195
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCAQ+N PGVY +V Y++WIK
Sbjct: 196 DSGGPVVCSGK----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 237
Score = 37.0 bits (84), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 19/55 (34%), Positives = 30/55 (54%), Gaps = 1/55 (1%)
Query: 81 VNKKTRIVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
V+ +IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 15 VDDDDKIVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 68
>pdb|1ZZZ|A Chain A, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
Length = 237
Score = 108 bits (270), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 54/106 (50%), Positives = 75/106 (70%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ CK +AY +IT NM CAGY +G KDSCQG
Sbjct: 131 LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCK-SAYPGQITSNMFCAGYLEGGKDSCQG 189
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCAQ+N PGVY +V Y++WIK
Sbjct: 190 DSGGPVVCSGK----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 231
Score = 37.4 bits (85), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 19/55 (34%), Positives = 30/55 (54%), Gaps = 1/55 (1%)
Query: 81 VNKKTRIVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
V+ +IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 9 VDDDDKIVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 62
>pdb|1TAB|E Chain E, Structure Of The Trypsin-Binding Domain Of Bowman-Birk
Type Protease Inhibitor And Its Interaction With Trypsin
pdb|1TPA|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2PTC|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1PPC|E Chain E, Geometry Of Binding Of The Benzamidine-and Arginine-based
Inhibitors
N-alpha-(2-naphthyl-sulphonyl-glycyl)-dl-p-
amidinophenylalanyl- Piperidine (napap) And
(2r,4r)-4-methyl-1-[n-alpha-(3-methyl-1,2,3,4-
Tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine
Carboxylic Acid (mqpa) To Human Alpha-thrombin: X-ray
Crystallographic Determination Of The Napap-trypsin
Complex And Modeling Of Napap- Thrombin And
Mqpa-thrombin
pdb|1PPE|E Chain E, The Refined 2.0 Angstroms X-Ray Crystal Structure Of The
Complex Formed Between Bovine Beta-Trypsin And Cmti-I, A
Trypsin Inhibitor From Squash Seeds (Cucurbita Maxima):
Topological Similarity Of The Squash Seed Inhibitors
With The Carboxypeptidase A Inhibitor From Potatoes
pdb|1PPH|E Chain E, Geometry Of Binding Of The Nalpha-Tosylated Piperidides Of
M-Amidino-, P-Amidino-And P-Guanidino Phenylalanine To
Thrombin And Trypsin: X- Ray Crystal Structures Of Their
Trypsin Complexes And Modeling Of Their Thrombin
Complexes
pdb|1SMF|E Chain E, Studies On An Artificial Trypsin Inhibitor Peptide Derived
From The Mung Bean Inhibitor
pdb|1JRT|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1JRS|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1CE5|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzamidine
pdb|2BZA|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzylamine
pdb|1QCP|A Chain A, Crystal Structure Of The Rwj-51084 Bovine Pancreatic Beta-
Trypsin At 1.8 A
pdb|1SBW|A Chain A, Crystal Structure Of Mung Bean Inhibitor Lysine Active
Fragment Complex With Bovine Beta-Trypsin At 1.8a
Resolution
pdb|1YYY|1 Chain 1, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1SFI|A Chain A, High Resolution Structure Of A Potent, Cyclic Protease
Inhibitor From Sunflower Seeds
pdb|1TIO|A Chain A, High Packing Density Form Of Bovine Beta-trypsin In
Cyclohexane
pdb|2TIO|A Chain A, Low Packing Density Form Of Bovine Beta-Trypsin In
Cyclohexane
pdb|2BTC|E Chain E, Bovine Trypsin In Complex With Squash Seed Inhibitor
(Cucurbita Pepo Trypsin Inhibitor Ii)
pdb|3BTE|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta-Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTD|E Chain E, The Crystal Structures Of The Complexes Between The Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTF|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTG|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTH|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTK|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTM|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTQ|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTT|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTW|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|1QBN|A Chain A, Bovine Trypsin 2-[amino(Imino)methyl]-2-Hydroxyphenoxy]-6-
[3-(4,5-Dihydro-1h-Imidazol-2-Yl)phenoxy]pyridine-4-
Carboxylic Acid (Zk-806688) Complex
pdb|1QBO|A Chain A, Bovine Trypsin
7-[[6-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
2-Methyl-Benzimidazol-1-Yl]methyl]naphthalene-2-
Carboximidamid Zk-806711 Inhibitor Complex
pdb|1QB9|A Chain A, Bovine Trypsin
7-[[2-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
9h-Carbozol-9-Yl] Methyl]naphthalene-2-Carboximidamide
(Zk- 806450) Complex
pdb|1QB1|A Chain A, Bovine Trypsin With 1-[2-[5-[amino(imino)methyl]-2-
Hydroxyphenoxy]-6-[3-(4,
5-dihydro-1-methyl-1h-imidazol-2-
Yl)phenoxy]pyridin-4-yl]piperidine-3-carboxylic Acid
(zk- 806974)
pdb|1QB6|A Chain A, Bovine Trypsin 3,3'-[3,5-Difluoro-4-Methyl-2, 6-
Pyridinediylbis(Oxy)]bis(Benzenecarboximidamide) (Zk-
805623) Complex
pdb|1QA0|A Chain A, Bovine Trypsin 2-Aminobenzimidazole Complex
pdb|1F2S|E Chain E, Crystal Structure Of The Complex Formed Between Bovine
Beta- Trypsin And Mcti-A, A Trypsin Inhibitor Of Squash
Family At 1.8 A Resolution
pdb|1D6R|A Chain A, Crystal Structure Of Cancer Chemopreventive Bowman-Birk
Inhibitor In Ternary Complex With Bovine Trypsin At 2.3
A Resolution. Structural Basis Of Janus-Faced Serine
Protease Inhibitor Specificity
pdb|1C9T|A Chain A, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|B Chain B, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|C Chain C, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|D Chain D, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|E Chain E, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|F Chain F, Complex Of Bdellastasin With Bovine Trypsin
pdb|1QL7|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1QL8|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1G9I|E Chain E, Crystal Structure Of Beta-Trysin Complex In Cyclohexane
pdb|1EJM|A Chain A, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|C Chain C, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|E Chain E, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1JIR|A Chain A, Crystal Structure Of Trypsin Complex With Amylamine In
Cyclohexane
pdb|1J8A|A Chain A, Crystal Structure Of Benzamidine Inhibited Bovine
Pancreatic Trypsin At 105k To 1.21a Resolution From
Laboratory Source With High Number Of Waters Modelled
pdb|1G36|A Chain A, Trypsin Inhibitor Complex
pdb|1K1P|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1O|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1N|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1M|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1L|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1J|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1I|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1EB2|A Chain A, Trypsin Inhibitor Complex (Bpo)
pdb|1GJ6|A Chain A, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1N6X|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1N6Y|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1OYQ|A Chain A, Trypsin Inhibitor Complex
pdb|1O2H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O2O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2P|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Q|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2R|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2S|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2T|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2U|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2V|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2W|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2X|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Y|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Z|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O30|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O31|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O32|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O33|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O34|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O35|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O36|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O37|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O38|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O39|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3A|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3B|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3C|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3D|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3E|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3F|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3G|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O3N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1NC6|A Chain A, Potent, Small Molecule Inhibitors Of Human Mast Cell
Tryptase. Anti-Asthmatic Action Of A Dipeptide-Based
Transition State Analogue Containing Benzothiazole
Ketone
pdb|1P2I|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2J|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2K|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OX1|A Chain A, Crystal Structure Of The Bovine Trypsin Complex With A
Synthetic 11 Peptide Inhibitor
pdb|1RXP|A Chain A, Structure Of Trypsin (Orthorhombic) With 1-(4-Tert-
Butylcarbamoyl- Piperazine-1-Carbonyl)-3-(3-Guanidino-
Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid
pdb|1S0Q|A Chain A, Native Bovine Pancreatic Trypsin
pdb|1S0R|A Chain A, Bovine Pancreatic Trypsin Inhibited With Benzamidine At
Atomic Resolution
pdb|2A7H|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|1TX7|A Chain A, Bovine Trypsin Complexed With P-
Amidinophenylmethylphosphinic Acid (Ampa)
pdb|2BLV|A Chain A, Trypsin Before A High Dose X-Ray "burn"
pdb|2BLW|A Chain A, Trypsin After A High Dose X-Ray "burn"
pdb|1TX8|A Chain A, Bovine Trypsin Complexed With Amso
pdb|1Y3U|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3V|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3W|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3X|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3Y|A Chain A, Trypsin Inhibitor Complex
pdb|1YP9|A Chain A, Trypsin Inhibitor Complex
pdb|2AYW|A Chain A, Crystal Structure Of The Complex Formed Between Trypsin
And A Designed Synthetic Highly Potent Inhibitor In The
Presence Of Benzamidine At 0.97 A Resolution
pdb|2FI3|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser,
Cys38->ser) In Complex With Trypsin
pdb|2FX4|A Chain A, Bovine Trypsin Bound By 4-piperidinebutyrate To Make
Acylenzyme Complex
pdb|2FX6|A Chain A, Bovine Trypsin Complexed With 2-Aminobenzamidazole
pdb|2AGE|X Chain X, Succinyl-Aapr-Trypsin Acyl-Enzyme At 1.15 A Resolution
pdb|2AGG|X Chain X, Succinyl-Aapk-Trypsin Acyl-Enzyme At 1.28 A Resolution
pdb|2AGI|X Chain X, The Leupeptin-Trypsin Covalent Complex At 1.14 A
Resolution
pdb|2AH4|X Chain X, Guanidinobenzoyl-Trypsin Acyl-Enzyme At 1.13 A Resolution
pdb|2G5N|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G5V|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G8T|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2F3C|E Chain E, Crystal Structure Of Infestin 1, A Kazal-Type
Serineprotease Inhibitor, In Complex With Trypsin
pdb|2G81|E Chain E, Crystal Structure Of The Bowman-Birk Inhibitor From Vigna
Unguiculata Seeds In Complex With Beta-Trypsin At 1.55
Angstrons Resolution
pdb|2G55|A Chain A, Anomalous Substructure Of Trypsin (P3121)
pdb|2OTV|A Chain A, Crystal Structure Of The Complex Formed Between Bovine
Trypsin And Nicotinamide At 1.56 A Resolution
pdb|2J9N|A Chain A, Robotically Harvested Trypsin Complexed With Benzamidine
Containing Polypeptide Mediated Crystal Contacts
pdb|2OXS|A Chain A, Crytal Structure Of The Trypsin Complex With Benzamidine
At High Temperature (35 C)
pdb|2UUY|A Chain A, Structure Of A Tick Tryptase Inhibitor In Complex With
Bovine Trypsin
pdb|2ILN|A Chain A, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2ILN|B Chain B, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2CMY|A Chain A, Crystal Complex Between Bovine Trypsin And Veronica
Hederifolia Trypsin Inhibitor
pdb|1AQ7|A Chain A, Trypsin With Inhibitor Aeruginosin 98-b
pdb|1AUJ|A Chain A, Bovine Trypsin Complexed To Meta-Cyano-Benzylic Inhibitor
pdb|1AZ8|A Chain A, Bovine Trypsin Complexed To Bis-Phenylamidine Inhibitor
pdb|1BJU|A Chain A, Beta-Trypsin Complexed With Acpu
pdb|1BJV|A Chain A, Beta-Trypsin Complexed With Appu
pdb|1GBT|A Chain A, Structure Of An Acyl-Enzyme Intermediate During Catalysis:
(Guanidinobenzoyl) Trypsin
pdb|1MAX|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MAY|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MTS|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTU|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTV|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTW|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1TLD|A Chain A, Crystal Structure Of Bovine Beta-Trypsin At 1.5 Angstroms
Resolution In A Crystal Form With Low Molecular Packing
Density. Active Site Geometry, Ion Pairs And Solvent
Structure
pdb|1TPO|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPP|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPS|A Chain A, Atomic Structure Of The Trypsin-A90720a Complex: A Unified
Approach To Structure And Function
pdb|1TYN|A Chain A, Atomic Structure Of The Trypsin-cyclotheonamide A Complex:
Lessons For The Design Of Serine Protease Inhibitors
pdb|1XUF|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUG|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUH|A Chain A, Trypsin-Keto-Babim-Co+2, Ph 8.2
pdb|1XUI|A Chain A, Trypsin-Keto-Babim, Zn+2-Free, Ph 8.2
pdb|1XUJ|A Chain A, Trypsin-Keto-Babim-Zn+2, Ph 8.2
pdb|1XUK|A Chain A, Trypsin-Babim-Sulfate, Ph 5.9
pdb|2PLX|A Chain A, Trypsin Complexed To A Synthetic Peptide From Veronica
Hederifolia
pdb|2PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3PTB|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|3PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1C1N|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1O|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1P|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1Q|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1R|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1T|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2D|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2E|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2F|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2G|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2H|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2I|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2J|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2K|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2L|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2M|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5P|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Q|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5R|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5S|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5T|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5U|A Chain A, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5V|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GHZ|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI0|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI1|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI2|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI3|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI4|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI5|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI6|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2O9Q|A Chain A, The Crystal Structure Of Bovine Trypsin Complexed With A
Small Inhibition Peptide Orb2k
pdb|2QN5|T Chain T, Crystal Structure And Functional Study Of The Bowman-Birk
Inhibitor From Rice Bran In Complex With Bovine Trypsin
pdb|2QYI|A Chain A, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2QYI|C Chain C, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2ZDK|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDL|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDM|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDN|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFS|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFT|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZHD|A Chain A, Exploring Trypsin S3 Pocket
pdb|3D65|E Chain E, Crystal Structure Of Textilinin-1, A Kunitz-Type Serine
Protease Inhibitor From The Australian Common Brown
Snake Venom, In Complex With Trypsin
pdb|3E8L|A Chain A, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|3E8L|B Chain B, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|2ZQ1|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZQ2|A Chain A, Exploring Trypsin S3 Pocket
pdb|3ITI|A Chain A, Structure Of Bovine Trypsin With The Mad Triangle B3c
pdb|3GY2|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY3|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY4|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY5|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY6|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Bis-Benzamidines Diminazene And Pentamidine
pdb|3GY7|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY8|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3AAS|A Chain A, Bovine Beta-Trypsin Bound To Meta-Guanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAU|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diguanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|B Chain B, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3M35|A Chain A, Trypsin In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3MFJ|A Chain A, Bovine Trypsin At 0.8 A Resolution, Restrained Refinement
pdb|3MI4|A Chain A, Bovine Trypsin At 0.8 A Resolution, Non-Restrained
Refinemen
pdb|3I29|A Chain A, Crystal Structure Of A Binary Complex Between An Mutant
Tryp Inhibitor With Bovine Trypsin
pdb|3A7T|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide
pdb|3A7V|A Chain A, Crystal Structure Of Trypsin Complexed With
3-Formylbenzimidamide
pdb|3A7W|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((Tetrahydro-2h-
Pyran-2-Yloxyimino)methyl)benzimidamide (Soaking 4hours)
pdb|3A7X|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
45seconds)
pdb|3A7Y|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
3-Yloxyimino)methyl)benzimidamide (Soaking 2hours)
pdb|3A7Z|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
4-Yloxyimino)methyl)benzimidamide (Soaking 3hours)
pdb|3A80|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic Acid
(Soaking 40seconds)
pdb|3A81|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 8
Hours)
pdb|3A82|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid
pdb|3A83|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide
pdb|3A84|A Chain A, Crystal Structure Of Trypsin Complexed With(E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 5
Seconds)
pdb|3A85|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 15
Seconds)
pdb|3A86|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 30
Seconds)
pdb|3A87|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 5
Minutes)
pdb|3A88|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 30
Minutes)
pdb|3A89|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 4
Hours)
pdb|3A8A|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide And Aniline
pdb|3A8B|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((4-
Bromophenylimino)methyl)benzimidamide
pdb|3A8C|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
With Mixture Of
[(E)-2-(4-Carbamimidoylbenzylideneaminooxy)acetic Acid]
And [(E)-2-
(4-Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic
Acid])
pdb|3A8D|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Under
Aniline-Free Condition)
pdb|3LJJ|A Chain A, Bovine Trypsin In Complex With Ub-Thr 10
pdb|3LJO|A Chain A, Bovine Trypsin In Complex With Ub-Thr 11
pdb|2XTT|B Chain B, Bovine Trypsin In Complex With Evolutionary Enhanced
Schistocerca Gregaria Protease Inhibitor 1 (Sgpi-1-P02)
pdb|3NK8|A Chain A, Trypsin In Complex With Fluorine-Containing Fragment
pdb|3NKK|A Chain A, Trypsin In Complex With Fluorine Containing Fragment
pdb|3M7Q|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Pancreatic Trypsin
pdb|3RDZ|A Chain A, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3RDZ|B Chain B, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3ATI|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3ATK|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3ATL|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamidine
pdb|3ATM|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXA|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3RXB|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobutanoic Acid
pdb|3RXC|A Chain A, Crystal Structure Of Trypsin Complexed With
2-Aminopyridine
pdb|3RXD|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3RXE|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide
pdb|3RXF|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminopyridine
pdb|3RXG|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminocyclohexanol
pdb|3RXH|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Imidazol-4-Yl) Ethanamine
pdb|3RXI|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXJ|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobenzoic Acid
pdb|3RXK|A Chain A, Crystal Structure Of Trypsin Complexed With Methyl
4-Amino-1-Methyl- Pyrrolidine-2-Carboxylate
pdb|3RXL|A Chain A, Crystal Structure Of Trypsin Complexed With
(2,5-Dimethyl-3-Furyl) Methanamine
pdb|3RXM|A Chain A, Crystal Structure Of Trypsin Complexed With
[2-(2-Thienyl)thiazol-4- Yl]methanamine
pdb|3RXO|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Pyrrol-1-Ylphenyl) Methanamine
pdb|3RXP|A Chain A, Crystal Structure Of Trypsin Complexed With
(1,5-Dimethylpyrazol-3- Yl)methanamine
pdb|3RXQ|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F01
And F05, Cocktail Experiment)
pdb|3RXR|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine (F01 And F03, Cocktail Experiment)
pdb|3RXS|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine (F04 And A06, Cocktail
Experiment)
pdb|3RXT|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamin (F04 And F03, Cocktail
Experiment)
pdb|3RXU|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And A06, Cocktail Experiment)
pdb|3RXV|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And F03, Cocktail Experiment)
pdb|3T25|A Chain A, Tmao-Grown Orthorhombic Trypsin (Bovine)
pdb|3T26|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Sarcosine
pdb|3T27|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Betaine
pdb|3T28|A Chain A, Tmao-Grown Trypsin (Bovine)-Previously Unreported
Tetragonal Crystal Form
pdb|3T29|A Chain A, Tmao-Grown Trigonal Trypsin (Bovine)
pdb|4AB8|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4AB9|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABA|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABB|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABD|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABE|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABF|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABG|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABH|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABI|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Pta)sfti-1(1,14), That Was 1,4-
Disubstituted With A 1,2,3-Trizol To Mimic A Trans Amide
Bond
pdb|4ABJ|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Ica)sfti-1(1,14), That Was 1,5-
Disubstituted With 1,2,3-Trizol To Mimic A Cis Amide
Bond
pdb|3VPK|A Chain A, Crystal Structure Of 6-guanidinohexanoyl Trypsin
pdb|3UNR|A Chain A, Bond Length Analysis Of Asp, Glu And His Residues In
Trypsin At 1.2a Resolution
pdb|3RU4|T Chain T, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
pdb|1C1S|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|4I8G|A Chain A, Bovine Trypsin At 0.8 Resolution
pdb|4I8H|A Chain A, Bovine Trypsin At 0.75 Resolution
pdb|4I8J|A Chain A, Bovine Trypsin At 0.87 A Resolution
pdb|4I8K|A Chain A, Bovine Trypsin At 0.85 Resolution
pdb|4I8L|A Chain A, Bovine Trypsin At 0.87 Resolution
pdb|4AOQ|A Chain A, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|B Chain B, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|C Chain C, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOR|A Chain A, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|B Chain B, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|C Chain C, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
Length = 223
Score = 108 bits (270), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 54/106 (50%), Positives = 75/106 (70%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ CK +AY +IT NM CAGY +G KDSCQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCK-SAYPGQITSNMFCAGYLEGGKDSCQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCAQ+N PGVY +V Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 35.0 bits (79), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|2FI4|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser) In
Complex With Trypsin
pdb|2FTL|E Chain E, Crystal Structure Of Trypsin Complexed With Bpti At 100k
Length = 223
Score = 108 bits (270), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 54/106 (50%), Positives = 75/106 (70%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ CK +AY +IT NM CAGY +G KDSCQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCK-SAYPGQITSNMFCAGYLEGGKDSCQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCAQ+N PGVY +V Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 35.0 bits (79), Expect = 0.047, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|2FI5|E Chain E, Crystal Structure Of A Bpti Variant (Cys38->ser) In
Complex With Trypsin
pdb|2FTM|A Chain A, Crystal Structure Of Trypsin Complexed With The Bpti
Variant (Tyr35- >gly)
Length = 224
Score = 108 bits (270), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 54/106 (50%), Positives = 75/106 (70%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ CK +AY +IT NM CAGY +G KDSCQG
Sbjct: 118 LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCK-SAYPGQITSNMFCAGYLEGGKDSCQG 176
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCAQ+N PGVY +V Y++WIK
Sbjct: 177 DSGGPVVCSGK----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 218
Score = 35.0 bits (79), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|1NTP|A Chain A, Use Of The Neutron Diffraction HD EXCHANGE TECHNIQUE TO
Determine The Conformational Dynamics Of Trypsin
Length = 223
Score = 108 bits (270), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 54/106 (50%), Positives = 75/106 (70%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ CK +AY +IT NM CAGY +G KDSCQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCK-SAYPGQITSNMFCAGYLEGGKDSCQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCAQ+N PGVY +V Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 31.6 bits (70), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 16/48 (33%), Positives = 26/48 (54%), Gaps = 1/48 (2%)
Query: 88 VGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
VGG + P+ L F CG +LI++ +V++AAHC G+ +
Sbjct: 2 VGGYTCGANTVPYQVSLNSGYHF-CGGSLIDSQWVVSAAHCYKSGIQV 48
>pdb|3OTJ|E Chain E, A Crystal Structure Of Trypsin Complexed With Bpti (Bovine
Pancreatic Trypsin Inhibitor) By X-RayNEUTRON JOINT
REFINEMENT
Length = 223
Score = 108 bits (270), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 54/106 (50%), Positives = 75/106 (70%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ CK +AY +IT NM CAGY +G KDSCQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCK-SAYPGQITSNMFCAGYLEGGKDSCQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCAQ+N PGVY +V Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 33.1 bits (74), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 17/48 (35%), Positives = 26/48 (54%), Gaps = 1/48 (2%)
Query: 88 VGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
VGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 2 VGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|1G3B|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Magnesium(Ii) Chelate
pdb|1G3C|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff Base
Iron(Iii) Chelate
pdb|1G3D|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Copper (Ii) Chelate
pdb|1G3E|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff-Base
Copper (Ii) Chelate
Length = 228
Score = 108 bits (270), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 54/106 (50%), Positives = 75/106 (70%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ CK +AY +IT NM CAGY +G KDSCQG
Sbjct: 122 LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCK-SAYPGQITSNMFCAGYLEGGKDSCQG 180
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCAQ+N PGVY +V Y++WIK
Sbjct: 181 DSGGPVVCSGK----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 222
Score = 36.2 bits (82), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 18/50 (36%), Positives = 28/50 (56%), Gaps = 1/50 (2%)
Query: 86 RIVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
+IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 5 KIVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 53
>pdb|1Y59|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5A|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5B|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5U|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
Length = 223
Score = 108 bits (270), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 54/106 (50%), Positives = 75/106 (70%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ CK +AY +IT NM CAGY +G KDSCQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCK-SAYPGQITSNMFCAGYLEGGKDSCQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCAQ+N PGVY +V Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 35.0 bits (79), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|1TGS|Z Chain Z, Three-Dimensional Structure Of The Complex Between
Pancreatic Secretory Inhibitor (Kazal Type) And
Trypsinogen At 1.8 Angstroms Resolution. Structure
Solution, Crystallographic Refinement And Preliminary
Structural Interpretation
pdb|2TGP|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2TPI|Z Chain Z, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3TPI|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|4TPI|Z Chain Z, The Refined 2.2-angstroms (0.22-nm) X-ray Crystal
Structure Of The Ternary Complex Formed By Bovine
Trypsinogen, Valine-valine And The Arg15 Analogue Of
Bovine Pancreatic Trypsin Inhibitor
pdb|1BTZ|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTX|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTW|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTP|A Chain A, Unique Binding Of A Novel Synthetic Inhibitor, N-[3-[4-[4-
(Amidinophenoxy)-Carbonyl]phenyl]-2-Methyl-2-Propenoyl]-
N- Allylglycine Methanesulfonate To Bovine Trypsin,
Revealed By The Crystal Structure Of The Complex
pdb|1BTY|A Chain A, Crystal Structure Of Beta-Trypsin In Complex With
Benzamidine
pdb|1TGB|A Chain A, Crystal Structure Of Bovine Trypsinogen At 1.8 Angstroms
Resolution. Ii. Crystallographic Refinement, Refined
Crystal Structure And Comparison With Bovine Trypsin
pdb|1TGC|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TGN|A Chain A, Structure Of Bovine Trypsinogen At 1.9 Angstroms
Resolution
pdb|1TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TNG|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNH|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNI|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNJ|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNK|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNL|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|2TGA|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|2TGD|A Chain A, Lack Of The Transition State Stabilization Site Is A
Factor In The Inactivity Of Trypsinogen, A Serine
Protease Zymogen. Structure Of Dfp Inhibited Bovine
Trypsinogen At 2.1 Angstroms Resolution
pdb|2TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
Length = 229
Score = 108 bits (270), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 54/106 (50%), Positives = 75/106 (70%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ CK +AY +IT NM CAGY +G KDSCQG
Sbjct: 123 LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCK-SAYPGQITSNMFCAGYLEGGKDSCQG 181
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCAQ+N PGVY +V Y++WIK
Sbjct: 182 DSGGPVVCSGK----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 223
Score = 37.4 bits (85), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 19/55 (34%), Positives = 30/55 (54%), Gaps = 1/55 (1%)
Query: 81 VNKKTRIVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
V+ +IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 VDDDDKIVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 54
>pdb|3QK1|A Chain A, Crystal Structure Of Enterokinase-Like Trypsin Variant
Length = 229
Score = 108 bits (270), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 54/106 (50%), Positives = 75/106 (70%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ CK +AY +IT NM CAGY +G KDSCQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCK-SAYPGQITSNMFCAGYLEGGKDSCQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCAQ+N PGVY +V Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 35.0 bits (79), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|1TAW|A Chain A, Bovine Trypsin Complexed To Appi
pdb|1ZR0|A Chain A, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
pdb|1ZR0|C Chain C, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
Length = 223
Score = 108 bits (269), Expect = 4e-24, Method: Compositional matrix adjust.
Identities = 54/106 (50%), Positives = 74/106 (69%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS + CK +AY +IT NM CAGY +G KDSCQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSTSSCK-SAYPGQITSNMFCAGYLEGGKDSCQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCAQ+N PGVY +V Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 34.7 bits (78), Expect = 0.048, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|1MCT|A Chain A, The Refined 1.6 Angstroms Resolution Crystal Structure Of
The Complex Formed Between Porcine Beta-trypsin And
Mcti-a, A Trypsin Inhibitor Of Squash Family
pdb|1QQU|A Chain A, Crystal Structure Of Porcine Beta Trypsin With Bound
Acetate Ion
pdb|1FMG|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.04%
Polydocanol
pdb|1FN6|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.1%
Polydocanol
pdb|1FNI|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01%
Polydocanol
Length = 223
Score = 107 bits (268), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 76/223 (34%), Positives = 107/223 (47%), Gaps = 61/223 (27%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC----VHQGLG---IWVTI 139
IVGG + P+ L F CG +LIN+ +V++AAHC + LG I V
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLE 59
Query: 140 RGKSFSNKTGIVT----------------------------------------------- 152
+ F N I+T
Sbjct: 60 GNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECLIS 119
Query: 153 GWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSG 211
GWG K GS+ +LL+ ++ P+LSN+ C K++Y +IT NM+C G+ +G KDSCQGDSG
Sbjct: 120 GWGNTKSSGSSYPSLLQCLKAPVLSNSSC-KSSYPGQITGNMICVGFLQGGKDSCQGDSG 178
Query: 212 GPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
GP+ + + G+VSWG GCAQ+N PGVY +V Y+ WI+
Sbjct: 179 GPVVCNGQ----LQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQ 217
>pdb|1OPH|B Chain B, Non-Covalent Complex Between Alpha-1-Pi-Pittsburgh And
S195a Trypsin
Length = 243
Score = 107 bits (268), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 53/106 (50%), Positives = 75/106 (70%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ CK +AY +IT NM CAGY +G KDSCQG
Sbjct: 137 LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCK-SAYPGQITSNMFCAGYLEGGKDSCQG 195
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
D+GGP+ + + + G+VSWG GCAQ+N PGVY +V Y++WIK
Sbjct: 196 DAGGPVVCSGK----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 237
Score = 37.0 bits (84), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 19/55 (34%), Positives = 30/55 (54%), Gaps = 1/55 (1%)
Query: 81 VNKKTRIVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
V+ +IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 15 VDDDDKIVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 68
>pdb|4AN7|A Chain A, Kunitz Type Trypsin Inhibitor Complex With Porcine Trypsin
Length = 231
Score = 107 bits (267), Expect = 7e-24, Method: Compositional matrix adjust.
Identities = 75/224 (33%), Positives = 108/224 (48%), Gaps = 61/224 (27%)
Query: 86 RIVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC----VHQGLG---IWVT 138
+IVGG + P+ L F CG +LIN+ +V++AAHC + LG I V
Sbjct: 8 KIVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVL 66
Query: 139 IRGKSFSNKTGIVT---------------------------------------------- 152
+ F N I+T
Sbjct: 67 EGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECLI 126
Query: 153 -GWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
GWG K GS+ +LL+ ++ P+LS++ C K++Y +IT NM+C G+ +G KDSCQGDS
Sbjct: 127 SGWGNTKSSGSSYPSLLQCLKAPVLSDSSC-KSSYPGQITGNMICVGFLEGGKDSCQGDS 185
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
GGP+ + + G+VSWG GCAQ+N PGVY +V Y+ WI+
Sbjct: 186 GGPVVCNGQ----LQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQ 225
>pdb|4DGJ|A Chain A, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|B Chain B, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|C Chain C, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|D Chain D, Structure Of A Human Enteropeptidase Light Chain Variant
Length = 235
Score = 107 bits (266), Expect = 8e-24, Method: Compositional matrix adjust.
Identities = 52/105 (49%), Positives = 67/105 (63%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
+ GWG G+T+D L E +VP+LSN C++ E IT NM+CAGY +G DSCQGDS
Sbjct: 128 IAGWGTVVYQGTTADILQEADVPLLSNERCQQQMPEYNITENMICAGYEEGGIDSCQGDS 187
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GGPL + GV S+G CA N PGVYARV+R+ WI++
Sbjct: 188 GGPLMCQENNRWFLAGVTSFGYECALPNRPGVYARVSRFTEWIQS 232
Score = 43.5 bits (101), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 18/44 (40%), Positives = 29/44 (65%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVH 130
IVGG +PW+ L Y R CGA+L+++ ++++AAHCV+
Sbjct: 1 IVGGSDAKEGAWPWVVGLYYDDRLLCGASLVSSDWLVSAAHCVY 44
>pdb|3MYW|A Chain A, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
pdb|3MYW|B Chain B, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
Length = 223
Score = 107 bits (266), Expect = 9e-24, Method: Compositional matrix adjust.
Identities = 76/223 (34%), Positives = 107/223 (47%), Gaps = 61/223 (27%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC----VHQGLG---IWVTI 139
IVGG + P+ L F CG +LIN+ +V++AAHC + LG I V
Sbjct: 1 IVGGYTCAANSVPYQVSLNSGSHF-CGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLE 59
Query: 140 RGKSFSNKTGIVT----------------------------------------------- 152
+ F N I+T
Sbjct: 60 GNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECLIS 119
Query: 153 GWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSG 211
GWG K GS+ +LL+ ++ P+LS++ C K+AY +IT NM+C G+ +G KDSCQGDSG
Sbjct: 120 GWGNTKSSGSSYPSLLQCLKAPVLSDSSC-KSAYPGQITGNMICVGFLEGGKDSCQGDSG 178
Query: 212 GPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
GP+ + + G+VSWG GCAQ+N PGVY +V Y+ WI+
Sbjct: 179 GPVVCNGQ----LQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQ 217
>pdb|5PTP|A Chain A, Structure Of Hydrolase (Serine Proteinase)
Length = 223
Score = 106 bits (265), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 53/106 (50%), Positives = 74/106 (69%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ CK +AY +IT NM CAGY +G KDSCQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCK-SAYPGQITSNMFCAGYLEGGKDSCQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
D GGP+ + + + G+VSWG GCAQ+N PGVY +V Y++WIK
Sbjct: 176 DXGGPVVCSGK----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 34.7 bits (78), Expect = 0.048, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|2D8W|A Chain A, Structure Of Hyper-Vil-Trypsin
Length = 223
Score = 106 bits (264), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 53/106 (50%), Positives = 74/106 (69%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGSTS-DTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ CK +AY +IT NM CAG +G KDSCQG
Sbjct: 117 LISGWGNTKSSGTSXPDVLKCLKAPILSDSSCK-SAYPGQITSNMFCAGXLEGGKDSCQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCAQ+N PGVY +V Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 35.4 bits (80), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCXKSGIQV 48
>pdb|1EKB|B Chain B, The Serine Protease Domain Of Enteropeptidase Bound To
Inhibitor Val- Asp-asp-asp-asp-lys-chloromethane
Length = 235
Score = 106 bits (264), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 53/105 (50%), Positives = 66/105 (62%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
+ GWG GST+D L E +VP+LSN +C++ E IT NM+CAGY G DSCQGDS
Sbjct: 128 IAGWGALIYQGSTADVLQEADVPLLSNEKCQQQMPEYNITENMVCAGYEAGGVDSCQGDS 187
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GGPL + GV S+G CA N PGVYARV R+ WI++
Sbjct: 188 GGPLMCQENNRWLLAGVTSFGYQCALPNRPGVYARVPRFTEWIQS 232
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 16/44 (36%), Positives = 29/44 (65%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVH 130
IVGG + +PW+ L + + CGA+L++ ++++AAHCV+
Sbjct: 1 IVGGSDSREGAWPWVVALYFDDQQVCGASLVSRDWLVSAAHCVY 44
>pdb|1TFX|A Chain A, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1TFX|B Chain B, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1LDT|T Chain T, Complex Of Leech-Derived Tryptase Inhibitor With Porcine
Trypsin
pdb|1AVW|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Orthorhombic Crystal Form
pdb|1AVX|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Tetragonal Crystal Form
pdb|1EJA|A Chain A, Structure Of Porcine Trypsin Complexed With Bdellastasin,
An Antistasin-Type Inhibitor
pdb|1S5S|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S6F|A Chain A, Porcine Trypsin Covalent Complex With Borate And
Guanidine- 3 Inhibitor
pdb|1S6H|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S81|A Chain A, Porcine Trypsin With No Inhibitor Bound
pdb|1S82|A Chain A, Porcine Trypsin Complexed With Borate And Ethylene Glycol
pdb|1S83|A Chain A, Porcine Trypsin Complexed With 4-amino Propanol
pdb|1S84|A Chain A, Porcine Trypsin Covalent Complex With 4-Amino Butanol,
Borate And Ethylene Glycol
pdb|1S85|A Chain A, Porcine Trypsin Complexed With P-Hydroxymethyl Benzamidine
And Borate
pdb|1H9I|E Chain E, Complex Of Eeti-Ii Mutant With Porcine Trypsin
pdb|1V6D|A Chain A, The Crystal Structure Of The Trypsin Complex With
Synthetic Heterochiral Peptide
pdb|1TX6|A Chain A, Trypsin:bbi Complex
pdb|1TX6|B Chain B, Trypsin:bbi Complex
pdb|1TX6|C Chain C, Trypsin:bbi Complex
pdb|1TX6|D Chain D, Trypsin:bbi Complex
pdb|1Z7K|A Chain A, Crystal Structure Of Trypsin- Ovomucoid Turkey Egg White
Inhibitor Complex
pdb|1YF4|A Chain A, Crystal Structure Of Trypsin-Vasopressin Complex
Length = 223
Score = 105 bits (263), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 75/223 (33%), Positives = 107/223 (47%), Gaps = 61/223 (27%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC----VHQGLG---IWVTI 139
IVGG + P+ L F CG +LIN+ +V++AAHC + LG I V
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLE 59
Query: 140 RGKSFSNKTGIVT----------------------------------------------- 152
+ F N I+T
Sbjct: 60 GNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECLIS 119
Query: 153 GWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSG 211
GWG K GS+ +LL+ ++ P+LS++ C K++Y +IT NM+C G+ +G KDSCQGDSG
Sbjct: 120 GWGNTKSSGSSYPSLLQCLKAPVLSDSSC-KSSYPGQITGNMICVGFLEGGKDSCQGDSG 178
Query: 212 GPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
GP+ + + G+VSWG GCAQ+N PGVY +V Y+ WI+
Sbjct: 179 GPVVCNGQ----LQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQ 217
>pdb|1AN1|E Chain E, Leech-Derived Tryptase InhibitorTRYPSIN COMPLEX
pdb|1C9P|A Chain A, Complex Of Bdellastasin With Porcine Trypsin
Length = 223
Score = 105 bits (263), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 75/223 (33%), Positives = 107/223 (47%), Gaps = 61/223 (27%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC----VHQGLG---IWVTI 139
IVGG + P+ L F CG +LIN+ +V++AAHC + LG I V
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLE 59
Query: 140 RGKSFSNKTGIVT----------------------------------------------- 152
+ F N I+T
Sbjct: 60 GNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLXSRVATVSLPRSCAAAGTECLIS 119
Query: 153 GWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSG 211
GWG K GS+ +LL+ ++ P+LS++ C K++Y +IT NM+C G+ +G KDSCQGDSG
Sbjct: 120 GWGNTKSSGSSYPSLLQCLKAPVLSDSSC-KSSYPGQITGNMICVGFLEGGKDSCQGDSG 178
Query: 212 GPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
GP+ + + G+VSWG GCAQ+N PGVY +V Y+ WI+
Sbjct: 179 GPVVCNGQ----LQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQ 217
>pdb|2A31|A Chain A, Trypsin In Complex With Borate
pdb|2A32|A Chain A, Trypsin In Complex With Benzene Boronic Acid
Length = 223
Score = 103 bits (258), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 74/222 (33%), Positives = 106/222 (47%), Gaps = 61/222 (27%)
Query: 88 VGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC----VHQGLG---IWVTIR 140
VGG + P+ L F CG +LIN+ +V++AAHC + LG I V
Sbjct: 2 VGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLEG 60
Query: 141 GKSFSNKTGIVT-----------------------------------------------G 153
+ F N I+T G
Sbjct: 61 NEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECLISG 120
Query: 154 WGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSGG 212
WG K GS+ +LL+ ++ P+LS++ C K++Y +IT NM+C G+ +G KDSCQGDSGG
Sbjct: 121 WGNTKSSGSSYPSLLQCLKAPVLSDSSC-KSSYPGQITGNMICVGFLEGGKDSCQGDSGG 179
Query: 213 PLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
P+ + + G+VSWG GCAQ+N PGVY +V Y+ WI+
Sbjct: 180 PVVCNGQ----LQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQ 217
>pdb|1KIG|H Chain H, Bovine Factor Xa
Length = 241
Score = 103 bits (256), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 50/110 (45%), Positives = 70/110 (63%), Gaps = 1/110 (0%)
Query: 144 FSNKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEK 203
+ KTGIV+G+G + G S TL +EVP + + CK ++ ITPNM CAGY +
Sbjct: 120 MTQKTGIVSGFGRTHEKGRLSSTLKMLEVPYVDRSTCKLSS-SFTITPNMFCAGYDTQPE 178
Query: 204 DSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
D+CQGDSGGP + + + G+VSWGEGCA++ GVY +V+ +L WI
Sbjct: 179 DACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKFGVYTKVSNFLKWI 228
>pdb|1TRN|A Chain A, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
pdb|1TRN|B Chain B, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
Length = 224
Score = 102 bits (253), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 71/224 (31%), Positives = 100/224 (44%), Gaps = 61/224 (27%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV--------- 137
IVGG + P+ L F CG +LIN +V++A HC + + +
Sbjct: 1 IVGGYNCEENSVPYQVSLNSGYHF-CGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLE 59
Query: 138 ----------TIRGKSFSNKT-----------------------------------GIVT 152
IR + KT +++
Sbjct: 60 GNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLIS 119
Query: 153 GWG-VQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSG 211
GWG G D L ++ P+LS A+C+ +Y +IT NM C G+ +G KDSCQGDSG
Sbjct: 120 GWGNTASSGADXPDELQCLDAPVLSQAKCE-ASYPGKITSNMFCVGFLEGGKDSCQGDSG 178
Query: 212 GPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GP+ + + GVVSWG+GCAQ+N PGVY +V Y+ WIKN
Sbjct: 179 GPVVCNGQ----LQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKN 218
>pdb|1A0J|A Chain A, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|B Chain B, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|C Chain C, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|D Chain D, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species
Length = 223
Score = 100 bits (250), Expect = 7e-22, Method: Compositional matrix adjust.
Identities = 55/109 (50%), Positives = 73/109 (66%), Gaps = 10/109 (9%)
Query: 150 IVTGWGVQKQGGSTS---DTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSC 206
+V+GWG GS+S DTL +++PILS++ C +AY +IT NM CAG+ +G KDSC
Sbjct: 117 LVSGWG--NLSGSSSNYPDTLRCLDLPILSSSSCN-SAYPGQITSNMFCAGFMEGGKDSC 173
Query: 207 QGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
QGDSGGP+ + + GVVSWG GCAQ N PGVY +V Y +WI +
Sbjct: 174 QGDSGGPVVCNGQ----LQGVVSWGYGCAQRNKPGVYTKVCNYRSWISS 218
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 16/42 (38%), Positives = 24/42 (57%), Gaps = 1/42 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC 128
IVGG + + A L F CG +LI++ +V++AAHC
Sbjct: 1 IVGGYECRKNSASYQASLQSGYHF-CGGSLISSTWVVSAAHC 41
>pdb|3I77|A Chain A, 3599170-Loops Of Fxa In Sgt
Length = 230
Score = 100 bits (249), Expect = 8e-22, Method: Compositional matrix adjust.
Identities = 69/225 (30%), Positives = 100/225 (44%), Gaps = 56/225 (24%)
Query: 87 IVGGQVTYVHQYPWMALLMYKK-RFYCGATLINNLYVLTAAHC----------------- 128
+VGG ++P+M L+ ++ +CG L VLTAAHC
Sbjct: 1 VVGGTRAAQGEFPFMVRLINEENEGFCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVV 60
Query: 129 --------------VHQGLGI--------WVTIR--------------GKSFSNKTGIVT 152
V Q G W I+ +++ T V
Sbjct: 61 DLQSSSAVKVRSTKVLQAPGFTKETYGKDWALIKLAQPINQPTLKIATTTAYNQGTFTVA 120
Query: 153 GWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPK-GEKDSCQGDSG 211
GWG ++GGS LL+ VP +S+A C+ ++ + M+CAGYP G D+CQGDSG
Sbjct: 121 GWGANREGGSQQRYLLKANVPFVSDAACRSSSSFILVANEMICAGYPDTGGVDTCQGDSG 180
Query: 212 GPLHYANETVHHI-VGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GP+ + I VG+VSWG GCA+ YPGVY V+ + + I +
Sbjct: 181 GPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIAS 225
>pdb|2RA3|A Chain A, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
pdb|2RA3|B Chain B, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
Length = 224
Score = 100 bits (249), Expect = 9e-22, Method: Compositional matrix adjust.
Identities = 70/224 (31%), Positives = 100/224 (44%), Gaps = 61/224 (27%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV--------- 137
IVGG + P+ L F CG +LIN +V++A HC + + +
Sbjct: 1 IVGGYNCEENSVPYQVSLNSGYHF-CGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLE 59
Query: 138 ----------TIRGKSFSNKT-----------------------------------GIVT 152
IR + KT +++
Sbjct: 60 GNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINAHVSTISLPTAPPATGTKCLIS 119
Query: 153 GWG-VQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSG 211
GWG G D L ++ P+LS A+C+ +Y +IT NM C G+ +G KDSCQGD+G
Sbjct: 120 GWGNTASSGADYPDELQCLDAPVLSQAKCE-ASYPGKITSNMFCVGFLEGGKDSCQGDAG 178
Query: 212 GPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GP+ + + GVVSWG+GCAQ+N PGVY +V Y+ WIKN
Sbjct: 179 GPVVCNGQ----LQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKN 218
>pdb|1XVM|A Chain A, Trypsin From Fusarium Oxysporum- Room Temperature To
Atomic Resolution
pdb|1XVO|A Chain A, Trypsin From Fusarium Oxysporum At Ph 6
pdb|1FY5|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDN|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FY4|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FN8|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDQ|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
Length = 224
Score = 100 bits (248), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 58/141 (41%), Positives = 79/141 (56%), Gaps = 8/141 (5%)
Query: 118 NNLYVLTAAHCVHQGLGIWVTIRGKSFSN----KTGIVTGWGVQKQGGSTSD-TLLEVEV 172
N+L +L + + G I S S+ + V GWG +GGS++ LL+V V
Sbjct: 83 NDLAILKLSTSIPSGGNIGYARLAASGSDPVAGSSATVAGWGATSEGGSSTPVNLLKVTV 142
Query: 173 PILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSGGPLHYANETVHHIVGVVSWGE 232
PI+S A C+ + IT M CAG G KDSCQGDSGGP+ ++ T ++G VSWG
Sbjct: 143 PIVSRATCRAQYGTSAITNQMFCAGVSSGGKDSCQGDSGGPIVDSSNT---LIGAVSWGN 199
Query: 233 GCAQENYPGVYARVNRYLTWI 253
GCA+ NY GVYA V ++I
Sbjct: 200 GCARPNYSGVYASVGALRSFI 220
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 22/65 (33%), Positives = 31/65 (47%)
Query: 88 VGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFSNK 147
VGG +P++ + +CG +L+N VLTAAHCV IR S S
Sbjct: 2 VGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGSLSRT 61
Query: 148 TGIVT 152
+G +T
Sbjct: 62 SGGIT 66
>pdb|1GDU|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1PQ5|A Chain A, Trypsin At Ph 5, 0.85 A
pdb|1PQ7|A Chain A, Trypsin At 0.8 A, Ph5 BORAX
pdb|1PQ8|A Chain A, Trypsin At Ph 4 At Atomic Resolution
pdb|2G51|A Chain A, Anomalous Substructure Of Trypsin (P1)
pdb|2G52|A Chain A, Anomalous Substructure Of Trypsin (P21)
pdb|1TRY|A Chain A, Structure Of Inhibited Trypsin From Fusarium Oxysporum At
1.55 Angstroms
pdb|2VU8|E Chain E, Crystal Structure Of An Insect Inhibitor With A Fungal
Trypsin
Length = 224
Score = 99.8 bits (247), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 58/141 (41%), Positives = 79/141 (56%), Gaps = 8/141 (5%)
Query: 118 NNLYVLTAAHCVHQGLGIWVTIRGKSFSN----KTGIVTGWGVQKQGGSTSD-TLLEVEV 172
N+L +L + + G I S S+ + V GWG +GGS++ LL+V V
Sbjct: 83 NDLAILKLSTSIPSGGNIGYARLAASGSDPVAGSSATVAGWGATSEGGSSTPVNLLKVTV 142
Query: 173 PILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSGGPLHYANETVHHIVGVVSWGE 232
PI+S A C+ + IT M CAG G KDSCQGDSGGP+ ++ T ++G VSWG
Sbjct: 143 PIVSRATCRAQYGTSAITNQMFCAGVSSGGKDSCQGDSGGPIVDSSNT---LIGAVSWGN 199
Query: 233 GCAQENYPGVYARVNRYLTWI 253
GCA+ NY GVYA V ++I
Sbjct: 200 GCARPNYSGVYASVGALRSFI 220
Score = 41.2 bits (95), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 23/66 (34%), Positives = 32/66 (48%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFSN 146
IVGG +P++ + +CG +L+N VLTAAHCV IR S S
Sbjct: 1 IVGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGSLSR 60
Query: 147 KTGIVT 152
+G +T
Sbjct: 61 TSGGIT 66
>pdb|1RJX|B Chain B, Human Plasminogen Catalytic Domain, K698m Mutant
Length = 247
Score = 98.6 bits (244), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 48/106 (45%), Positives = 68/106 (64%), Gaps = 2/106 (1%)
Query: 150 IVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYEN-RITPNMLCAGYPKGEKDSCQG 208
+TGWG + QG + L+E ++P++ N C + + N R+ LCAG+ G DSCQG
Sbjct: 137 FITGWG-ETQGTFGAGLLMEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQG 195
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGPL + + + GV SWG GCA+ N PGVY RV+R++TWI+
Sbjct: 196 DSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIE 241
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 23/48 (47%), Positives = 31/48 (64%), Gaps = 5/48 (10%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRF---YCGATLINNLYVLTAAHCVHQ 131
+VGG V Y H +PW L + RF +CG TLI+ +VLTAAHC+ +
Sbjct: 18 VVGGCVAYPHSWPWQVSL--RTRFGMHFCGGTLISPEWVLTAAHCLEK 63
>pdb|1PPZ|A Chain A, Trypsin Complexes At Atomic And Ultra-High Resolution
pdb|1PQA|A Chain A, Trypsin With Pmsf At Atomic Resolution
Length = 224
Score = 98.2 bits (243), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 57/141 (40%), Positives = 78/141 (55%), Gaps = 8/141 (5%)
Query: 118 NNLYVLTAAHCVHQGLGIWVTIRGKSFSN----KTGIVTGWGVQKQGGSTSD-TLLEVEV 172
N+L +L + + G I S S+ + V GWG +GGS++ LL+V V
Sbjct: 83 NDLAILKLSTSIPSGGNIGYARLAASGSDPVAGSSATVAGWGATSEGGSSTPVNLLKVTV 142
Query: 173 PILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSGGPLHYANETVHHIVGVVSWGE 232
PI+S A C+ + IT M CAG G KDSCQGD GGP+ ++ T ++G VSWG
Sbjct: 143 PIVSRATCRAQYGTSAITNQMFCAGVSSGGKDSCQGDXGGPIVDSSNT---LIGAVSWGN 199
Query: 233 GCAQENYPGVYARVNRYLTWI 253
GCA+ NY GVYA V ++I
Sbjct: 200 GCARPNYSGVYASVGALRSFI 220
Score = 41.2 bits (95), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 23/66 (34%), Positives = 32/66 (48%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFSN 146
IVGG +P++ + +CG +L+N VLTAAHCV IR S S
Sbjct: 1 IVGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGSLSR 60
Query: 147 KTGIVT 152
+G +T
Sbjct: 61 TSGGIT 66
>pdb|1SGT|A Chain A, Refined Crystal Structure Of Streptomyces Griseus Trypsin
At 1.7 Angstroms Resolution
Length = 223
Score = 98.2 bits (243), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 72/223 (32%), Positives = 99/223 (44%), Gaps = 59/223 (26%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCV----------------- 129
+VGG ++P+M L CG L VLTAAHCV
Sbjct: 1 VVGGTRAAQGEFPFMVRL----SMGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 130 -------------------HQGLGI-WVTIR--------------GKSFSNKTGIVTGWG 155
+ G G W I+ +++ T V GWG
Sbjct: 57 LQSGAAVKVRSTKVLQAPGYNGTGKDWALIKLAQPINQPTLKIATTTAYNQGTFTVAGWG 116
Query: 156 VQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPN-MLCAGYPK-GEKDSCQGDSGGP 213
++GGS LL+ VP +S+A C ++AY N + N +CAGYP G D+CQGDSGGP
Sbjct: 117 ANREGGSQQRYLLKANVPFVSDAAC-RSAYGNELVANEEICAGYPDTGGVDTCQGDSGGP 175
Query: 214 LHYANETVHHI-VGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
+ + I VG+VSWG GCA+ YPGVY V+ + + I +
Sbjct: 176 MFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIAS 218
>pdb|3I78|A Chain A, 3599170186220-Loops Of Fxa In Sgt
Length = 229
Score = 98.2 bits (243), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 55/224 (24%)
Query: 87 IVGGQVTYVHQYPWMALLMYKK-RFYCGATLINNLYVLTAAHC----------------- 128
+VGG ++P+M L+ ++ +CG L VLTAAHC
Sbjct: 1 VVGGTRAAQGEFPFMVRLINEENEGFCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVV 60
Query: 129 --------------VHQGLGI--------WVTIR--------------GKSFSNKTGIVT 152
V Q G W I+ +++ T V
Sbjct: 61 DLQSSSAVKVRSTKVLQAPGFTKETYGKDWALIKLAQPINQPTLKIATTTAYNQGTFTVA 120
Query: 153 GWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSGG 212
GWG ++GGS LL+ VP +S+A C+ ++ + M+CAGY ++D+CQGDSGG
Sbjct: 121 GWGANREGGSQQRYLLKANVPFVSDAACRSSSSFILVANEMICAGYDTKQEDTCQGDSGG 180
Query: 213 PLHYANETVHHI-VGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
P+ + + VG+VSWGEGCA++ GVY V+ + + I +
Sbjct: 181 PMFRKDNADEWVQVGIVSWGEGCARKGKYGVYTEVSTFASAIAS 224
>pdb|1OS8|A Chain A, Recombinant Streptomyces Griseus Trypsin
Length = 223
Score = 97.8 bits (242), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 72/223 (32%), Positives = 99/223 (44%), Gaps = 59/223 (26%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCV----------------- 129
+VGG ++P+M L CG L VLTAAHCV
Sbjct: 1 VVGGTRAAQGEFPFMVRL----SMGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 130 -------------------HQGLGI-WVTIR--------------GKSFSNKTGIVTGWG 155
+ G G W I+ +++ T V GWG
Sbjct: 57 LQSSSAVKVRSTKVLQAPGYNGTGKDWALIKLAQPINQPTLKIATTTAYNQGTFTVAGWG 116
Query: 156 VQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPN-MLCAGYPK-GEKDSCQGDSGGP 213
++GGS LL+ VP +S+A C ++AY N + N +CAGYP G D+CQGDSGGP
Sbjct: 117 ANREGGSQQRYLLKANVPFVSDAAC-RSAYGNELVANEEICAGYPDTGGVDTCQGDSGGP 175
Query: 214 LHYANETVHHI-VGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
+ + I VG+VSWG GCA+ YPGVY V+ + + I +
Sbjct: 176 MFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIAS 218
>pdb|1CO7|E Chain E, R117h Mutant Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
Length = 245
Score = 97.8 bits (242), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 68/230 (29%), Positives = 104/230 (45%), Gaps = 61/230 (26%)
Query: 81 VNKKTRIVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV--- 137
V+ +IVGG + P+ L F CG +LIN+ +V++AAHC + + +
Sbjct: 17 VDDDDKIVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSRIQVRLGEH 75
Query: 138 ----------------TIRGKSFSNKT--------------------------------- 148
I+ +F KT
Sbjct: 76 NINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNAHVATVALPSSCAPAG 135
Query: 149 --GIVTGWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDS 205
+++GWG G LL+ ++ P+L A+C+ + Y +IT NM+C G+ +G KDS
Sbjct: 136 TQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEAS-YPGKITDNMVCVGFLEGGKDS 194
Query: 206 CQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
CQGDSGGP+ E + G+VSWG GCA + PGVY +V Y+ WI++
Sbjct: 195 CQGDSGGPVVCNGE----LQGIVSWGYGCALPDNPGVYTKVCNYVDWIQD 240
>pdb|1FAX|A Chain A, Coagulation Factor Xa Inhibitor Complex
Length = 254
Score = 97.4 bits (241), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 47/113 (41%), Positives = 68/113 (60%), Gaps = 1/113 (0%)
Query: 144 FSNKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEK 203
+ KTGIV+G+G + G S L +EVP + CK ++ IT NM CAGY ++
Sbjct: 120 MTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSS-SFIITQNMFCAGYDTKQE 178
Query: 204 DSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNN 256
D+CQGDSGGP + + + G+VSWGEGCA++ G+Y +V +L WI +
Sbjct: 179 DACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRS 231
Score = 48.1 bits (113), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 15/98 (15%)
Query: 87 IVGGQVTYVHQYPWMALLMYKK-RFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFS 145
IVGGQ + PW ALL+ ++ +CG T+++ Y+LTAAHC++Q V + ++ +
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTA 60
Query: 146 NKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKT 183
+ G + + EVEV I N K+T
Sbjct: 61 AEEG--------------GEAVHEVEVVIKHNRFTKET 84
>pdb|1EZQ|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr128515
pdb|1F0R|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208815
pdb|1F0S|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208707
pdb|1KSN|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Fxv673
pdb|1NFU|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr132747
pdb|1NFW|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr209685
pdb|1NFX|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208944
pdb|1NFY|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr200095
pdb|1LPG|B Chain B, Crystal Structure Of Fxa In Complex With 79.
pdb|1LPK|B Chain B, Crystal Structure Of Fxa In Complex With 125.
pdb|1LPZ|B Chain B, Crystal Structure Of Fxa In Complex With 41.
pdb|1LQD|B Chain B, Crystal Structure Of Fxa In Complex With 45.
pdb|1P0S|H Chain H, Crystal Structure Of Blood Coagulation Factor Xa In
Complex With Ecotin M84r
pdb|2BOH|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound
"1"
pdb|2CJI|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J2U|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J34|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J38|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J4I|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J94|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J95|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2UWL|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWO|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWP|A Chain A, Factor Xa Inhibitor Complex
pdb|2VH0|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Biaryl Pyrrolidin-2-Ones Incorporating Basic
Heterocyclic Motifs
pdb|2VH6|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Biaryl P4 Motifs
pdb|2WYG|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2WYJ|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2Y7X|A Chain A, The Discovery Of Potent And Long-Acting Oral Factor Xa
Inhibitors With Tetrahydroisoquinoline And Benzazepine
P4 Motifs
pdb|2Y7Z|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y80|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y81|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y82|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|4A7I|B Chain B, Factor Xa In Complex With A Potent 2-Amino-Ethane
Sulfonamide Inhibitor
Length = 254
Score = 97.4 bits (241), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 47/113 (41%), Positives = 68/113 (60%), Gaps = 1/113 (0%)
Query: 144 FSNKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEK 203
+ KTGIV+G+G + G S L +EVP + CK ++ IT NM CAGY ++
Sbjct: 120 MTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSS-SFIITQNMFCAGYDTKQE 178
Query: 204 DSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNN 256
D+CQGDSGGP + + + G+VSWGEGCA++ G+Y +V +L WI +
Sbjct: 179 DACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRS 231
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 87 IVGGQVTYVHQYPWMALLMYKK-RFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFS 145
IVGGQ + PW ALL+ ++ +CG T+++ Y+LTAAHC++Q V + ++
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTE 60
Query: 146 NKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKT 183
Q++GG + + EVEV I N K+T
Sbjct: 61 -----------QEEGG---EAVHEVEVVIKHNRFTKET 84
>pdb|1XKA|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|D Chain D, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1G2L|A Chain A, Factor Xa Inhibitor Complex
pdb|1G2M|A Chain A, Factor Xa Inhibitor Complex
pdb|1IOE|A Chain A, Human Coagulation Factor Xa In Complex With M55532
pdb|1IQE|A Chain A, Human Coagulation Factor Xa In Complex With M55590
pdb|1IQF|A Chain A, Human Coagulation Factor Xa In Complex With M55165
pdb|1IQG|A Chain A, Human Coagulation Factor Xa In Complex With M55159
pdb|1IQH|A Chain A, Human Coagulation Factor Xa In Complex With M55143
pdb|1IQI|A Chain A, Human Coagulation Factor Xa In Complex With M55125
pdb|1IQJ|A Chain A, Human Coagulation Factor Xa In Complex With M55124
pdb|1IQK|A Chain A, Human Coagulation Factor Xa In Complex With M55113
pdb|1IQL|A Chain A, Human Coagulation Factor Xa In Complex With M54476
pdb|1IQM|A Chain A, Human Coagulation Factor Xa In Complex With M54471
pdb|1IQN|A Chain A, Human Coagulation Factor Xa In Complex With M55192
pdb|2P3F|H Chain H, Crystal Structure Of The Factor XaNAP5 COMPLEX
Length = 235
Score = 97.4 bits (241), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 47/113 (41%), Positives = 68/113 (60%), Gaps = 1/113 (0%)
Query: 144 FSNKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEK 203
+ KTGIV+G+G + G S L +EVP + CK ++ IT NM CAGY ++
Sbjct: 120 MTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSS-SFIITQNMFCAGYDTKQE 178
Query: 204 DSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNN 256
D+CQGDSGGP + + + G+VSWGEGCA++ G+Y +V +L WI +
Sbjct: 179 DACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRS 231
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 87 IVGGQVTYVHQYPWMALLMYKK-RFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFS 145
IVGGQ + PW ALL+ ++ +CG T+++ Y+LTAAHC++Q V + ++
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTE 60
Query: 146 NKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKT 183
Q++GG + + EVEV I N K+T
Sbjct: 61 -----------QEEGG---EAVHEVEVVIKHNRFTKET 84
>pdb|1C5M|D Chain D, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
Length = 255
Score = 97.4 bits (241), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 47/113 (41%), Positives = 68/113 (60%), Gaps = 1/113 (0%)
Query: 144 FSNKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEK 203
+ KTGIV+G+G + G S L +EVP + CK ++ IT NM CAGY ++
Sbjct: 120 MTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSS-SFIITQNMFCAGYDTKQE 178
Query: 204 DSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNN 256
D+CQGDSGGP + + + G+VSWGEGCA++ G+Y +V +L WI +
Sbjct: 179 DACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRS 231
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 87 IVGGQVTYVHQYPWMALLMYKK-RFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFS 145
IVGGQ + PW ALL+ ++ +CG T+++ Y+LTAAHC++Q V + ++
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTE 60
Query: 146 NKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKT 183
Q++GG + + EVEV I N K+T
Sbjct: 61 -----------QEEGG---EAVHEVEVVIKHNRFTKET 84
>pdb|1FJS|A Chain A, Crystal Structure Of The Inhibitor Zk-807834 (Ci-1031)
Complexed With Factor Xa
pdb|1Z6E|A Chain A, Factor Xa In Complex With The Inhibitor
1-(3'-Amino-1,2-Benzisoxazol-
5'-Yl)-N-(4-(2'-((Dimethylamino)methyl)-1h-Imidazol-1-
Yl)-2-
Fluorophenyl)-3-(Trifluoromethyl)-1h-Pyrazole-5-
Carboxamide (Razaxaban; Dpc906; Bms-561389)
pdb|2BMG|B Chain B, Crystal Structure Of Factor Xa In Complex With 50
pdb|2FZZ|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-Amino-1,2-
Benzisoxazol-5-Yl)-6-(2'-(((3r)-3-Hydroxy-1-
Pyrrolidinyl)
Methyl)-4-Biphenylyl)-3-(Trifluoromethyl)-1,4,5,6-
Tetrahydro-7h-Pyrazolo[3,4-C]pyridin-7-One
pdb|2G00|A Chain A, Factor Xa In Complex With The Inhibitor 3-(6-(2'-
((Dimethylamino)methyl)-4-Biphenylyl)-7-Oxo-3-
(Trifluoromethyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3,4-
C]pyridin-1-Yl)benzamide
pdb|2P93|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-(2-(4-(2-
Oxopyridin-1(2h)-Yl)benzamido)ethyl)thiophene-2-
Carboxamide
pdb|2P94|A Chain A, Factor Xa In Complex With The Inhibitor
3-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido)cyclohexyl)-1h-
Indole-6-Carboxamide
pdb|2P95|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido) Cyclopentyl)
Thiophene-2-Carboxamide
pdb|2PR3|A Chain A, Factor Xa Inhibitor
pdb|2Q1J|A Chain A, The Discovery Of Glycine And Related Amino Acid-Based
Factor Xa Inhibitors
pdb|2P16|A Chain A, Factor Xa In Complex With The Inhibitor Apixaban (Bms-
562247) Aka 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxo-1-
Piperidinyl)phenyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3, 4-
C]pyridine-3-Carboxamide
pdb|2RA0|A Chain A, X-Ray Structure Of Fxa In Complex With 7-Fluoroindazole
pdb|2PHB|A Chain A, An Orally Efficacious Factor Xa Inhibitor
pdb|3CEN|A Chain A, Factor Xa In Complex With The Inhibitor
N-(2-(((5-Chloro-2- Pyridinyl)
Amino)sulfonyl)phenyl)-4-(2-Oxo-1(2h)-
Pyridinyl)benzamide
pdb|3CS7|A Chain A, Factor Xa In Complex With The Inhibitor
1-(4-Methoxyphenyl)-
6-(4-(1-(Pyrrolidin-1-Ylmethyl)cyclopropyl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|2W26|A Chain A, Factor Xa In Complex With Bay59-7939
pdb|2W3I|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-disubstituted
Pyrrolidine-1,2-dicarboxamide Inhibitor 2
pdb|2W3K|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-Disubstituted
Pyrrolidine-1,2-Dicarboxamide Inhibitor 1
pdb|3FFG|A Chain A, Factor Xa In Complex With The Inhibitor (R)-6-(2'-((3-
Hydroxypyrrolidin-1-Yl)methyl)biphenyl-4-Yl)-1-(3-(5-
Oxo-4, 5-Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|3KQB|A Chain A, Factor Xa In Complex With The Inhibitor N-(3-Fluoro-2'-
(Methylsulfonyl)biphenyl-4-Yl)-1-(3-(5-Oxo-4,
5-Dihydro-1h-
Triazol-3-Yl)phenyl)-3-(Trifluoromethyl)-1h-
Pyrazole-5-Car
pdb|3KQC|A Chain A, Factor Xa In Complex With The Inhibitor 6-(2'-
(Methylsulfon Biphenyl-4-Yl)-1-(3-(5-Oxo-4,5-Dihydro-1h-
1,2,4-Triazol-3- Phenyl)-3-(Trifluoromethyl)-5,6-
Dihydro-1h-Pyrazolo[3,4-C] 7(4h)-One
pdb|3KQD|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-(5-Oxo-4,5-
Dih 2,4-Triazol-3-Yl)phenyl)-6-(2'-(Pyrrolidin-1-
Ylmethyl)biph Yl)-3-(Trifluoromethyl)-5,6-Dihydro-
1h-Pyrazolo[3,4-C]pyri One
pdb|3KQE|A Chain A, Factor Xa In Complex With The Inhibitor 3-Methyl-1-(3-(5-
Ox Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-6-(2'-
(Pyrrolidin-1- Biphenyl-4-Yl)-5,6-Dihydro-1h-
Pyrazolo[3,4-C]pyridin-7(4h)
pdb|3LIW|A Chain A, Factor Xa In Complex With
(R)-2-(1-Adamantylcarbamoylamino)-
3-(3-Carbamidoyl-Phenyl)-N-Phenethyl-Propionic Acid
Amide
pdb|3M36|A Chain A, Factor Xa In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3M37|A Chain A, Factor Xa In Complex With The Inhibitor 1-[2-(Aminomethyl)
Phenyl]-N-(3-Fluoro-2'-Sulfamoylbiphenyl-4-Yl)-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc602)
Length = 234
Score = 97.4 bits (241), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 47/113 (41%), Positives = 68/113 (60%), Gaps = 1/113 (0%)
Query: 144 FSNKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEK 203
+ KTGIV+G+G + G S L +EVP + CK ++ IT NM CAGY ++
Sbjct: 120 MTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSS-SFIITQNMFCAGYDTKQE 178
Query: 204 DSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNN 256
D+CQGDSGGP + + + G+VSWGEGCA++ G+Y +V +L WI +
Sbjct: 179 DACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRS 231
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 87 IVGGQVTYVHQYPWMALLMYKK-RFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFS 145
IVGGQ + PW ALL+ ++ +CG T+++ Y+LTAAHC++Q V + ++
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTE 60
Query: 146 NKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKT 183
Q++GG + + EVEV I N K+T
Sbjct: 61 -----------QEEGG---EAVHEVEVVIKHNRFTKET 84
>pdb|1MQ5|A Chain A, Crystal Structure Of
3-chloro-n-[4-chloro-2-[[(4-chlorophenyl)
Amino]carbonyl]phenyl]-4-[(4-methyl-1-
piperazinyl)methyl]-2- Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1MQ6|A Chain A, Crystal Structure Of
3-Chloro-N-[4-Chloro-2-[[(5-Chloro-2-Pyridinyl)
Amino]carbonyl]-6-Methoxyphenyl]-4-[[(4,
5-Dihydro-2-Oxazolyl)
Methylamino]methyl]-2-Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1V3X|A Chain A, Factor Xa In Complex With The Inhibitor
1-[6-Methyl-4,5,6,7-
Tetrahydrothiazolo(5,4-C)pyridin-2-Yl] Carbonyl-2-
Carbamoyl-4-(6-Chloronaphth-2-Ylsulphonyl)piperazine
pdb|1WU1|A Chain A, Factor Xa In Complex With The Inhibitor
4-[(5-Chloroindol-2-Yl)
Sulfonyl]-2-(2-Methylpropyl)-1-[[5-(Pyridin-4-Yl)
Pyrimidin-2- Yl]carbonyl]piperazine
pdb|2D1J|A Chain A, Factor Xa In Complex With The Inhibitor 2-[[4-[(5-
Chloroindol-2-Yl)sulfonyl]piperazin-1-Yl]
Carbonyl]thieno[3,2-B]pyridine N-Oxide
pdb|2H9E|H Chain H, Crystal Structure Of FxaSELECTIDENAPC2 TERNARY COMPLEX
pdb|2P3U|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-N-(4-Chloro-2-{[(5-Chloropyridin-2-Yl)
Amino]carbonyl}-6-Methoxyphenyl)-4-[(1-Methyl-1h-
Imidazol- 2-Yl)methyl]thiophene-2-Carboxamide {pfizer
320663}
pdb|2P3T|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-4-(2-Methylamino-Imidazol-1-Ylmethyl)-Thiophene-
2- Carboxylic Acid [4-Chloro-2-(5-Chloro-Pyridin-2-
Ylcarbamoyl)-6-Methoxy-Phenyl]-Amide
pdb|2EI6|A Chain A, Factor Xa In Complex With The Inhibitor (-)-Cis-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI7|A Chain A, Factor Xa In Complex With The Inhibitor Trans-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI8|A Chain A, Factor Xa In Complex With The Inhibitor (1s,2r,4s)-N1-[(5-
Chloroindol-2-Yl)carbonyl]-4-(N,N-Dimethylcarbamoyl)-N2-
[(5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,
4-C]pyridin-2-Yl) Carbonyl]-1,2-Cyclohexanediamine
pdb|3IIT|A Chain A, Factor Xa In Complex With A Cis-1,2-Diaminocyclohexane
Derivative
pdb|3Q3K|A Chain A, Factor Xa In Complex With A Phenylenediamine Derivative
pdb|3TK5|A Chain A, Factor Xa In Complex With D102-4380
pdb|3TK6|A Chain A, Factor Xa In Complex With D46-5241
Length = 233
Score = 97.4 bits (241), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 47/113 (41%), Positives = 68/113 (60%), Gaps = 1/113 (0%)
Query: 144 FSNKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEK 203
+ KTGIV+G+G + G S L +EVP + CK ++ IT NM CAGY ++
Sbjct: 120 MTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSS-SFIITQNMFCAGYDTKQE 178
Query: 204 DSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNN 256
D+CQGDSGGP + + + G+VSWGEGCA++ G+Y +V +L WI +
Sbjct: 179 DACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRS 231
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 87 IVGGQVTYVHQYPWMALLMYKK-RFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFS 145
IVGGQ + PW ALL+ ++ +CG T+++ Y+LTAAHC++Q V + ++
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTE 60
Query: 146 NKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKT 183
Q++GG + + EVEV I N K+T
Sbjct: 61 -----------QEEGG---EAVHEVEVVIKHNRFTKET 84
>pdb|3ENS|B Chain B, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3ENS|D Chain D, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3HPT|B Chain B, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3HPT|D Chain D, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3K9X|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3K9X|D Chain D, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3SW2|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
6-Chloro-N-((3s)-
2-Oxo-1-(2-Oxo-2-((5s)-8-Oxo-5,6-Dihydro-1h-1,
5-Methanopyrido[1,2-
A][1,5]diazocin-3(2h,4h,
8h)-Yl)ethyl)piperidin-3-Yl)naphthalene-2- Sulfonamide
Length = 238
Score = 97.4 bits (241), Expect = 8e-21, Method: Compositional matrix adjust.
Identities = 47/113 (41%), Positives = 68/113 (60%), Gaps = 1/113 (0%)
Query: 144 FSNKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEK 203
+ KTGIV+G+G + G S L +EVP + CK ++ IT NM CAGY ++
Sbjct: 120 MTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSS-SFIITQNMFCAGYDTKQE 178
Query: 204 DSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNN 256
D+CQGDSGGP + + + G+VSWGEGCA++ G+Y +V +L WI +
Sbjct: 179 DACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRS 231
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 87 IVGGQVTYVHQYPWMALLMYKK-RFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFS 145
IVGGQ + PW ALL+ ++ +CG T+++ Y+LTAAHC++Q V + ++
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTE 60
Query: 146 NKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKT 183
Q++GG + + EVEV I N K+T
Sbjct: 61 -----------QEEGG---EAVHEVEVVIKHNRFTKET 84
>pdb|2Y5F|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5G|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5H|A Chain A, Factor Xa - Cation Inhibitor Complex
Length = 234
Score = 97.4 bits (241), Expect = 8e-21, Method: Compositional matrix adjust.
Identities = 47/113 (41%), Positives = 68/113 (60%), Gaps = 1/113 (0%)
Query: 144 FSNKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEK 203
+ KTGIV+G+G + G S L +EVP + CK ++ IT NM CAGY ++
Sbjct: 120 MTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSS-SFIITQNMFCAGYDTKQE 178
Query: 204 DSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNN 256
D+CQGDSGGP + + + G+VSWGEGCA++ G+Y +V +L WI +
Sbjct: 179 DACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRS 231
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 87 IVGGQVTYVHQYPWMALLMYKK-RFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFS 145
IVGGQ + PW ALL+ ++ +CG T+++ Y+LTAAHC++Q V + ++
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTE 60
Query: 146 NKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKT 183
Q++GG + + EVEV I N K+T
Sbjct: 61 -----------QEEGG---EAVHEVEVVIKHNRFTKET 84
>pdb|2BOK|A Chain A, Factor Xa- Cation
pdb|2JKH|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2VVC|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVC|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVU|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVV|A Chain A, Aminopyrrolidine-Related Triazole Factor Xa Inhibitor
pdb|2VWL|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWN|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWO|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2XBV|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 97.1 bits (240), Expect = 8e-21, Method: Compositional matrix adjust.
Identities = 47/113 (41%), Positives = 68/113 (60%), Gaps = 1/113 (0%)
Query: 144 FSNKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEK 203
+ KTGIV+G+G + G S L +EVP + CK ++ IT NM CAGY ++
Sbjct: 120 MTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSS-SFIITQNMFCAGYDTKQE 178
Query: 204 DSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNN 256
D+CQGDSGGP + + + G+VSWGEGCA++ G+Y +V +L WI +
Sbjct: 179 DACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRS 231
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 87 IVGGQVTYVHQYPWMALLMYKK-RFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFS 145
IVGGQ + PW ALL+ ++ +CG T+++ Y+LTAAHC++Q V + ++
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTE 60
Query: 146 NKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKT 183
Q++GG + + EVEV I N K+T
Sbjct: 61 -----------QEEGG---EAVHEVEVVIKHNRFTKET 84
>pdb|1HCG|A Chain A, Structure Of Human Des(1-45) Factor Xa At 2.2 Angstroms
Resolution
pdb|3KL6|A Chain A, Discovery Of Tetrahydropyrimidin-2(1h)-One Derivative
Tak-44 Potent, Selective And Orally Active Factor Xa
Inhibitor
pdb|2XBW|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBX|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBY|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC0|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC4|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC5|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 97.1 bits (240), Expect = 8e-21, Method: Compositional matrix adjust.
Identities = 47/113 (41%), Positives = 68/113 (60%), Gaps = 1/113 (0%)
Query: 144 FSNKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEK 203
+ KTGIV+G+G + G S L +EVP + CK ++ IT NM CAGY ++
Sbjct: 120 MTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSS-SFIITQNMFCAGYDTKQE 178
Query: 204 DSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNN 256
D+CQGDSGGP + + + G+VSWGEGCA++ G+Y +V +L WI +
Sbjct: 179 DACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRS 231
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 87 IVGGQVTYVHQYPWMALLMYKK-RFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFS 145
IVGGQ + PW ALL+ ++ +CG T+++ Y+LTAAHC++Q V + ++
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTE 60
Query: 146 NKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKT 183
Q++GG + + EVEV I N K+T
Sbjct: 61 -----------QEEGG---EAVHEVEVVIKHNRFTKET 84
>pdb|1OSS|A Chain A, T190p Streptomyces Griseus Trypsin In Complex With
Benzamidine
Length = 223
Score = 97.1 bits (240), Expect = 9e-21, Method: Compositional matrix adjust.
Identities = 72/223 (32%), Positives = 98/223 (43%), Gaps = 59/223 (26%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCV----------------- 129
+VGG ++P+M L CG L VLTAAHCV
Sbjct: 1 VVGGTRAAQGEFPFMVRL----SMGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 130 -------------------HQGLGI-WVTIR--------------GKSFSNKTGIVTGWG 155
+ G G W I+ +++ T V GWG
Sbjct: 57 LQSSSAVKVRSTKVLQAPGYNGTGKDWALIKLAQPINQPTLKIATTTAYNQGTFTVAGWG 116
Query: 156 VQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPN-MLCAGYPK-GEKDSCQGDSGGP 213
++GGS LL+ VP +S+A C ++AY N + N +CAGYP G D CQGDSGGP
Sbjct: 117 ANREGGSQQRYLLKANVPFVSDAAC-RSAYGNELVANEEICAGYPDTGGVDPCQGDSGGP 175
Query: 214 LHYANETVHHI-VGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
+ + I VG+VSWG GCA+ YPGVY V+ + + I +
Sbjct: 176 MFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIAS 218
>pdb|3BN9|B Chain B, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3BN9|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3NCL|A Chain A, Crystal Structure Of Mt-Sp1 Bound To Benzamidine
Phosphonate Inhibitor
pdb|3NPS|A Chain A, Crystal Structure Of Membrane-Type Serine Protease 1
(Mt-Sp1) In Complex With The Fab Inhibitor S4
pdb|3SO3|A Chain A, Structures Of Fab-Protease Complexes Reveal A Highly
Specific Non- Canonical Mechanism Of Inhibition
Length = 241
Score = 97.1 bits (240), Expect = 9e-21, Method: Compositional matrix adjust.
Identities = 54/145 (37%), Positives = 76/145 (52%), Gaps = 16/145 (11%)
Query: 114 ATLINNLYVLTAAHCVHQGLGIWVTIRGKSFSNKTGIVTGWGVQKQGGSTSDTLLEVEVP 173
++++ + + A+H G IWVT GWG + GG+ + L + E+
Sbjct: 110 SSMVRPISLPDASHVFPAGKAIWVT--------------GWGHTQYGGTGALILQKGEIR 155
Query: 174 ILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSGGPLHYANETVHHI-VGVVSWGE 232
+++ C+ +ITP M+C G+ G DSCQGDSGGPL GVVSWG+
Sbjct: 156 VINQTTCENL-LPQQITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGD 214
Query: 233 GCAQENYPGVYARVNRYLTWIKNNT 257
GCAQ N PGVY R+ + WIK NT
Sbjct: 215 GCAQRNKPGVYTRLPLFRDWIKENT 239
Score = 32.3 bits (72), Expect = 0.26, Method: Compositional matrix adjust.
Identities = 21/74 (28%), Positives = 38/74 (51%), Gaps = 8/74 (10%)
Query: 87 IVGGQVTYVHQYPW-MALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFS 145
+VGG ++PW ++L + CGA+LI+ ++++AAHC ++ RG +S
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHC-------YIDDRGFRYS 53
Query: 146 NKTGIVTGWGVQKQ 159
+ T G+ Q
Sbjct: 54 DPTQWTAFLGLHDQ 67
>pdb|2BQ6|B Chain B, Crystal Structure Of Factor Xa In Complex With 21
pdb|2BQ7|B Chain B, Crystal Structure Of Factor Xa In Complex With 43
pdb|2BQW|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound 45
Length = 249
Score = 97.1 bits (240), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 47/113 (41%), Positives = 68/113 (60%), Gaps = 1/113 (0%)
Query: 144 FSNKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEK 203
+ KTGIV+G+G + G S L +EVP + CK ++ IT NM CAGY ++
Sbjct: 135 MTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSS-SFIITQNMFCAGYDTKQE 193
Query: 204 DSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNN 256
D+CQGDSGGP + + + G+VSWGEGCA++ G+Y +V +L WI +
Sbjct: 194 DACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRS 246
Score = 54.3 bits (129), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 36/103 (34%), Positives = 55/103 (53%), Gaps = 15/103 (14%)
Query: 82 NKKTRIVGGQVTYVHQYPWMALLMYKK-RFYCGATLINNLYVLTAAHCVHQGLGIWVTIR 140
N TRIVGGQ + PW ALL+ ++ +CG T+++ Y+LTAAHC++Q V +
Sbjct: 11 NNLTRIVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG 70
Query: 141 GKSFSNKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKT 183
++ Q++GG + + EVEV I N K+T
Sbjct: 71 DRNTE-----------QEEGG---EAVHEVEVVIKHNRFTKET 99
>pdb|3TGJ|E Chain E, S195a Trypsinogen Complexed With Bovine Pancreatic Trypsin
Inhibitor (Bpti)
Length = 233
Score = 96.7 bits (239), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 67/230 (29%), Positives = 104/230 (45%), Gaps = 61/230 (26%)
Query: 81 VNKKTRIVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV--- 137
V+ +IVGG + P+ L F CG +LIN+ +V++AAHC + + +
Sbjct: 5 VDDDDKIVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSRIQVRLGEH 63
Query: 138 ----------------TIRGKSFSNKT--------------------------------- 148
I+ +F KT
Sbjct: 64 NINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPAG 123
Query: 149 --GIVTGWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDS 205
+++GWG G LL+ ++ P+L A+C+ +Y +IT NM+C G+ +G KDS
Sbjct: 124 TQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCE-ASYPGKITDNMVCVGFLEGGKDS 182
Query: 206 CQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
CQGD+GGP+ E + G+VSWG GCA + PGVY +V Y+ WI++
Sbjct: 183 CQGDAGGPVVCNGE----LQGIVSWGYGCALPDNPGVYTKVCNYVDWIQD 228
>pdb|2FMJ|A Chain A, 220-Loop Mutant Of Streptomyces Griseus Trypsin
Length = 222
Score = 96.7 bits (239), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 70/222 (31%), Positives = 98/222 (44%), Gaps = 58/222 (26%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCV----------------- 129
+VGG ++P+M L CG L VLTAAHCV
Sbjct: 1 VVGGTRAAQGEFPFMVRL----SMGCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 130 -------------------HQGLGI-WVTIR--------------GKSFSNKTGIVTGWG 155
+ G G W I+ +++ T V GWG
Sbjct: 57 LQSSSAVKVRSTKVLQAPGYNGTGKDWALIKLAQPINQPTLKIATTTAYNQGTFTVAGWG 116
Query: 156 VQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNM-LCAGYPKGEKDSCQGDSGGPL 214
++GGS LL+ VP +S+A C+ +AY N + N +CAGY G D+CQGDSGGP+
Sbjct: 117 ANREGGSQQRYLLKANVPFVSDAACR-SAYGNELVANEEICAGYDTGGVDTCQGDSGGPM 175
Query: 215 HYANETVHHI-VGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
+ I VG+VSWGEGCA++ GVY V+ + + I +
Sbjct: 176 FRKDNADEWIQVGIVSWGEGCARKGKYGVYTEVSTFASAIAS 217
>pdb|3UIR|A Chain A, Crystal Structure Of The Plasmin-Textilinin-1 Complex
pdb|3UIR|B Chain B, Crystal Structure Of The Plasmin-Textilinin-1 Complex
Length = 247
Score = 96.7 bits (239), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 48/106 (45%), Positives = 67/106 (63%), Gaps = 2/106 (1%)
Query: 150 IVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYEN-RITPNMLCAGYPKGEKDSCQG 208
+TGWG + QG + L E ++P++ N C + + N R+ LCAG+ G DSCQG
Sbjct: 137 FITGWG-ETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQG 195
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGPL + + + GV SWG GCA+ N PGVY RV+R++TWI+
Sbjct: 196 DSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIE 241
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 23/49 (46%), Positives = 32/49 (65%), Gaps = 5/49 (10%)
Query: 86 RIVGGQVTYVHQYPWMALLMYKKRF---YCGATLINNLYVLTAAHCVHQ 131
R+VGG V + H +PW L + RF +CG TLI+ +VLTAAHC+ +
Sbjct: 17 RVVGGCVAHPHSWPWQVSL--RTRFGMHFCGGTLISPEWVLTAAHCLEK 63
>pdb|1BUI|A Chain A, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
pdb|1BUI|B Chain B, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
Length = 250
Score = 96.7 bits (239), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 48/106 (45%), Positives = 67/106 (63%), Gaps = 2/106 (1%)
Query: 150 IVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYEN-RITPNMLCAGYPKGEKDSCQG 208
+TGWG + QG + L E ++P++ N C + + N R+ LCAG+ G DSCQG
Sbjct: 140 FITGWG-ETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQG 198
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGPL + + + GV SWG GCA+ N PGVY RV+R++TWI+
Sbjct: 199 DSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIE 244
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 23/49 (46%), Positives = 32/49 (65%), Gaps = 5/49 (10%)
Query: 86 RIVGGQVTYVHQYPWMALLMYKKRF---YCGATLINNLYVLTAAHCVHQ 131
R+VGG V + H +PW L + RF +CG TLI+ +VLTAAHC+ +
Sbjct: 20 RVVGGCVAHPHSWPWQVSL--RTRFGMHFCGGTLISPEWVLTAAHCLEK 66
>pdb|1EAW|A Chain A, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAW|C Chain C, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAX|A Chain A, Crystal Structure Of Mtsp1 (Matriptase)
pdb|2GV6|A Chain A, Crystal Structure Of Matriptase With Inhibitor Cj-730
pdb|2GV7|A Chain A, Structure Of Matriptase In Complex With Inhibitor Cj-672
Length = 241
Score = 96.7 bits (239), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 54/145 (37%), Positives = 76/145 (52%), Gaps = 16/145 (11%)
Query: 114 ATLINNLYVLTAAHCVHQGLGIWVTIRGKSFSNKTGIVTGWGVQKQGGSTSDTLLEVEVP 173
++++ + + A+H G IWVT GWG + GG+ + L + E+
Sbjct: 110 SSMVRPICLPDASHVFPAGKAIWVT--------------GWGHTQYGGTGALILQKGEIR 155
Query: 174 ILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSGGPLHYANETVHHI-VGVVSWGE 232
+++ C+ +ITP M+C G+ G DSCQGDSGGPL GVVSWG+
Sbjct: 156 VINQTTCENL-LPQQITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGD 214
Query: 233 GCAQENYPGVYARVNRYLTWIKNNT 257
GCAQ N PGVY R+ + WIK NT
Sbjct: 215 GCAQRNKPGVYTRLPLFRDWIKENT 239
Score = 32.3 bits (72), Expect = 0.26, Method: Compositional matrix adjust.
Identities = 21/74 (28%), Positives = 38/74 (51%), Gaps = 8/74 (10%)
Query: 87 IVGGQVTYVHQYPW-MALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFS 145
+VGG ++PW ++L + CGA+LI+ ++++AAHC ++ RG +S
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHC-------YIDDRGFRYS 53
Query: 146 NKTGIVTGWGVQKQ 159
+ T G+ Q
Sbjct: 54 DPTQWTAFLGLHDQ 67
>pdb|1QRZ|A Chain A, Catalytic Domain Of Plasminogen
pdb|1QRZ|B Chain B, Catalytic Domain Of Plasminogen
pdb|1QRZ|C Chain C, Catalytic Domain Of Plasminogen
pdb|1QRZ|D Chain D, Catalytic Domain Of Plasminogen
Length = 246
Score = 96.7 bits (239), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 48/106 (45%), Positives = 67/106 (63%), Gaps = 2/106 (1%)
Query: 150 IVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYEN-RITPNMLCAGYPKGEKDSCQG 208
+TGWG + QG + L E ++P++ N C + + N R+ LCAG+ G DSCQG
Sbjct: 136 FITGWG-ETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQG 194
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGPL + + + GV SWG GCA+ N PGVY RV+R++TWI+
Sbjct: 195 DSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIE 240
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 23/49 (46%), Positives = 32/49 (65%), Gaps = 5/49 (10%)
Query: 86 RIVGGQVTYVHQYPWMALLMYKKRF---YCGATLINNLYVLTAAHCVHQ 131
R+VGG V + H +PW L + RF +CG TLI+ +VLTAAHC+ +
Sbjct: 16 RVVGGCVAHPHSWPWQVSL--RTRFGQHFCGGTLISPEWVLTAAHCLEK 62
>pdb|1F7Z|A Chain A, Rat Trypsinogen K15a Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 233
Score = 96.7 bits (239), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 68/230 (29%), Positives = 103/230 (44%), Gaps = 61/230 (26%)
Query: 81 VNKKTRIVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV--- 137
V+ IVGG + P+ L F CG +LIN+ +V++AAHC + + +
Sbjct: 5 VDDDDAIVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSRIQVRLGEH 63
Query: 138 ----------------TIRGKSFSNKT--------------------------------- 148
I+ +F KT
Sbjct: 64 NINVLEGNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPAG 123
Query: 149 --GIVTGWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDS 205
+++GWG G LL+ ++ P+L A+C+ +Y +IT NM+C G+ +G KDS
Sbjct: 124 TQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCE-ASYPGKITDNMVCVGFLEGGKDS 182
Query: 206 CQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
CQGDSGGP+ E + G+VSWG GCA + PGVY +V Y+ WI++
Sbjct: 183 CQGDSGGPVVCNGE----LQGIVSWGYGCALPDNPGVYTKVCNYVDWIQD 228
>pdb|1H9H|E Chain E, Complex Of Eeti-Ii With Porcine Trypsin
Length = 231
Score = 96.7 bits (239), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 75/229 (32%), Positives = 109/229 (47%), Gaps = 65/229 (28%)
Query: 87 IVGG-QVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQG-----LG---IWV 137
IVGG + + P+ L F G +LIN+ +V++AAHC ++ LG I V
Sbjct: 1 IVGGYTCSAANSIPYQVSLNSGSHFCSGGSLINSQWVVSAAHCSYKSRIQVRLGEHNIDV 60
Query: 138 TIRGKSFSNKTGIVT--------------------------------------------- 152
+ F N I+T
Sbjct: 61 LEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECS 120
Query: 153 ---GWGVQKQGGSTSDTLLE--VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSC- 206
GWG K GS+ +LL+ ++ P+LS++ C K++Y +IT NM+C G+ +G KDSC
Sbjct: 121 LISGWGNTKSSGSSYPSLLQCSLKAPVLSDSSC-KSSYPGQITGNMICVGFLEGGKDSCS 179
Query: 207 QGDSGGPLHYANETVHHIVGVVSWGEGC-AQENYPGVYARVNRYLTWIK 254
QGDSGGP+ +N + G+VSWG GC AQ+N PGVY +V Y+ WI+
Sbjct: 180 QGDSGGPVVCSNGQLQ---GIVSWGYGCSAQKNKPGVYTKVCNYVNWIQ 225
>pdb|3P8G|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Benzamidine
pdb|3P8F|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Sfti-1
Length = 241
Score = 96.3 bits (238), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 54/145 (37%), Positives = 75/145 (51%), Gaps = 16/145 (11%)
Query: 114 ATLINNLYVLTAAHCVHQGLGIWVTIRGKSFSNKTGIVTGWGVQKQGGSTSDTLLEVEVP 173
++++ + + A+H G IWVT GWG + GG+ + L + E+
Sbjct: 110 SSMVRPICLPDASHVFPAGKAIWVT--------------GWGHTQYGGTGALILQKGEIR 155
Query: 174 ILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSGGPLHYANETVHHI-VGVVSWGE 232
++ C+ +ITP M+C G+ G DSCQGDSGGPL GVVSWG+
Sbjct: 156 VIQQTTCENL-LPQQITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGD 214
Query: 233 GCAQENYPGVYARVNRYLTWIKNNT 257
GCAQ N PGVY R+ + WIK NT
Sbjct: 215 GCAQRNKPGVYTRLPLFRDWIKENT 239
Score = 32.3 bits (72), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 21/74 (28%), Positives = 38/74 (51%), Gaps = 8/74 (10%)
Query: 87 IVGGQVTYVHQYPW-MALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFS 145
+VGG ++PW ++L + CGA+LI+ ++++AAHC ++ RG +S
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHC-------YIDDRGFRYS 53
Query: 146 NKTGIVTGWGVQKQ 159
+ T G+ Q
Sbjct: 54 DPTQWTAFLGLHDQ 67
>pdb|2GD4|H Chain H, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
pdb|2GD4|B Chain B, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
Length = 241
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 46/113 (40%), Positives = 68/113 (60%), Gaps = 1/113 (0%)
Query: 144 FSNKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEK 203
+ KTGIV+G+G + G S L +EVP + CK ++ IT NM CAGY ++
Sbjct: 120 MTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSS-SFIITQNMFCAGYDTKQE 178
Query: 204 DSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNN 256
D+CQGD+GGP + + + G+VSWGEGCA++ G+Y +V +L WI +
Sbjct: 179 DACQGDAGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRS 231
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 87 IVGGQVTYVHQYPWMALLMYKK-RFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFS 145
IVGGQ + PW ALL+ ++ +CG T+++ Y+LTAAHC++Q V + ++
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTE 60
Query: 146 NKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKT 183
Q++GG + + EVEV I N K+T
Sbjct: 61 -----------QEEGG---EAVHEVEVVIKHNRFTKET 84
>pdb|2WPH|S Chain S, Factor Ixa Superactive Triple Mutant
pdb|2WPJ|S Chain S, Factor Ixa Superactive Triple Mutant, Nacl-Soaked
pdb|2WPK|S Chain S, Factor Ixa Superactive Triple Mutant, Ethylene
Glycol-Soaked
pdb|2WPL|S Chain S, Factor Ixa Superactive Triple Mutant, Edta-Soaked
Length = 235
Score = 95.9 bits (237), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 46/110 (41%), Positives = 67/110 (60%), Gaps = 1/110 (0%)
Query: 148 TGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQ 207
+G V+GWG G ++ L + VP++ A C ++ + IT NM CAG+ +G +DSCQ
Sbjct: 124 SGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRST-KFTITNNMFCAGFHEGGRDSCQ 182
Query: 208 GDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
GDSGGP E + G++SWGE CA + G+Y +V+RY+ WIK T
Sbjct: 183 GDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKT 232
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 20/51 (39%), Positives = 32/51 (62%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV 137
+VGG+ Q+PW +L K +CG +++N +++TAAHCV G+ I V
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITV 51
>pdb|2WPI|S Chain S, Factor Ixa Superactive Double Mutant
Length = 235
Score = 95.9 bits (237), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 46/110 (41%), Positives = 67/110 (60%), Gaps = 1/110 (0%)
Query: 148 TGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQ 207
+G V+GWG G ++ L + VP++ A C ++ + IT NM CAG+ +G +DSCQ
Sbjct: 124 SGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRST-KFTITNNMFCAGFHEGGRDSCQ 182
Query: 208 GDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
GDSGGP E + G++SWGE CA + G+Y +V+RY+ WIK T
Sbjct: 183 GDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKT 232
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 20/51 (39%), Positives = 32/51 (62%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV 137
+VGG+ Q+PW +L K +CG +++N +++TAAHCV G+ I V
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITV 51
>pdb|1HJ9|A Chain A, Atomic Resolution Structures Of Trypsin Provide Insight
Into Structural Radiation Damage
Length = 223
Score = 95.9 bits (237), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 49/106 (46%), Positives = 71/106 (66%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ CK +AY +IT NM CA +G+ DSCQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCK-SAYPGQITSNMFCAYGLEGKGDSCQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GC +N PGVY +V Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGSGCQAKNKPGVYTKVCNYVSWIK 217
>pdb|1DDJ|A Chain A, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|B Chain B, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|C Chain C, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|D Chain D, Crystal Structure Of Human Plasminogen Catalytic Domain
Length = 247
Score = 95.5 bits (236), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 47/106 (44%), Positives = 67/106 (63%), Gaps = 2/106 (1%)
Query: 150 IVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYEN-RITPNMLCAGYPKGEKDSCQG 208
+TGWG + QG + L E ++P++ N C + + N R+ LCAG+ G DSCQG
Sbjct: 137 FITGWG-ETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQG 195
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
D+GGPL + + + GV SWG GCA+ N PGVY RV+R++TWI+
Sbjct: 196 DAGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIE 241
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 23/49 (46%), Positives = 32/49 (65%), Gaps = 5/49 (10%)
Query: 86 RIVGGQVTYVHQYPWMALLMYKKRF---YCGATLINNLYVLTAAHCVHQ 131
R+VGG V + H +PW L + RF +CG TLI+ +VLTAAHC+ +
Sbjct: 17 RVVGGCVAHPHSWPWQVSL--RTRFGMHFCGGTLISPEWVLTAAHCLEK 63
>pdb|1L4Z|A Chain A, X-Ray Crystal Structure Of The Complex Of Microplasminogen
With Alpha Domain Of Streptokinase In The Presence
Cadmium Ions
Length = 248
Score = 95.5 bits (236), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 47/106 (44%), Positives = 67/106 (63%), Gaps = 2/106 (1%)
Query: 150 IVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYEN-RITPNMLCAGYPKGEKDSCQG 208
+TGWG + QG + L E ++P++ N C + + N R+ LCAG+ G DSCQG
Sbjct: 138 FITGWG-ETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQG 196
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
D+GGPL + + + GV SWG GCA+ N PGVY RV+R++TWI+
Sbjct: 197 DAGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIE 242
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 23/49 (46%), Positives = 32/49 (65%), Gaps = 5/49 (10%)
Query: 86 RIVGGQVTYVHQYPWMALLMYKKRF---YCGATLINNLYVLTAAHCVHQ 131
R+VGG V + H +PW L + RF +CG TLI+ +VLTAAHC+ +
Sbjct: 18 RVVGGCVAHPHSWPWQVSL--RTRFGMHFCGGTLISPEWVLTAAHCLEK 64
>pdb|1BML|A Chain A, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
pdb|1BML|B Chain B, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
Length = 250
Score = 95.5 bits (236), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 47/106 (44%), Positives = 67/106 (63%), Gaps = 2/106 (1%)
Query: 150 IVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYEN-RITPNMLCAGYPKGEKDSCQG 208
+TGWG + QG + L E ++P++ N C + + N R+ LCAG+ G DSCQG
Sbjct: 140 FITGWG-ETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQG 198
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
D+GGPL + + + GV SWG GCA+ N PGVY RV+R++TWI+
Sbjct: 199 DAGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIE 244
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 23/49 (46%), Positives = 32/49 (65%), Gaps = 5/49 (10%)
Query: 86 RIVGGQVTYVHQYPWMALLMYKKRF---YCGATLINNLYVLTAAHCVHQ 131
R+VGG V + H +PW L + RF +CG TLI+ +VLTAAHC+ +
Sbjct: 20 RVVGGCVAHPHSWPWQVSL--RTRFGMHFCGGTLISPEWVLTAAHCLEK 66
>pdb|1L4D|A Chain A, Crystal Structure Of Microplasminogen-streptokinase Alpha
Domain Complex
Length = 249
Score = 95.5 bits (236), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 47/106 (44%), Positives = 67/106 (63%), Gaps = 2/106 (1%)
Query: 150 IVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYEN-RITPNMLCAGYPKGEKDSCQG 208
+TGWG + QG + L E ++P++ N C + + N R+ LCAG+ G DSCQG
Sbjct: 139 FITGWG-ETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQG 197
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
D+GGPL + + + GV SWG GCA+ N PGVY RV+R++TWI+
Sbjct: 198 DAGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIE 243
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 23/49 (46%), Positives = 32/49 (65%), Gaps = 5/49 (10%)
Query: 86 RIVGGQVTYVHQYPWMALLMYKKRF---YCGATLINNLYVLTAAHCVHQ 131
R+VGG V + H +PW L + RF +CG TLI+ +VLTAAHC+ +
Sbjct: 19 RVVGGCVAHPHSWPWQVSL--RTRFGMHFCGGTLISPEWVLTAAHCLEK 65
>pdb|1Z8G|A Chain A, Crystal Structure Of The Extracellular Region Of The
Transmembrane Serine Protease Hepsin With Covalently
Bound Preferred Substrate
Length = 372
Score = 95.5 bits (236), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 50/112 (44%), Positives = 62/112 (55%), Gaps = 5/112 (4%)
Query: 147 KTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECK-KTAYENRITPNMLCAGYPKGEKDS 205
K VTGWG + G + L E VPI+SN C Y N+I P M CAGYP+G D+
Sbjct: 244 KICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADFYGNQIKPKMFCAGYPEGGIDA 303
Query: 206 CQGDSGGPLHYANETVH----HIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
CQGDSGGP + + G+VSWG GCA PGVY +V+ + WI
Sbjct: 304 CQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWI 355
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 20/43 (46%), Positives = 28/43 (65%)
Query: 86 RIVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC 128
RIVGG+ T + ++PW L Y CG +L++ +VLTAAHC
Sbjct: 117 RIVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHC 159
>pdb|3T2N|A Chain A, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
pdb|3T2N|B Chain B, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
Length = 372
Score = 95.5 bits (236), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 50/112 (44%), Positives = 62/112 (55%), Gaps = 5/112 (4%)
Query: 147 KTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECK-KTAYENRITPNMLCAGYPKGEKDS 205
K VTGWG + G + L E VPI+SN C Y N+I P M CAGYP+G D+
Sbjct: 244 KICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADFYGNQIKPKMFCAGYPEGGIDA 303
Query: 206 CQGDSGGPLHYANETVH----HIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
CQGDSGGP + + G+VSWG GCA PGVY +V+ + WI
Sbjct: 304 CQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWI 355
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 20/43 (46%), Positives = 28/43 (65%)
Query: 86 RIVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC 128
RIVGG+ T + ++PW L Y CG +L++ +VLTAAHC
Sbjct: 117 RIVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHC 159
>pdb|2WPM|S Chain S, Factor Ixa Superactive Mutant, Egr-Cmk Inhibited
Length = 235
Score = 95.5 bits (236), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 46/110 (41%), Positives = 66/110 (60%), Gaps = 1/110 (0%)
Query: 148 TGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQ 207
+G V+GWG G + L + VP++ A C ++ + IT NM CAG+ +G +DSCQ
Sbjct: 124 SGYVSGWGRVFHKGRAALVLQYLRVPLVDRATCLRST-KFTITNNMFCAGFHEGGRDSCQ 182
Query: 208 GDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
GDSGGP E + G++SWGE CA + G+Y +V+RY+ WIK T
Sbjct: 183 GDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKT 232
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 20/51 (39%), Positives = 32/51 (62%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV 137
+VGG+ Q+PW +L K +CG +++N +++TAAHCV G+ I V
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITV 51
>pdb|3BEU|A Chain A, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
pdb|3BEU|B Chain B, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
Length = 224
Score = 95.1 bits (235), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 44/114 (38%), Positives = 70/114 (61%), Gaps = 1/114 (0%)
Query: 143 SFSNKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
+++ T V GWG ++GGS LL+ VP +S+A C+ ++ + M+CAGY +
Sbjct: 106 AYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSSSSFILVANEMICAGYDTKQ 165
Query: 203 KDSCQGDSGGPLHYANETVHHI-VGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
+D+CQGDSGGP+ + + VG+VSWGEGCA++ GVY V+ + + I +
Sbjct: 166 EDTCQGDSGGPMFRKDNADEWVQVGIVSWGEGCARKGKYGVYTEVSTFASAIAS 219
Score = 30.8 bits (68), Expect = 0.85, Method: Compositional matrix adjust.
Identities = 17/44 (38%), Positives = 21/44 (47%), Gaps = 4/44 (9%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVH 130
+VGG ++P+M L CG L VLTAAHCV
Sbjct: 1 VVGGTRAAQGEFPFMVRL----SMGCGGALYAQDIVLTAAHCVS 40
>pdb|1O5E|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5F|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1P57|B Chain B, Extracellular Domain Of Human Hepsin
Length = 255
Score = 94.7 bits (234), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 50/112 (44%), Positives = 62/112 (55%), Gaps = 5/112 (4%)
Query: 147 KTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKT-AYENRITPNMLCAGYPKGEKDS 205
K VTGWG + G + L E VPI+SN C Y N+I P M CAGYP+G D+
Sbjct: 127 KICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADFYGNQIKPKMFCAGYPEGGIDA 186
Query: 206 CQGDSGGPLHYANETVH----HIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
CQGDSGGP + + G+VSWG GCA PGVY +V+ + WI
Sbjct: 187 CQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWI 238
Score = 43.5 bits (101), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 19/42 (45%), Positives = 27/42 (64%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC 128
IVGG+ T + ++PW L Y CG +L++ +VLTAAHC
Sbjct: 1 IVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHC 42
>pdb|4DUR|A Chain A, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUR|B Chain B, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUU|A Chain A, The X-Ray Crystal Structure Of Full-Length Type I Human
Plasminogen
pdb|4A5T|S Chain S, Structural Basis For The Conformational Modulation
Length = 791
Score = 94.7 bits (234), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 48/106 (45%), Positives = 67/106 (63%), Gaps = 2/106 (1%)
Query: 150 IVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYEN-RITPNMLCAGYPKGEKDSCQG 208
+TGWG + QG + L E ++P++ N C + + N R+ LCAG+ G DSCQG
Sbjct: 681 FITGWG-ETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQG 739
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGPL + + + GV SWG GCA+ N PGVY RV+R++TWI+
Sbjct: 740 DSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIE 785
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 23/50 (46%), Positives = 32/50 (64%), Gaps = 5/50 (10%)
Query: 86 RIVGGQVTYVHQYPWMALLMYKKRF---YCGATLINNLYVLTAAHCVHQG 132
R+VGG V + H +PW L + RF +CG TLI+ +VLTAAHC+ +
Sbjct: 561 RVVGGCVAHPHSWPWQVSL--RTRFGMHFCGGTLISPEWVLTAAHCLEKS 608
>pdb|1AND|A Chain A, Anionic Trypsin Mutant With Arg 96 Replaced By His
Length = 223
Score = 94.7 bits (234), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 102/224 (45%), Gaps = 61/224 (27%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV--------- 137
IVGG + P+ L F CG +LIN+ +V++AAHC + + +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLE 59
Query: 138 ----------TIRGKSFSNKT-----------------------------------GIVT 152
I+ +F +KT +++
Sbjct: 60 GNEQFVNAAKIIKHPNFDHKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLIS 119
Query: 153 GWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSG 211
GWG G LL+ ++ P+L A+C+ + Y +IT NM+C G+ +G KDSCQGDSG
Sbjct: 120 GWGNTLSSGVNEPDLLQCLDAPLLPQADCEAS-YPGKITDNMVCVGFLEGGKDSCQGDSG 178
Query: 212 GPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GP+ E + G+VSWG GCA + PGVY +V Y+ WI++
Sbjct: 179 GPVVCNGE----LQGIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|1YBW|A Chain A, Protease Domain Of Hgfa With No Inhibitor
pdb|1YBW|B Chain B, Protease Domain Of Hgfa With No Inhibitor
pdb|1YC0|A Chain A, Short Form Hgfa With First Kunitz Domain From Hai-1
pdb|2R0K|A Chain A, Protease Domain Of Hgfa With Inhibitor Fab58
Length = 283
Score = 94.4 bits (233), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 45/108 (41%), Positives = 66/108 (61%), Gaps = 2/108 (1%)
Query: 151 VTGWG-VQKQGGSTSDTLLEVEVPILSNAECKK-TAYENRITPNMLCAGYPKGEKDSCQG 208
+ GWG + + S +L E VP++++ +C Y I+PNMLCAGY + D+CQG
Sbjct: 165 IAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEVYGADISPNMLCAGYFDCKSDACQG 224
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNN 256
DSGGPL V ++ G++SWG+GC + + PGVY RV Y+ WI +
Sbjct: 225 DSGGPLACEKNGVAYLYGIISWGDGCGRLHKPGVYTRVANYVDWINDR 272
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 33/108 (30%), Positives = 53/108 (49%), Gaps = 15/108 (13%)
Query: 59 STPPEPVKPVDLEKCGPCTCGAVNKKT-----RIVGGQVTYVHQYPWMALLMYKKRFYCG 113
+T PEP P G CG +KK RI+GG + +PW+A + Y +C
Sbjct: 9 ATLPEPASP------GRQACGRRHKKRTFLRPRIIGGSSSLPGSHPWLAAI-YIGDSFCA 61
Query: 114 ATLINNLYVLTAAHCVHQG--LGIWVTIRGKSFSNKTGIVT-GWGVQK 158
+L++ +V++AAHC + G+ F N+T VT +G++K
Sbjct: 62 GSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQHFFNRTTDVTQTFGIEK 109
>pdb|1PFX|C Chain C, Porcine Factor Ixa
pdb|1X7A|C Chain C, Porcine Factor Ixa Complexed To 1-{3-[amino(Imino)
Methyl]phenyl}-N-[4-(1h-Benzimidazol-1-Yl)-2-
Fluorophenyl]-
3-(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide
Length = 235
Score = 94.4 bits (233), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 46/110 (41%), Positives = 67/110 (60%), Gaps = 1/110 (0%)
Query: 148 TGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQ 207
+G V+GWG G ++ L ++VP++ A C ++ + I NM CAG+ +G KDSCQ
Sbjct: 124 SGYVSGWGRVFNRGRSATILQYLKVPLVDRATCLRST-KFTIYSNMFCAGFHEGGKDSCQ 182
Query: 208 GDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
GDSGGP E + G++SWGE CA + G+Y +V+RY+ WIK T
Sbjct: 183 GDSGGPHVTEVEGTSFLTGIISWGEECAVKGKYGIYTKVSRYVNWIKEKT 232
Score = 48.1 bits (113), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 23/51 (45%), Positives = 32/51 (62%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV 137
IVGG+ Q+PW LL K +CG ++IN +V+TAAHC+ G+ I V
Sbjct: 1 IVGGENAKPGQFPWQVLLNGKIDAFCGGSIINEKWVVTAAHCIEPGVKITV 51
>pdb|2WUB|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUB|C Chain C, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUC|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non- Inhibitory Antibody Fab40.Deltatrp And
Ac-Kqlr-Chloromethylketone
pdb|3K2U|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Inhibitory Antibody Fab40
Length = 257
Score = 94.4 bits (233), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 45/108 (41%), Positives = 66/108 (61%), Gaps = 2/108 (1%)
Query: 151 VTGWG-VQKQGGSTSDTLLEVEVPILSNAECKK-TAYENRITPNMLCAGYPKGEKDSCQG 208
+ GWG + + S +L E VP++++ +C Y I+PNMLCAGY + D+CQG
Sbjct: 130 IAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEVYGADISPNMLCAGYFDCKSDACQG 189
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNN 256
DSGGPL V ++ G++SWG+GC + + PGVY RV Y+ WI +
Sbjct: 190 DSGGPLACEKNGVAYLYGIISWGDGCGRLHKPGVYTRVANYVDWINDR 237
Score = 37.7 bits (86), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 22/75 (29%), Positives = 40/75 (53%), Gaps = 4/75 (5%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQG--LGIWVTIRGKSF 144
I+GG + +PW+A + Y +C +L++ +V++AAHC + G+ F
Sbjct: 1 IIGGSSSLPGSHPWLAAI-YIGDSFCAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQHF 59
Query: 145 SNKTGIVT-GWGVQK 158
N+T VT +G++K
Sbjct: 60 FNRTTDVTQTFGIEK 74
>pdb|2R0L|A Chain A, Short Form Hgfa With Inhibitory Fab75
Length = 248
Score = 94.4 bits (233), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 45/108 (41%), Positives = 66/108 (61%), Gaps = 2/108 (1%)
Query: 151 VTGWG-VQKQGGSTSDTLLEVEVPILSNAECKK-TAYENRITPNMLCAGYPKGEKDSCQG 208
+ GWG + + S +L E VP++++ +C Y I+PNMLCAGY + D+CQG
Sbjct: 130 IAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEVYGADISPNMLCAGYFDCKSDACQG 189
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNN 256
DSGGPL V ++ G++SWG+GC + + PGVY RV Y+ WI +
Sbjct: 190 DSGGPLACEKNGVAYLYGIISWGDGCGRLHKPGVYTRVANYVDWINDR 237
Score = 37.7 bits (86), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 22/75 (29%), Positives = 40/75 (53%), Gaps = 4/75 (5%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQG--LGIWVTIRGKSF 144
I+GG + +PW+A + Y +C +L++ +V++AAHC + G+ F
Sbjct: 1 IIGGSSSLPGSHPWLAAI-YIGDSFCAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQHF 59
Query: 145 SNKTGIVT-GWGVQK 158
N+T VT +G++K
Sbjct: 60 FNRTTDVTQTFGIEK 74
>pdb|2OQ5|A Chain A, Crystal Structure Of Desc1, A New Member Of The Type Ii
Transmembrane Serine Proteinases Family
Length = 232
Score = 94.4 bits (233), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 47/110 (42%), Positives = 68/110 (61%), Gaps = 2/110 (1%)
Query: 150 IVTGWGVQKQGGSTSDTLLEVEVPILSNAECKK-TAYENRITPNMLCAGYPKGEKDSCQG 208
VTG+G K G + + L + +V ++ C + AY + ITP MLCAG +G+ D+CQG
Sbjct: 121 FVTGFGALKNDGYSQNHLRQAQVTLIDATTCNEPQAYNDAITPRMLCAGSLEGKTDACQG 180
Query: 209 DSGGPLHYAN-ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
DSGGPL ++ + ++ G+VSWG+ CA+ N PGVY RV WI + T
Sbjct: 181 DSGGPLVSSDARDIWYLAGIVSWGDECAKPNKPGVYTRVTALRDWITSKT 230
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 19/42 (45%), Positives = 26/42 (61%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC 128
IVGG ++PW A L + CGATLIN ++++AAHC
Sbjct: 1 IVGGTEVEEGEWPWQASLQWDGSHRCGATLINATWLVSAAHC 42
>pdb|1EZS|C Chain C, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZS|D Chain D, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZU|C Chain C, Ecotin Y69f, D70p Bound To D102n Trypsin
pdb|1EZU|D Chain D, Ecotin Y69f, D70p Bound To D102n Trypsin
Length = 223
Score = 94.4 bits (233), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 101/224 (45%), Gaps = 61/224 (27%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV--------- 137
IVGG + P+ L F CG +LIN+ +V++AAHC + + +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLE 59
Query: 138 ----------TIRGKSFSNKT-----------------------------------GIVT 152
I+ +F KT +++
Sbjct: 60 GDEQFVNAAKIIKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLIS 119
Query: 153 GWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSG 211
GWG G LL+ ++ P+L A+C+ +Y +IT NM+C G+ +G KDSCQGDSG
Sbjct: 120 GWGNTLSSGVNEPDLLQCLDAPLLPQADCE-ASYPGKITDNMVCVGFLEGGKDSCQGDSG 178
Query: 212 GPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GP+ E + G+VSWG GCA + PGVY +V Y+ WI++
Sbjct: 179 GPVVCNGE----LQGIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|3TGI|E Chain E, Wild-Type Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
pdb|1ANE|A Chain A, Anionic Trypsin Wild Type
pdb|3FP6|E Chain E, Anionic Trypsin In Complex With Bovine Pancreatic Trypsin
Inhibitor (Bpti) Determined To The 1.49 A Resolution
Limit
Length = 223
Score = 94.4 bits (233), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 101/224 (45%), Gaps = 61/224 (27%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV--------- 137
IVGG + P+ L F CG +LIN+ +V++AAHC + + +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLE 59
Query: 138 ----------TIRGKSFSNKT-----------------------------------GIVT 152
I+ +F KT +++
Sbjct: 60 GNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLIS 119
Query: 153 GWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSG 211
GWG G LL+ ++ P+L A+C+ +Y +IT NM+C G+ +G KDSCQGDSG
Sbjct: 120 GWGNTLSSGVNEPDLLQCLDAPLLPQADCE-ASYPGKITDNMVCVGFLEGGKDSCQGDSG 178
Query: 212 GPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GP+ E + G+VSWG GCA + PGVY +V Y+ WI++
Sbjct: 179 GPVVCNGE----LQGIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|1EPT|C Chain C, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
pdb|1AKS|B Chain B, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
Length = 98
Score = 94.4 bits (233), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 47/95 (49%), Positives = 68/95 (71%), Gaps = 6/95 (6%)
Query: 161 GSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSGGPLHYANE 219
GS+ +LL+ ++ P+LSN+ C K++Y +IT NM+C G+ +G KDSCQGDSGGP+ +
Sbjct: 3 GSSYPSLLQCLKAPVLSNSSC-KSSYPGQITGNMICVGFLQGGKDSCQGDSGGPVVCNGQ 61
Query: 220 TVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
+ G+VSWG GCAQ+N PGVY +V Y+ WI+
Sbjct: 62 ----LQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQ 92
>pdb|1TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|1TRM|B Chain B, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|2TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
Length = 223
Score = 94.0 bits (232), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 101/224 (45%), Gaps = 61/224 (27%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV--------- 137
IVGG + P+ L F CG +LIN+ +V++AAHC + + +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLE 59
Query: 138 ----------TIRGKSFSNKT-----------------------------------GIVT 152
I+ +F KT +++
Sbjct: 60 GNEQFVNAAKIIKHPNFDRKTLNNNIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLIS 119
Query: 153 GWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSG 211
GWG G LL+ ++ P+L A+C+ +Y +IT NM+C G+ +G KDSCQGDSG
Sbjct: 120 GWGNTLSSGVNEPDLLQCLDAPLLPQADCE-ASYPGKITDNMVCVGFLEGGKDSCQGDSG 178
Query: 212 GPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GP+ E + G+VSWG GCA + PGVY +V Y+ WI++
Sbjct: 179 GPVVCNGE----LQGIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|1V2S|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Ssfi.Glu)bt.D1
pdb|1V2T|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(ssfi.glu)bt.b4
Length = 223
Score = 94.0 bits (232), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 53/106 (50%), Positives = 73/106 (68%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ K+A IT NM CAGY +G KDSCQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSS-CKSASSFIITSNMFCAGYLEGGKDSCQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWGEGCAQ+N PGVY +V Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGEGCAQKNKPGVYTKVCNYVSWIK 217
Score = 34.3 bits (77), Expect = 0.063, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|1SLW|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Nickel- Bound
Length = 223
Score = 94.0 bits (232), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 101/224 (45%), Gaps = 61/224 (27%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV--------- 137
IVGG + P+ L F CG +LIN+ +V++AAHC + + +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLE 59
Query: 138 ----------TIRGKSFSNKT-----------------------------------GIVT 152
I+ +F KT +++
Sbjct: 60 GNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATIALPSSCAPAGTQCLIS 119
Query: 153 GWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSG 211
GWG G LL+ ++ P+L A+C+ +Y +IT NM+C G+ +G KDSCQGDSG
Sbjct: 120 GWGHTLSSGVNHPDLLQCLDAPLLPQADCE-ASYPGKITDNMVCVGFLEGGKDSCQGDSG 178
Query: 212 GPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GP+ E + G+VSWG GCA + PGVY +V Y+ WI++
Sbjct: 179 GPVVCNGE----LQGIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|1SLX|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Zinc-Bound
pdb|1SLV|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Copper- Bound
pdb|1SLU|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin
Length = 223
Score = 94.0 bits (232), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 101/224 (45%), Gaps = 61/224 (27%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV--------- 137
IVGG + P+ L F CG +LIN+ +V++AAHC + + +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLE 59
Query: 138 ----------TIRGKSFSNKT-----------------------------------GIVT 152
I+ +F KT +++
Sbjct: 60 GNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLIS 119
Query: 153 GWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSG 211
GWG G LL+ ++ P+L A+C+ + Y +IT NM+C G+ +G KDSCQGDSG
Sbjct: 120 GWGHTLSSGVNHPDLLQCLDAPLLPQADCEAS-YPGKITDNMVCVGFLEGGKDSCQGDSG 178
Query: 212 GPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GP+ E + G+VSWG GCA + PGVY +V Y+ WI++
Sbjct: 179 GPVVCNGE----LQGIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|1RFN|A Chain A, Human Coagulation Factor Ixa In Complex With P-Amino
Benzamidine
pdb|3LC3|A Chain A, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC3|C Chain C, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC5|A Chain A, Selective Benzothiophine Inhibitors Of Factor Ixa
Length = 235
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 45/110 (40%), Positives = 66/110 (60%), Gaps = 1/110 (0%)
Query: 148 TGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQ 207
+G V+GWG G ++ L + VP++ A C ++ + I NM CAG+ +G +DSCQ
Sbjct: 124 SGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRST-KFTIYNNMFCAGFHEGGRDSCQ 182
Query: 208 GDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
GDSGGP E + G++SWGE CA + G+Y +V+RY+ WIK T
Sbjct: 183 GDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKT 232
Score = 45.4 bits (106), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 20/51 (39%), Positives = 32/51 (62%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV 137
+VGG+ Q+PW +L K +CG +++N +++TAAHCV G+ I V
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITV 51
>pdb|1DAN|H Chain H, Complex Of Active Site Inhibited Human Blood Coagulation
Factor Viia With Human Recombinant Soluble Tissue Factor
pdb|1QFK|H Chain H, Structure Of Human Factor Viia And Its Implications For
The Triggering Of Blood Coagulation
pdb|1CVW|H Chain H, Crystal Structure Of Active Site-inhibited Human
Coagulation Factor Viia (des-gla)
pdb|1FAK|H Chain H, Human Tissue Factor Complexed With Coagulation Factor Viia
Inhibited With A Bpti-Mutant
pdb|1DVA|H Chain H, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1DVA|I Chain I, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1JBU|H Chain H, Coagulation Factor Vii Zymogen (Egf2PROTEASE) IN COMPLEX
WITH Inhibitory Exosite Peptide A-183
pdb|1KLI|H Chain H, Cofactor-And Substrate-Assisted Activation Of Factor Viia
pdb|1KLJ|H Chain H, Crystal Structure Of Uninhibited Factor Viia
pdb|1J9C|H Chain H, Crystal Structure Of Tissue Factor-Factor Viia Complex
pdb|1W0Y|H Chain H, Tf7a_3771 Complex
pdb|1YGC|H Chain H, Short Factor Viia With A Small Molecule Inhibitor
pdb|1Z6J|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
Viia/tissue Factor/pyrazinone Inhibitor
pdb|1W2K|H Chain H, Tf7a_4380 Complex
pdb|1WQV|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Propylsulfonamide-D- Thr-Met-P-Aminobenzamidine
pdb|1W7X|H Chain H, Factor7- 413 Complex
pdb|1W8B|H Chain H, Factor7 - 413 Complex
pdb|1WSS|H Chain H, Human Factor Viia-Tissue Factor In Complex With Peprid
Mimetic Inhibitor That Has Two Charge Groups In P2 And
P4
pdb|1WTG|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Biphenylalanine-Gln-P-
Aminobenzamidine
pdb|1WUN|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Trp-Gln-P-Aminobenzamidine
pdb|1WV7|H Chain H, Human Factor Viia-tissue Factor Complexed With
Ethylsulfonamide-d-5-propoxy-trp-gln-p-aminobenzamidine
pdb|2B7D|H Chain H, Factor Viia Inhibitors: Chemical Optimization, Preclinical
Pharmacokinetics, Pharmacodynamics, And Efficacy In A
Baboon Thrombosis Model
pdb|2F9B|H Chain H, Discovery Of Novel Heterocyclic Factor Viia Inhibitors
pdb|2FLB|H Chain H, Discovery Of A Novel Hydroxy Pyrazole Based Factor Ixa
Inhibitor
pdb|2A2Q|H Chain H, Complex Of Active-Site Inhibited Human Coagulation Factor
Viia With Human Soluble Tissue Factor In The Presence Of
Ca2+, Mg2+, Na+, And Zn2+
pdb|2AER|H Chain H, Crystal Structure Of Benzamidine-Factor ViiaSOLUBLE TISSUE
Factor Complex.
pdb|2AEI|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
ViiaTISSUE FACTOR And
2-[[6-[3-(Aminoiminomethyl)phenoxy]-3,
5-Difluro-4-[(1-Methyl-3-
Phenylpropyl)amino]-2-Pyridinyl]oxy]-Benzoic Acid
pdb|2FIR|H Chain H, Crystal Structure Of Dfpr-ViiaSTF
pdb|2C4F|H Chain H, Crystal Structure Of Factor Vii.Stf Complexed With
Pd0297121
pdb|2FLR|H Chain H, Novel 5-azaindole Factor Viia Inhibitors
pdb|2B8O|H Chain H, Crystal Structure Of Glu-gly-arg-chloromethyl
Ketone-factor Viia/soluble Tissue Factor Complex
pdb|2PUQ|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia In Complex With Soluble Tissue Factor
pdb|2EC9|H Chain H, Crystal Structure Analysis Of Human Factor Viia , Souluble
Tissue Factor Complexed With Bcx-3607
pdb|2ZP0|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Benzylsulfonamide-D- Ile-Gln-P-Aminobenzamidine
pdb|2ZWL|H Chain H, Human Factor Viia-Tissue Factor Complexed With Highly
Selective Peptide Inhibitor
pdb|2ZZU|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-5-
(3-Carboxybenzyloxy)-Trp-Gln-P-Aminobenzamidine
pdb|3TH2|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH3|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH4|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|1O5D|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|2BZ6|H Chain H, Orally Available Factor7a Inhibitor
pdb|4ISI|H Chain H, Structure Of Factor Viia In Complex With The Inhibitor
(6s)-n-(4-
Carbamimidoylbenzyl)-1-chloro-3-(cyclobutylamino)-8,
8-diethyl-4-oxo-
4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide
Length = 254
Score = 93.2 bits (230), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 48/124 (38%), Positives = 70/124 (56%), Gaps = 10/124 (8%)
Query: 142 KSFSNKT------GIVTGWGVQKQGGSTSDTLLEVEVPILSNAEC----KKTAYENRITP 191
++FS +T +V+GWG G+T+ L+ + VP L +C +K IT
Sbjct: 114 RTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITE 173
Query: 192 NMLCAGYPKGEKDSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLT 251
M CAGY G KDSC+GDSGGP ++ G+VSWG+GCA + GVY RV++Y+
Sbjct: 174 YMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIE 233
Query: 252 WIKN 255
W++
Sbjct: 234 WLQK 237
Score = 43.5 bits (101), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 20/42 (47%), Positives = 27/42 (64%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC 128
IVGG+V + PW LL+ CG TLIN ++V++AAHC
Sbjct: 1 IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHC 42
>pdb|1K9O|E Chain E, Crystal Structure Of Michaelis Serpin-Trypsin Complex
pdb|1YKT|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLC|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLD|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|3FP7|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Cleaved At The
Scissile Bond (Lys15-Ala16) Determined To The 1.46 A
Resolution Limit
pdb|3FP8|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Determined To The
1.46 A Resolution Limit
Length = 223
Score = 93.2 bits (230), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 61/224 (27%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV--------- 137
IVGG + P+ L F CG +LIN+ +V++AAHC + + +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLE 59
Query: 138 ----------TIRGKSFSNKT-----------------------------------GIVT 152
I+ +F KT +++
Sbjct: 60 GNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLIS 119
Query: 153 GWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSG 211
GWG G LL+ ++ P+L A+C+ +Y +IT NM+C G+ +G KDSCQGD+G
Sbjct: 120 GWGNTLSSGVNEPDLLQCLDAPLLPQADCE-ASYPGKITDNMVCVGFLEGGKDSCQGDAG 178
Query: 212 GPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GP+ E + G+VSWG GCA + PGVY +V Y+ WI++
Sbjct: 179 GPVVCNGE----LQGIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|1V2J|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssri)
Bt.C1
pdb|1V2R|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssri)bt.B4
Length = 223
Score = 93.2 bits (230), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 52/106 (49%), Positives = 72/106 (67%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ K+A IT NM CAGY +G KDSCQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSS-CKSASSRIITSNMFCAGYLEGGKDSCQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCAQ+N PGVY +V Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 34.7 bits (78), Expect = 0.058, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|1FIZ|A Chain A, Three Dimensional Structure Of Beta-Acrosin From Boar
Spermatozoa
Length = 263
Score = 92.8 bits (229), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 52/120 (43%), Positives = 70/120 (58%), Gaps = 4/120 (3%)
Query: 141 GKSFSNKTGIVTGWG-VQKQGGSTSDTLLEVEVPILSNAECKKTAYEN-RITPNMLCAGY 198
G + +T VTGWG ++++G TS TL E V ++ C T + N RI +CAGY
Sbjct: 128 GPPRAPQTCWVTGWGYLKEKGPRTSPTLQEARVALIDLELCNSTRWYNGRIRSTNVCAGY 187
Query: 199 PKGEKDSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNN 256
P+G+ D+CQGDSGGPL + E +VG+ SWG GCA+ PGVY YL WI +
Sbjct: 188 PRGKIDTCQGDSGGPLMCRDRAENTFVVVGITSWGVGCARAKRPGVYTSTWPYLNWIASK 247
Score = 37.7 bits (86), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 20/48 (41%), Positives = 29/48 (60%), Gaps = 6/48 (12%)
Query: 87 IVGGQVTYVHQYPWMA---LLMY--KKRFY-CGATLINNLYVLTAAHC 128
+VGG +PWM + MY +R++ CG L+N+ +VLTAAHC
Sbjct: 1 VVGGMSAEPGAWPWMVSLQIFMYHNNRRYHTCGGILLNSHWVLTAAHC 48
>pdb|1V2K|T Chain T, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin Variant X(Triple.Glu)bt.D2
pdb|1V2L|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.D1
pdb|1V2M|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.A1
Length = 223
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 52/106 (49%), Positives = 73/106 (68%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ K+A IT NM CAGY +G KD+CQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSS-CKSASSFIITSNMFCAGYLEGGKDACQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWGEGCAQ+N PGVY +V Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGEGCAQKNKPGVYTKVCNYVSWIK 217
Score = 34.3 bits (77), Expect = 0.063, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|1ANC|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Lys
Length = 223
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 61/224 (27%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV--------- 137
IVGG + P+ L F CG +LIN+ +V++AAHC + + +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLE 59
Query: 138 ----------TIRGKSFSNKT-----------------------------------GIVT 152
I+ +F KT +++
Sbjct: 60 GNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLIS 119
Query: 153 GWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSG 211
GWG G LL+ ++ P+L A+C+ +Y +IT NM+C G+ +G KDSCQGDSG
Sbjct: 120 GWGNTLSSGVNEPDLLQCLDAPLLPQADCE-ASYPGKITDNMVCVGFLEGGKDSCQGDSG 178
Query: 212 GPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GP+ E + G+V WG GCA + PGVY +V Y+ WI++
Sbjct: 179 GPVVCNGE----LQGIVKWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|1ANB|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Glu
Length = 223
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 61/224 (27%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV--------- 137
IVGG + P+ L F CG +LIN+ +V++AAHC + + +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLE 59
Query: 138 ----------TIRGKSFSNKT-----------------------------------GIVT 152
I+ +F KT +++
Sbjct: 60 GNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLIS 119
Query: 153 GWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSG 211
GWG G LL+ ++ P+L A+C+ +Y +IT NM+C G+ +G KDSCQGDSG
Sbjct: 120 GWGNTLSSGVNEPDLLQCLDAPLLPQADCE-ASYPGKITDNMVCVGFLEGGKDSCQGDSG 178
Query: 212 GPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GP+ E + G+V WG GCA + PGVY +V Y+ WI++
Sbjct: 179 GPVVCNGE----LQGIVEWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|1V2U|T Chain T, Benzamidine In Complex With Bovine Trypsin Varinat X(Ssai)
Bt.D1
pdb|1V2V|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssai)
Bt.C1
pdb|1V2W|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssai)bt.B4
Length = 223
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 52/106 (49%), Positives = 72/106 (67%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ K+A IT NM CAGY +G KDSCQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSS-CKSASSAIITSNMFCAGYLEGGKDSCQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCAQ+N PGVY +V Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 34.7 bits (78), Expect = 0.059, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|2TLD|E Chain E, Crystal Structure Of An Engineered Subtilisin Inhibitor
Complexed With Bovine Trypsin
Length = 220
Score = 92.4 bits (228), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 51/106 (48%), Positives = 71/106 (66%), Gaps = 9/106 (8%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ CK +AY +IT NM CAG G DSCQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSSCK-SAYPGQITSNMFCAGLEGG--DSCQG 173
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCA+ N PGVY +V Y++WIK
Sbjct: 174 DSGGPVVCSGK----LQGIVSWGSGCAK-NKPGVYTKVCNYVSWIK 214
>pdb|1DPO|A Chain A, Structure Of Rat Trypsin
Length = 223
Score = 92.4 bits (228), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 61/224 (27%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV--------- 137
IVGG + P+ L F CG +LIN+ +V++AAHC + + +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLE 59
Query: 138 ----------TIRGKSFSNKT-----------------------------------GIVT 152
I+ +F KT +++
Sbjct: 60 GNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLIS 119
Query: 153 GWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSG 211
GWG G LL+ ++ P+L A+C+ + Y +IT NM+C G+ +G KDSCQGD G
Sbjct: 120 GWGNTLSSGVNEPDLLQCLDAPLLPQADCEAS-YPGKITDNMVCVGFLEGGKDSCQGDCG 178
Query: 212 GPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GP+ E + G+VSWG GCA + PGVY +V Y+ WI++
Sbjct: 179 GPVVCNGE----LQGIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|3KCG|H Chain H, Crystal Structure Of The Antithrombin-Factor Ixa-
Pentasaccharide Complex
Length = 235
Score = 92.4 bits (228), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 44/110 (40%), Positives = 66/110 (60%), Gaps = 1/110 (0%)
Query: 148 TGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQ 207
+G V+GWG G ++ L + VP++ A C ++ + I NM CAG+ +G +DSCQ
Sbjct: 124 SGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRST-KFTIYNNMFCAGFHEGGRDSCQ 182
Query: 208 GDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
GD+GGP E + G++SWGE CA + G+Y +V+RY+ WIK T
Sbjct: 183 GDAGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKT 232
Score = 45.4 bits (106), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 20/51 (39%), Positives = 32/51 (62%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV 137
+VGG+ Q+PW +L K +CG +++N +++TAAHCV G+ I V
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITV 51
>pdb|3PWB|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PWC|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PYH|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3Q00|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Comlex
With Small Molecule Inhibitor
Length = 223
Score = 92.4 bits (228), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 51/106 (48%), Positives = 73/106 (68%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ K+A IT NM CAGY +G KD+CQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSS-CKSASSFIITSNMFCAGYLEGGKDACQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWGEGCAQ+N PG+Y +V Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGEGCAQKNKPGIYTKVCNYVSWIK 217
Score = 34.3 bits (77), Expect = 0.062, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|2EEK|A Chain A, Crystal Structure Of Atlantic Cod Trypsin Complexed With
Benzamidine
Length = 220
Score = 92.4 bits (228), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 49/105 (46%), Positives = 67/105 (63%), Gaps = 5/105 (4%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
V+GWG + D L + +PILS+A+C + Y IT +M CAGY +G KDSCQGDS
Sbjct: 118 VSGWGNTMSSVADGDKLQCLSLPILSHADCANS-YPGMITQSMFCAGYLEGGKDSCQGDS 176
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GGP+ N + GVVSWG GCA+ ++PGVYA+V W+++
Sbjct: 177 GGPV-VCNGVLQ---GVVSWGYGCAERDHPGVYAKVCVLSGWVRD 217
>pdb|1FY8|E Chain E, Crystal Structure Of The Deltaile16val17 Rat Anionic
Trypsinogen-Bpti Complex
Length = 231
Score = 92.0 bits (227), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 61/222 (27%)
Query: 89 GGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV----------- 137
GG + P+ L F CG +LIN+ +V++AAHC + + +
Sbjct: 11 GGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGN 69
Query: 138 --------TIRGKSFSNKT-----------------------------------GIVTGW 154
I+ +F KT +++GW
Sbjct: 70 EQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISGW 129
Query: 155 GVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSGGP 213
G G LL+ ++ P+L A+C+ +Y +IT NM+C G+ +G KDSCQGDSGGP
Sbjct: 130 GNTLSSGVNEPDLLQCLDAPLLPQADCE-ASYPGKITDNMVCVGFLEGGKDSCQGDSGGP 188
Query: 214 LHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
+ E + G+VSWG GCA + PGVY +V Y+ WI++
Sbjct: 189 VVCNGE----LQGIVSWGYGCALPDNPGVYTKVCNYVDWIQD 226
>pdb|1UHB|B Chain B, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 98
Score = 92.0 bits (227), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 46/95 (48%), Positives = 68/95 (71%), Gaps = 6/95 (6%)
Query: 161 GSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSGGPLHYANE 219
GS+ +LL+ ++ P+LS++ C K++Y +IT NM+C G+ +G KDSCQGDSGGP+ +
Sbjct: 3 GSSYPSLLQCLKAPVLSDSSC-KSSYPGQITGNMICVGFLEGGKDSCQGDSGGPVVCNGQ 61
Query: 220 TVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
+ G+VSWG GCAQ+N PGVY +V Y+ WI+
Sbjct: 62 ----LQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQ 92
>pdb|1V2O|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.B4
pdb|1V2P|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.A4
Length = 223
Score = 92.0 bits (227), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 52/106 (49%), Positives = 72/106 (67%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ K+A IT NM CAGY +G KDSCQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSS-CKSASSYIITSNMFCAGYLEGGKDSCQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCAQ+N PGVY +V Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 34.3 bits (77), Expect = 0.064, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|1QL9|A Chain A, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99rt
pdb|1J14|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99rt
Length = 223
Score = 92.0 bits (227), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 70/224 (31%), Positives = 100/224 (44%), Gaps = 61/224 (27%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC----VHQGLG---IWVTI 139
IVGG + P+ L F CG +LIN+ +V++AAHC + LG I V
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLE 59
Query: 140 RGKSFSNKTGIV-----------------------------------------------T 152
+ F N I+ +
Sbjct: 60 GNEQFVNAAKIIKHPNFDRETYNNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLIS 119
Query: 153 GWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSG 211
GWG G LL+ ++ P+L A+C+ + Y +IT NM+C G+ +G KDSCQGDSG
Sbjct: 120 GWGNTLSSGVNEPDLLQCLDAPLLPQADCEAS-YPGKITDNMVCVGFLEGGKDSCQGDSG 178
Query: 212 GPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GP+ E + G+VSWG GCA + PGVY +V Y+ WI++
Sbjct: 179 GPVVCNGE----LQGIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|1AMH|A Chain A, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
pdb|1AMH|B Chain B, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
Length = 223
Score = 91.7 bits (226), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 61/224 (27%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV--------- 137
IVGG + P+ L F CG +LIN+ +V++AAHC + + +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLE 59
Query: 138 ----------TIRGKSFSNKT-----------------------------------GIVT 152
I+ +F KT +++
Sbjct: 60 GNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLIS 119
Query: 153 GWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSG 211
GWG G LL+ ++ P+L A+C+ +Y +IT NM+C G+ +G K SCQGDSG
Sbjct: 120 GWGNTLSSGVNEPDLLQCLDAPLLPQADCE-ASYPGKITDNMVCVGFLEGGKSSCQGDSG 178
Query: 212 GPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GP+ E + G+VSWG GCA + PGVY +V Y+ WI++
Sbjct: 179 GPVVCNGE----LQGIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|3ELA|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia Mutant In Complex With Soluble Tissue Factor
Length = 254
Score = 91.7 bits (226), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 48/124 (38%), Positives = 69/124 (55%), Gaps = 10/124 (8%)
Query: 142 KSFSNKT------GIVTGWGVQKQGGSTSDTLLEVEVPILSNAEC----KKTAYENRITP 191
++FS +T +V+GWG G+T+ L + VP L +C +K IT
Sbjct: 114 RTFSERTLAFVRFSLVSGWGQLLDRGATALVLQVLNVPRLMTQDCLQQSRKVGDSPNITE 173
Query: 192 NMLCAGYPKGEKDSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLT 251
M CAGY G KDSC+GDSGGP ++ G+VSWG+GCA + GVY RV++Y+
Sbjct: 174 YMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIE 233
Query: 252 WIKN 255
W++
Sbjct: 234 WLQK 237
Score = 40.8 bits (94), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 19/42 (45%), Positives = 26/42 (61%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC 128
IVGG+ + PW LL+ CG TLIN ++V++AAHC
Sbjct: 1 IVGGKDCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHC 42
>pdb|1F5R|A Chain A, Rat Trypsinogen Mutant Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 231
Score = 91.7 bits (226), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 61/222 (27%)
Query: 89 GGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV----------- 137
GG + P+ L F CG +LIN+ +V++AAHC + + +
Sbjct: 11 GGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGN 69
Query: 138 --------TIRGKSFSNKT-----------------------------------GIVTGW 154
I+ +F KT +++GW
Sbjct: 70 EQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISGW 129
Query: 155 GVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSGGP 213
G G LL+ ++ P+L A+C+ +Y +IT NM+C G+ +G KDSCQGDSGGP
Sbjct: 130 GNTLSSGVNEPDLLKCLDAPLLPQADCE-ASYPGKITDNMVCVGFLEGGKDSCQGDSGGP 188
Query: 214 LHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
+ E + G+VSWG GCA + PGVY +V Y+ WI++
Sbjct: 189 VVCNGE----LQGIVSWGYGCALPDNPGVYTKVCNYVDWIQD 226
>pdb|4B2A|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
pdb|4B2A|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
Length = 223
Score = 91.7 bits (226), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 51/106 (48%), Positives = 73/106 (68%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ K+A IT NM CAGY +G KD+CQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSS-CKSASSFIITSNMFCAGYLEGGKDACQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
D+GGP+ + + + G+VSWGEGCAQ+N PGVY +V Y++WIK
Sbjct: 176 DAGGPVVCSGK----LQGIVSWGEGCAQKNKPGVYTKVCNYVSWIK 217
Score = 34.3 bits (77), Expect = 0.064, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|1H4W|A Chain A, Structure Of Human Trypsin Iv (Brain Trypsin)
Length = 224
Score = 91.7 bits (226), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 48/107 (44%), Positives = 67/107 (62%), Gaps = 6/107 (5%)
Query: 150 IVTGWG-VQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG G D L ++ P+L+ AECK +Y +IT +M C G+ +G KDSCQ
Sbjct: 117 LISGWGNTLSFGADYPDELKCLDAPVLTQAECK-ASYPGKITNSMFCVGFLEGGKDSCQR 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
DSGGP+ + + GVVSWG GCA +N PGVY +V Y+ WIK+
Sbjct: 176 DSGGPVVCNGQ----LQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKD 218
>pdb|1V2Q|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Sswi)bt.B4
Length = 223
Score = 90.9 bits (224), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 52/106 (49%), Positives = 72/106 (67%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ K+A IT NM CAGY +G KDSCQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSS-CKSASSWIITSNMFCAGYLEGGKDSCQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCAQ+N PGVY +V Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 34.3 bits (77), Expect = 0.065, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|1V2N|T Chain T, Potent Factor Xa Inhibitor In Complex With Bovine Trypsin
Variant X(99175190)BT
Length = 223
Score = 90.9 bits (224), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 51/106 (48%), Positives = 72/106 (67%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGSTS-DTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ K+A IT NM CAGY +G KD+CQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSS-CKSASSFIITSNMFCAGYLEGGKDACQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCAQ+N PGVY +V Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 34.3 bits (77), Expect = 0.063, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|2R9P|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|B Chain B, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|C Chain C, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|D Chain D, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|3L33|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L3T|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3P92|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17G)
pdb|3P95|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17D)
Length = 224
Score = 90.5 bits (223), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 47/107 (43%), Positives = 67/107 (62%), Gaps = 6/107 (5%)
Query: 150 IVTGWG-VQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG G D L ++ P+L+ AECK +Y +IT +M C G+ +G KDSCQ
Sbjct: 117 LISGWGNTLSFGADYPDELKCLDAPVLTQAECK-ASYPGKITNSMFCVGFLEGGKDSCQR 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+GGP+ + + GVVSWG GCA +N PGVY +V Y+ WIK+
Sbjct: 176 DAGGPVVCNGQ----LQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKD 218
>pdb|3PLK|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 90.5 bits (223), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 50/106 (47%), Positives = 72/106 (67%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGSTS-DTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ K+A IT NM CAGY +G KD+CQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSS-CKSASSFIITSNMFCAGYLEGGKDACQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCAQ+N PG+Y +V Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGSGCAQKNKPGIYTKVCNYVSWIK 217
Score = 33.5 bits (75), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 17/49 (34%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +L+N+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLLNSQWVVSAAHCYKSGIQV 48
>pdb|4DG4|A Chain A, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|B Chain B, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|D Chain D, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|G Chain G, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
Length = 224
Score = 90.5 bits (223), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 47/107 (43%), Positives = 67/107 (62%), Gaps = 6/107 (5%)
Query: 150 IVTGWG-VQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG G D L ++ P+L+ AECK +Y +IT +M C G+ +G KDSCQ
Sbjct: 117 LISGWGNTLSFGADYPDELKCLDAPVLTQAECK-ASYPGKITNSMFCVGFLEGGKDSCQR 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+GGP+ + + GVVSWG GCA +N PGVY +V Y+ WIK+
Sbjct: 176 DAGGPVVCNGQ----LQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKD 218
>pdb|3PMJ|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLB|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLP|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PM3|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 90.5 bits (223), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 50/106 (47%), Positives = 72/106 (67%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGSTS-DTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ K+A IT NM CAGY +G KD+CQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSS-CKSASSFIITSNMFCAGYLEGGKDACQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCAQ+N PG+Y +V Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGSGCAQKNKPGIYTKVCNYVSWIK 217
Score = 34.3 bits (77), Expect = 0.065, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|3UQV|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 90.5 bits (223), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 51/106 (48%), Positives = 71/106 (66%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGSTS-DTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ K+A IT NM CAGY +G KDSCQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSS-CKSASSFIITSNMFCAGYLEGGKDSCQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCAQ+N PG Y +V Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGSGCAQKNKPGFYTKVCNYVSWIK 217
Score = 34.3 bits (77), Expect = 0.062, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|3TGK|E Chain E, Trypsinogen Mutant D194n And Deletion Of Ile 16-Val 17
Complexed With Bovine Pancreatic Trypsin Inhibitor
(Bpti)
Length = 231
Score = 90.1 bits (222), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 64/222 (28%), Positives = 99/222 (44%), Gaps = 61/222 (27%)
Query: 89 GGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV----------- 137
GG + P+ L F CG +LIN+ +V++AAHC + + +
Sbjct: 11 GGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLEGN 69
Query: 138 --------TIRGKSFSNKT-----------------------------------GIVTGW 154
I+ +F KT +++GW
Sbjct: 70 EQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLISGW 129
Query: 155 GVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSGGP 213
G G LL+ ++ P+L A+C+ +Y +IT NM+C G+ +G KDSCQG+SGGP
Sbjct: 130 GNTLSSGVNEPDLLQCLDAPLLPQADCE-ASYPGKITDNMVCVGFLEGGKDSCQGNSGGP 188
Query: 214 LHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
+ E + G+VSWG GCA + PGVY +V Y+ WI++
Sbjct: 189 VVCNGE----LQGIVSWGYGCALPDNPGVYTKVCNYVDWIQD 226
>pdb|4B2B|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
pdb|4B2B|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
Length = 223
Score = 89.7 bits (221), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 50/106 (47%), Positives = 72/106 (67%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGSTS-DTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ K+A IT NM CAGY +G KD+CQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSS-CKSASSFIITSNMFCAGYLEGGKDACQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
D+GGP+ + + + G+VSWGEGCAQ+N PG Y +V Y++WIK
Sbjct: 176 DAGGPVVCSGK----LQGIVSWGEGCAQKNKPGFYTKVCNYVSWIK 217
Score = 34.3 bits (77), Expect = 0.065, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|2TBS|A Chain A, Cold-Adaption Of Enzymes: Structural Comparison Between
Salmon And Bovine Trypsins
Length = 222
Score = 89.7 bits (221), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 49/103 (47%), Positives = 63/103 (61%), Gaps = 5/103 (4%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
V+GWG + SD L + +PILS ++C + Y IT M CAGY +G KDSCQGDS
Sbjct: 118 VSGWGNTMSSTADSDKLQCLNIPILSYSDCNDS-YPGMITNAMFCAGYLEGGKDSCQGDS 176
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
GGP+ E + GVVSWG GCA+ PGVYA+V + W+
Sbjct: 177 GGPVVCNGE----LQGVVSWGYGCAEPGNPGVYAKVCIFSDWL 215
>pdb|4B1T|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
pdb|4B1T|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
Length = 223
Score = 89.7 bits (221), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 50/106 (47%), Positives = 72/106 (67%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ K+A IT NM CAGY +G KD+CQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSS-CKSASSFIITSNMFCAGYLEGGKDACQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
D+GGP+ + + + G+VSWG GCAQ+N PGVY +V Y++WIK
Sbjct: 176 DAGGPVVCSGK----LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 34.3 bits (77), Expect = 0.066, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|3V0X|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 89.4 bits (220), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 50/106 (47%), Positives = 71/106 (66%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGSTS-DTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ K+A IT NM C GY +G KD+CQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSS-CKSASSFIITSNMFCVGYLEGGKDACQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWGEGCAQ+N PG Y +V Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGEGCAQKNKPGFYTKVCNYVSWIK 217
Score = 34.3 bits (77), Expect = 0.063, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|3UWI|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|B Chain B, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|C Chain C, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|D Chain D, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|E Chain E, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|F Chain F, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|G Chain G, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|H Chain H, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|I Chain I, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|J Chain J, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|K Chain K, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|L Chain L, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|M Chain M, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|N Chain N, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|O Chain O, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|P Chain P, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V12|A Chain A, Bovine Trypsin Variant X(tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V13|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 89.4 bits (220), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 50/106 (47%), Positives = 71/106 (66%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGSTS-DTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ K+A IT NM C GY +G KD+CQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSS-CKSASSFIITSNMFCVGYLEGGKDACQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWGEGCAQ+N PG Y +V Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGEGCAQKNKPGFYTKVCNYVSWIK 217
Score = 34.3 bits (77), Expect = 0.063, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|3UNS|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UOP|A Chain A, Bovine Trypsin Variant X(triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UQO|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 89.4 bits (220), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 50/106 (47%), Positives = 71/106 (66%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGSTS-DTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ K+A IT NM CAGY +G KD+CQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSS-CKSASSFIITSNMFCAGYLEGGKDACQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCAQ+N PG Y +V Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGSGCAQKNKPGFYTKVCNYVSWIK 217
Score = 34.3 bits (77), Expect = 0.063, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|1FIW|A Chain A, Three-Dimensional Structure Of Beta-Acrosin From Ram
Spermatozoa
Length = 290
Score = 89.0 bits (219), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 49/114 (42%), Positives = 65/114 (57%), Gaps = 4/114 (3%)
Query: 147 KTGIVTGWG-VQKQGGSTSDTLLEVEVPILSNAECKKTAYEN-RITPNMLCAGYPKGEKD 204
+T V GWG +Q+ TS L E V ++ C T + N RI +CAGYP+G+ D
Sbjct: 134 QTCWVAGWGFLQENARRTSPMLQEARVDLIDLGLCNSTRWYNGRIRSTNVCAGYPEGKID 193
Query: 205 SCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNN 256
+CQGDSGGPL + E + +VG+ SWG GCA+ PGVY YL WI +
Sbjct: 194 TCQGDSGGPLMCKDSAENSYVVVGITSWGVGCARAKRPGVYTSTWSYLNWIASK 247
Score = 38.5 bits (88), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 19/50 (38%), Positives = 29/50 (58%), Gaps = 6/50 (12%)
Query: 87 IVGGQVTYVHQYPWMALLMY-----KKRFY-CGATLINNLYVLTAAHCVH 130
I+GGQ +PWM L +R++ CG +L+N+ ++LTAAHC
Sbjct: 1 IIGGQDAAHGAWPWMVSLQIFTYHNNRRYHVCGGSLLNSQWLLTAAHCFR 50
>pdb|1BRB|E Chain E, Crystal Structures Of Rat Anionic Trypsin Complexed With
The Protein Inhibitors Appi And Bpti
pdb|1BRC|E Chain E, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
pdb|1BRA|A Chain A, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
Length = 223
Score = 88.6 bits (218), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 65/224 (29%), Positives = 99/224 (44%), Gaps = 61/224 (27%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV--------- 137
IVGG + P+ L F CG +LIN+ +V++AAHC + + +
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLE 59
Query: 138 ----------TIRGKSFSNKT-----------------------------------GIVT 152
I+ +F KT +++
Sbjct: 60 GNEQFVNAAKIIKHPNFDRKTLNNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLIS 119
Query: 153 GWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSG 211
GWG G LL+ ++ P+L A+C+ +Y +IT NM+C G+ +G K SCQGDSG
Sbjct: 120 GWGNTLSSGVNEPDLLQCLDAPLLPQADCE-ASYPGKITDNMVCVGFLEGGKGSCQGDSG 178
Query: 212 GPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GP+ E + G+VSWG GCA + P VY +V Y+ WI++
Sbjct: 179 GPVVCNGE----LQGIVSWGYGCALPDNPDVYTKVCNYVDWIQD 218
>pdb|3UNQ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UPE|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|B Chain B, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 88.2 bits (217), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 49/106 (46%), Positives = 71/106 (66%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGSTS-DTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ K+A IT NM CAGY +G KD+CQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSS-CKSASSFIITSNMFCAGYLEGGKDACQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
DSGGP+ + + + G+VSWG GCAQ+N PG Y ++ Y++WIK
Sbjct: 176 DSGGPVVCSGK----LQGIVSWGSGCAQKNKPGFYTKLCNYVSWIK 217
Score = 34.3 bits (77), Expect = 0.067, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|4B2C|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
pdb|4B2C|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
Length = 223
Score = 88.2 bits (217), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 49/106 (46%), Positives = 71/106 (66%), Gaps = 6/106 (5%)
Query: 150 IVTGWGVQKQGGSTS-DTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+++GWG K G++ D L ++ PILS++ K+A IT NM CAGY +G KD+CQG
Sbjct: 117 LISGWGNTKSSGTSYPDVLKCLKAPILSDSS-CKSASSFIITSNMFCAGYLEGGKDACQG 175
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
D+GGP+ + + + G+VSWG GCAQ+N PG Y +V Y++WIK
Sbjct: 176 DAGGPVVCSGK----LQGIVSWGSGCAQKNKPGFYTKVCNYVSWIK 217
Score = 34.3 bits (77), Expect = 0.065, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 27/49 (55%), Gaps = 1/49 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGI 135
IVGG + P+ L F CG +LIN+ +V++AAHC G+ +
Sbjct: 1 IVGGYTCGANTVPYQVSLNSGYHF-CGGSLINSQWVVSAAHCYKSGIQV 48
>pdb|1UTJ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTK|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTL|M Chain M, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTM|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
Length = 242
Score = 88.2 bits (217), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 48/103 (46%), Positives = 63/103 (61%), Gaps = 5/103 (4%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
V+GWG + S+ L + +PILS ++C + Y IT M CAGY +G KDSCQGDS
Sbjct: 138 VSGWGNTMSSTADSNKLQCLNIPILSYSDCNNS-YPGMITNAMFCAGYLEGGKDSCQGDS 196
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
GGP+ E + GVVSWG GCA+ PGVYA+V + W+
Sbjct: 197 GGPVVCNGE----LQGVVSWGYGCAEPGNPGVYAKVCIFNDWL 235
>pdb|1BIT|A Chain A, The Crystal Structure Of Anionic Salmon Trypsin In A
Second Crystal Form
Length = 237
Score = 88.2 bits (217), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 48/103 (46%), Positives = 63/103 (61%), Gaps = 5/103 (4%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
V+GWG + S+ L + +PILS ++C + Y IT M CAGY +G KDSCQGDS
Sbjct: 133 VSGWGNTMSSTADSNKLQCLNIPILSYSDCNNS-YPGMITNAMFCAGYLEGGKDSCQGDS 191
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
GGP+ E + GVVSWG GCA+ PGVYA+V + W+
Sbjct: 192 GGPVVCNGE----LQGVVSWGYGCAEPGNPGVYAKVCIFNDWL 230
>pdb|2ZPR|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
pdb|2ZPR|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
Length = 222
Score = 87.8 bits (216), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 48/103 (46%), Positives = 62/103 (60%), Gaps = 5/103 (4%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
V+GWG + D L + +PILS ++C + Y IT M CAGY +G KDSCQGDS
Sbjct: 118 VSGWGNTMSSTADGDKLQCLNIPILSYSDCNNS-YPGMITNAMFCAGYLEGGKDSCQGDS 176
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
GGP+ E + GVVSWG GCA+ PGVYA+V + W+
Sbjct: 177 GGPVVCNGE----LQGVVSWGYGCAEPGNPGVYAKVCIFNDWL 215
>pdb|1HJ8|A Chain A, 1.00 Aa Trypsin From Atlantic Salmon
Length = 222
Score = 87.8 bits (216), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 48/103 (46%), Positives = 63/103 (61%), Gaps = 5/103 (4%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
V+GWG + S+ L + +PILS ++C + Y IT M CAGY +G KDSCQGDS
Sbjct: 118 VSGWGNTMSSTADSNKLQCLNIPILSYSDCNNS-YPGMITNAMFCAGYLEGGKDSCQGDS 176
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
GGP+ E + GVVSWG GCA+ PGVYA+V + W+
Sbjct: 177 GGPVVCNGE----LQGVVSWGYGCAEPGNPGVYAKVCIFNDWL 215
>pdb|1BZX|E Chain E, The Crystal Structure Of Anionic Salmon Trypsin In Complex
With Bovine Pancreatic Trypsin Inhibitor
pdb|2STA|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (Cucurbita Maxima Trypsin Inhibitor I)
pdb|2STB|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (cucurbita Pepo Trypsin Inhibitor Ii)
Length = 222
Score = 87.8 bits (216), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 48/103 (46%), Positives = 63/103 (61%), Gaps = 5/103 (4%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
V+GWG + S+ L + +PILS ++C + Y IT M CAGY +G KDSCQGDS
Sbjct: 118 VSGWGNTMSSTADSNKLQCLNIPILSYSDCNNS-YPGMITNAMFCAGYLEGGKDSCQGDS 176
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
GGP+ E + GVVSWG GCA+ PGVYA+V + W+
Sbjct: 177 GGPVVCNGE----LQGVVSWGYGCAEPGNPGVYAKVCIFNDWL 215
>pdb|1L2E|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor
pdb|1LO6|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor At 1.56 A Resolution
Length = 223
Score = 87.4 bits (215), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 70/218 (32%), Positives = 92/218 (42%), Gaps = 62/218 (28%)
Query: 98 YPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV---TIRGKSFSNKTGIVT-- 152
+P+ A L CG LI+ L+VLTAAHC L +++ +R + S + V
Sbjct: 12 HPYQAALYTSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFLGKHNLRQRESSQEQSSVVRA 71
Query: 153 -------------------------------------------------GWGVQKQGGST 163
GWG + G
Sbjct: 72 VIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLERDCSANTTSCHILGWG-KTADGDF 130
Query: 164 SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSGGPLHYANETVHH 223
DT+ + ++S EC+ AY +IT NMLCAG K KDSCQGDSGGPL + H
Sbjct: 131 PDTIQCAYIHLVSREECEH-AYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGD----H 185
Query: 224 IVGVVSWGE-GCAQENYPGVYARVNRYLTWIKNNTIDA 260
+ G+VSWG C + PGVY V RY WI+ TI A
Sbjct: 186 LRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQ-KTIQA 222
>pdb|3GYL|B Chain B, Structure Of Prostasin At 1.3 Angstroms Resolution In
Complex With A Calcium Ion.
pdb|3GYM|A Chain A, Structure Of Prostasin In Complex With Aprotinin
pdb|3GYM|B Chain B, Structure Of Prostasin In Complex With Aprotinin
Length = 261
Score = 87.0 bits (214), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 66/118 (55%), Gaps = 9/118 (7%)
Query: 151 VTGWGVQKQGGS--TSDTLLEVEVPILSNAECK-------KTAYENRITPNMLCAGYPKG 201
VTGWG S T L ++EVP++S C K + + +M+CAGY +G
Sbjct: 126 VTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNSLYNIDAKPEEPHFVQEDMVCAGYVEG 185
Query: 202 EKDSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNTID 259
KD+CQGDSGGPL E + ++ G+VSWG+ C N PGVY + Y +WI++ +
Sbjct: 186 GKDACQGDSGGPLSCPVEGLWYLTGIVSWGDACGARNRPGVYTLASSYASWIQSKVTE 243
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 16/42 (38%), Positives = 24/42 (57%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC 128
I GG Q+PW + Y+ CG +L++ +VL+AAHC
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHC 42
>pdb|3E0P|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With A
Covalent Benzoxazole Inhibitor
pdb|3E16|B Chain B, X-Ray Structure Of Human Prostasin In Complex With
Benzoxazole Warhead Peptidomimic, Lysine In P3
pdb|3E1X|B Chain B, The Crystal Structure Of Apo Prostasin At 1.7 Angstroms
Resolution
pdb|3FVF|B Chain B, The Crystal Structure Of Prostasin Complexed With Camostat
At 1.6 Angstroms Resolution
pdb|3E0N|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With
Dffr- Chloromethyl Ketone Inhibitor
Length = 271
Score = 87.0 bits (214), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 66/118 (55%), Gaps = 9/118 (7%)
Query: 151 VTGWGVQKQGGS--TSDTLLEVEVPILSNAECK-------KTAYENRITPNMLCAGYPKG 201
VTGWG S T L ++EVP++S C K + + +M+CAGY +G
Sbjct: 126 VTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNSLYNIDAKPEEPHFVQEDMVCAGYVEG 185
Query: 202 EKDSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNTID 259
KD+CQGDSGGPL E + ++ G+VSWG+ C N PGVY + Y +WI++ +
Sbjct: 186 GKDACQGDSGGPLSCPVEGLWYLTGIVSWGDACGARNRPGVYTLASSYASWIQSKVTE 243
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 16/42 (38%), Positives = 24/42 (57%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC 128
I GG Q+PW + Y+ CG +L++ +VL+AAHC
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHC 42
>pdb|3DFJ|A Chain A, Crystal Structure Of Human Prostasin
pdb|3DFL|A Chain A, Crystal Structure Of Human Prostasin Complexed To 4-
Guanidinobenzoic Acid
Length = 263
Score = 87.0 bits (214), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 66/118 (55%), Gaps = 9/118 (7%)
Query: 151 VTGWGVQKQGGS--TSDTLLEVEVPILSNAECK-------KTAYENRITPNMLCAGYPKG 201
VTGWG S T L ++EVP++S C K + + +M+CAGY +G
Sbjct: 126 VTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNALYNIDAKPEEPHFVQEDMVCAGYVEG 185
Query: 202 EKDSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNTID 259
KD+CQGDSGGPL E + ++ G+VSWG+ C N PGVY + Y +WI++ +
Sbjct: 186 GKDACQGDSGGPLSCPVEGLWYLTGIVSWGDACGARNRPGVYTLASSYASWIQSKVTE 243
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 16/42 (38%), Positives = 24/42 (57%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC 128
I GG Q+PW + Y+ CG +L++ +VL+AAHC
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHC 42
>pdb|1J15|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J16|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J17|T Chain T, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99175190RT
Length = 223
Score = 86.7 bits (213), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 68/224 (30%), Positives = 99/224 (44%), Gaps = 61/224 (27%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC----VHQGLG---IWVTI 139
IVGG + P+ L F CG +LIN+ +V++AAHC + LG I V
Sbjct: 1 IVGGYTCQENSVPYQVSLNSGYHF-CGGSLINDQWVVSAAHCYKSRIQVRLGEHNINVLE 59
Query: 140 RGKSFSNKTGIV-----------------------------------------------T 152
+ F N I+ +
Sbjct: 60 GNEQFVNAAKIIKHPNFDRETYNNDIMLIKLSSPVKLNARVATVALPSSCAPAGTQCLIS 119
Query: 153 GWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSG 211
GWG G LL+ ++ P+L A+C+ ++ IT NM+C G+ +G KD+CQGDSG
Sbjct: 120 GWGNTLSSGVNEPDLLQCLDAPLLPQADCEASS-SFIITDNMVCVGFLEGGKDACQGDSG 178
Query: 212 GPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GP+ E + G+VSWG GCA + PGVY +V Y+ WI++
Sbjct: 179 GPVVCNGE----LQGIVSWGYGCALPDNPGVYTKVCNYVDWIQD 218
>pdb|4FU7|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU8|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU9|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUB|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUC|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUD|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUE|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUF|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUG|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUH|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUI|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUJ|A Chain A, Crystal Structure Of The Urokinase
pdb|4DVA|U Chain U, The Crystal Structure Of Human Urokinase-type Plasminogen
Activator Catalytic Domain
pdb|4DW2|U Chain U, The Crystal Structure Of Upa In Complex With The Fab
Fragment Of Mab- 112
Length = 246
Score = 86.7 bits (213), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 44/109 (40%), Positives = 70/109 (64%), Gaps = 2/109 (1%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEV-PILSNAECKKTAYE-NRITPNMLCAGYPKGEKDSCQG 208
+TG+G ++ L++ V ++S+ EC++ Y + +T MLCA P+ + DSCQG
Sbjct: 137 ITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 196
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
DSGGPL + + + G+VSWG GCA ++ PGVY RV+ +L WI+++T
Sbjct: 197 DSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 16/48 (33%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKR-----FYCGATLINNLYVLTAAHCV 129
I+GG+ T + PW A + + R + CG +LI+ +V++A HC
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCF 48
>pdb|1OWE|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWH|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQA|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQO|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
Length = 245
Score = 86.7 bits (213), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 44/109 (40%), Positives = 70/109 (64%), Gaps = 2/109 (1%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEV-PILSNAECKKTAYE-NRITPNMLCAGYPKGEKDSCQG 208
+TG+G ++ L++ V ++S+ EC++ Y + +T MLCA P+ + DSCQG
Sbjct: 137 ITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 196
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
DSGGPL + + + G+VSWG GCA ++ PGVY RV+ +L WI+++T
Sbjct: 197 DSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
Score = 37.0 bits (84), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 15/48 (31%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKR-----FYCGATLINNLYVLTAAHCV 129
I+GG+ T + PW A + + R + CG +L++ +V++A HC
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCF 48
>pdb|2ZPS|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 3 From Chum
Salmon
Length = 222
Score = 86.3 bits (212), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 47/103 (45%), Positives = 62/103 (60%), Gaps = 5/103 (4%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
V+GWG + + L + +PILS ++C + Y IT M CAGY +G KDSCQGDS
Sbjct: 118 VSGWGNTMSSTADKNKLQCLNIPILSYSDCNNS-YPGMITNAMFCAGYLEGGKDSCQGDS 176
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
GGP+ E + GVVSWG GCA+ PGVYA+V + W+
Sbjct: 177 GGPVVCNGE----LQGVVSWGYGCAEPGNPGVYAKVCIFNNWL 215
>pdb|2NWN|A Chain A, New Pharmacophore For Serine Protease Inhibition Revealed
By Crystal Structure Of Human Urokinase-Type Plasminogen
Activator Complexed With A Cyclic Peptidyl Inhibitor,
Upain-1
pdb|2O8T|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145Q) IN COMPLEX WITH
Inhibitors
pdb|3KGP|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KHV|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KID|U Chain U, The Crystal Structures Of 2-Aminobenzothiazole-Based
Inhibitors In Complexes With Urokinase-Type Plasminogen
Activator
pdb|3M61|U Chain U, Crystal Structure Of Complex Of Urokinase And A Upain-1
Variant(W3a) In Ph4.6 Condition
pdb|3OX7|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph4.6
pdb|3OY5|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph7.4
pdb|3OY6|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh036 At Ph4.6
pdb|3QN7|A Chain A, Potent And Selective Bicyclic Peptide Inhibitor (Uk18) Of
Human Urokinase-Type Plasminogen Activator(Upa)
Length = 253
Score = 86.3 bits (212), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 44/109 (40%), Positives = 70/109 (64%), Gaps = 2/109 (1%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEV-PILSNAECKKTAYE-NRITPNMLCAGYPKGEKDSCQG 208
+TG+G ++ L++ V ++S+ EC++ Y + +T MLCA P+ + DSCQG
Sbjct: 137 ITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 196
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
DSGGPL + + + G+VSWG GCA ++ PGVY RV+ +L WI+++T
Sbjct: 197 DSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
Score = 38.1 bits (87), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 16/48 (33%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKR-----FYCGATLINNLYVLTAAHCV 129
I+GG+ T + PW A + + R + CG +LI+ +V++A HC
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCF 48
>pdb|1MBQ|A Chain A, Anionic Trypsin From Pacific Chum Salmon
Length = 220
Score = 86.3 bits (212), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 47/103 (45%), Positives = 62/103 (60%), Gaps = 5/103 (4%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
V+GWG + + L + +PILS ++C + Y IT M CAGY +G KDSCQGDS
Sbjct: 118 VSGWGNTMSSTADKNKLQCLNIPILSYSDCNNS-YPGMITNAMFCAGYLEGGKDSCQGDS 176
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
GGP+ E + GVVSWG GCA+ PGVYA+V + W+
Sbjct: 177 GGPVVCNGE----LQGVVSWGYGCAEPGNPGVYAKVCIFNDWL 215
>pdb|2ZPQ|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
pdb|2ZPQ|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
Length = 222
Score = 85.9 bits (211), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 47/103 (45%), Positives = 62/103 (60%), Gaps = 5/103 (4%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
V+GWG + + L + +PILS ++C + Y IT M CAGY +G KDSCQGDS
Sbjct: 118 VSGWGNTMSSTADKNKLQCLNIPILSYSDCNNS-YPGMITNAMFCAGYLEGGKDSCQGDS 176
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
GGP+ E + GVVSWG GCA+ PGVYA+V + W+
Sbjct: 177 GGPVVCNGE----LQGVVSWGYGCAEPGNPGVYAKVCIFNDWL 215
>pdb|1SC8|U Chain U, Urokinase Plasminogen Activator B-Chain-J435 Complex
pdb|1VJ9|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt464 Complex
pdb|1VJA|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt463 Complex
Length = 262
Score = 85.9 bits (211), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 44/109 (40%), Positives = 69/109 (63%), Gaps = 2/109 (1%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEV-PILSNAECKKTAYE-NRITPNMLCAGYPKGEKDSCQG 208
+TG+G + L++ V ++S+ EC++ Y + +T MLCA P+ + DSCQG
Sbjct: 152 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 211
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
DSGGPL + + + G+VSWG GCA ++ PGVY RV+ +L WI+++T
Sbjct: 212 DSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 260
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 17/59 (28%), Positives = 31/59 (52%), Gaps = 5/59 (8%)
Query: 76 CTCGAVNKKTRIVGGQVTYVHQYPWMALLMYKKR-----FYCGATLINNLYVLTAAHCV 129
C + + +I+GG+ T + PW A + + R + CG +LI+ +V++A HC
Sbjct: 5 CGQKTLRPRFKIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCF 63
>pdb|1GI8|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI7|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI9|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
Length = 245
Score = 85.9 bits (211), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 40/87 (45%), Positives = 60/87 (68%), Gaps = 1/87 (1%)
Query: 172 VPILSNAECKKTAYE-NRITPNMLCAGYPKGEKDSCQGDSGGPLHYANETVHHIVGVVSW 230
V ++S+ EC++ Y + +T MLCA P+ + DSCQGDSGGPL + + + G+VSW
Sbjct: 159 VKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSW 218
Query: 231 GEGCAQENYPGVYARVNRYLTWIKNNT 257
G GCA ++ PGVY RV+ +L WI+++T
Sbjct: 219 GRGCALKDKPGVYTRVSHFLPWIRSHT 245
Score = 37.0 bits (84), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 15/48 (31%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKR-----FYCGATLINNLYVLTAAHCV 129
I+GG+ T + PW A + + R + CG +L++ +V++A HC
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCF 48
>pdb|1FV9|A Chain A, Crystal Structure Of Human Microurokinase In Complex With
2- Amino-5-Hydroxy-Benzimidazole
Length = 245
Score = 85.9 bits (211), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 44/109 (40%), Positives = 69/109 (63%), Gaps = 2/109 (1%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEV-PILSNAECKKTAYE-NRITPNMLCAGYPKGEKDSCQG 208
+TG+G + L++ V ++S+ EC++ Y + +T MLCA P+ + DSCQG
Sbjct: 137 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 196
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
DSGGPL + + + G+VSWG GCA ++ PGVY RV+ +L WI+++T
Sbjct: 197 DSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
Score = 37.0 bits (84), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 15/48 (31%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKR-----FYCGATLINNLYVLTAAHCV 129
I+GG+ T + PW A + + R + CG +L++ +V++A HC
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCF 48
>pdb|2VNT|A Chain A, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|B Chain B, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|C Chain C, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|D Chain D, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|E Chain E, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|F Chain F, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
Length = 276
Score = 85.9 bits (211), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 44/109 (40%), Positives = 69/109 (63%), Gaps = 2/109 (1%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEV-PILSNAECKKTAYE-NRITPNMLCAGYPKGEKDSCQG 208
+TG+G + L++ V ++S+ EC++ Y + +T MLCA P+ + DSCQG
Sbjct: 160 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 219
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
DSGGPL + + + G+VSWG GCA ++ PGVY RV+ +L WI+++T
Sbjct: 220 DSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 268
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 23/76 (30%), Positives = 41/76 (53%), Gaps = 12/76 (15%)
Query: 59 STPPEPVKPVDLEKCGPCTCGAVNKKTRIVGGQVTYVHQYPWMALLMYKKR-----FYCG 113
S+PPE +K +CG T + + +I+GG+ T + PW A + + R + CG
Sbjct: 3 SSPPEELK----FQCGQKT---LRPRFKIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCG 55
Query: 114 ATLINNLYVLTAAHCV 129
+L++ +V++A HC
Sbjct: 56 GSLMSPCWVISATHCF 71
>pdb|1W0Z|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W10|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W11|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W12|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W13|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W14|U Chain U, Urokinase Type Plasminogen Activator
pdb|3MHW|U Chain U, The Complex Crystal Structure Of Urokianse And 2-
Aminobenzothiazole
Length = 247
Score = 85.9 bits (211), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 44/109 (40%), Positives = 69/109 (63%), Gaps = 2/109 (1%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEV-PILSNAECKKTAYE-NRITPNMLCAGYPKGEKDSCQG 208
+TG+G + L++ V ++S+ EC++ Y + +T MLCA P+ + DSCQG
Sbjct: 137 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 196
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
DSGGPL + + + G+VSWG GCA ++ PGVY RV+ +L WI+++T
Sbjct: 197 DSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
Score = 38.5 bits (88), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 16/48 (33%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKR-----FYCGATLINNLYVLTAAHCV 129
I+GG+ T + PW A + + R + CG +LI+ +V++A HC
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCF 48
>pdb|3MWI|U Chain U, The Complex Crystal Structure Of Urokianse And
5-Nitro-1h-Indole-2- Amidine
Length = 246
Score = 85.9 bits (211), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 44/109 (40%), Positives = 69/109 (63%), Gaps = 2/109 (1%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEV-PILSNAECKKTAYE-NRITPNMLCAGYPKGEKDSCQG 208
+TG+G + L++ V ++S+ EC++ Y + +T MLCA P+ + DSCQG
Sbjct: 137 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 196
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
DSGGPL + + + G+VSWG GCA ++ PGVY RV+ +L WI+++T
Sbjct: 197 DSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 16/48 (33%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKR-----FYCGATLINNLYVLTAAHCV 129
I+GG+ T + PW A + + R + CG +LI+ +V++A HC
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCF 48
>pdb|1GJ7|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJ8|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJA|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJB|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1O3P|B Chain B, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1C5W|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5X|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Y|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Z|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GJ9|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJD|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJC|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
Length = 253
Score = 85.9 bits (211), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 40/87 (45%), Positives = 60/87 (68%), Gaps = 1/87 (1%)
Query: 172 VPILSNAECKKTAYE-NRITPNMLCAGYPKGEKDSCQGDSGGPLHYANETVHHIVGVVSW 230
V ++S+ EC++ Y + +T MLCA P+ + DSCQGDSGGPL + + + G+VSW
Sbjct: 159 VKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSW 218
Query: 231 GEGCAQENYPGVYARVNRYLTWIKNNT 257
G GCA ++ PGVY RV+ +L WI+++T
Sbjct: 219 GRGCALKDKPGVYTRVSHFLPWIRSHT 245
Score = 37.0 bits (84), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 15/48 (31%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKR-----FYCGATLINNLYVLTAAHCV 129
I+GG+ T + PW A + + R + CG +L++ +V++A HC
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCF 48
>pdb|1EJN|A Chain A, Urokinase Plasminogen Activator B-Chain Inhibitor Complex
pdb|1F5K|U Chain U, Urokinase Plasminogen Activator B-Chain-Benzamidine
Complex
pdb|1F5L|A Chain A, Urokinase Plasminogen Activator B-Chain-Amiloride Complex
pdb|1F92|A Chain A, Urokinase Plasminogen Activator B Chain-Uki-1d Complex
pdb|2R2W|U Chain U, Urokinase Plasminogen Activator B-Chain-Gppe Complex
pdb|2VIN|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIO|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIP|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIQ|A Chain A, Fragment-based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-type
Plasminogen Activator
pdb|2VIV|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIW|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
Length = 253
Score = 85.5 bits (210), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 40/87 (45%), Positives = 60/87 (68%), Gaps = 1/87 (1%)
Query: 172 VPILSNAECKKTAYE-NRITPNMLCAGYPKGEKDSCQGDSGGPLHYANETVHHIVGVVSW 230
V ++S+ EC++ Y + +T MLCA P+ + DSCQGDSGGPL + + + G+VSW
Sbjct: 159 VKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSW 218
Query: 231 GEGCAQENYPGVYARVNRYLTWIKNNT 257
G GCA ++ PGVY RV+ +L WI+++T
Sbjct: 219 GRGCALKDKPGVYTRVSHFLPWIRSHT 245
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 16/48 (33%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKR-----FYCGATLINNLYVLTAAHCV 129
I+GG+ T + PW A + + R + CG +LI+ +V++A HC
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCF 48
>pdb|1OWD|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWI|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWJ|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWK|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQT|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1U6Q|A Chain A, Substituted 2-naphthamadine Inhibitors Of Urokinase
Length = 245
Score = 85.5 bits (210), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 44/109 (40%), Positives = 69/109 (63%), Gaps = 2/109 (1%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEV-PILSNAECKKTAYE-NRITPNMLCAGYPKGEKDSCQG 208
+TG+G + L++ V ++S+ EC++ Y + +T MLCA P+ + DSCQG
Sbjct: 137 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 196
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
DSGGPL + + + G+VSWG GCA ++ PGVY RV+ +L WI+++T
Sbjct: 197 DSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
Score = 37.0 bits (84), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 15/48 (31%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKR-----FYCGATLINNLYVLTAAHCV 129
I+GG+ T + PW A + + R + CG +L++ +V++A HC
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCF 48
>pdb|1LMW|B Chain B, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
pdb|1LMW|D Chain D, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
Length = 253
Score = 85.5 bits (210), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 44/109 (40%), Positives = 69/109 (63%), Gaps = 2/109 (1%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEV-PILSNAECKKTAYE-NRITPNMLCAGYPKGEKDSCQG 208
+TG+G + L++ V ++S+ EC++ Y + +T MLCA P+ + DSCQG
Sbjct: 137 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 196
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
DSGGPL + + + G+VSWG GCA ++ PGVY RV+ +L WI+++T
Sbjct: 197 DSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
Score = 37.0 bits (84), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 15/48 (31%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKR-----FYCGATLINNLYVLTAAHCV 129
I+GG+ T + PW A + + R + CG +L++ +V++A HC
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCF 48
>pdb|3IG6|B Chain B, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
pdb|3IG6|D Chain D, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
Length = 253
Score = 85.5 bits (210), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 44/109 (40%), Positives = 69/109 (63%), Gaps = 2/109 (1%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEV-PILSNAECKKTAYE-NRITPNMLCAGYPKGEKDSCQG 208
+TG+G + L++ V ++S+ EC++ Y + +T MLCA P+ + DSCQG
Sbjct: 137 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 196
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
DSGGPL + + + G+VSWG GCA ++ PGVY RV+ +L WI+++T
Sbjct: 197 DSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 16/48 (33%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKR-----FYCGATLINNLYVLTAAHCV 129
I+GG+ T + PW A + + R + CG +LI+ +V++A HC
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCF 48
>pdb|3F6U|H Chain H, Crystal Structure Of Human Activated Protein C (Apc)
Complexed With Ppack
Length = 240
Score = 85.5 bits (210), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 44/115 (38%), Positives = 68/115 (59%), Gaps = 6/115 (5%)
Query: 150 IVTGWGV----QKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKD 204
+VTGWG +K+ +L +++P++ + EC + N ++ NMLCAG +D
Sbjct: 127 LVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEV-MSNMVSENMLCAGILGDRQD 185
Query: 205 SCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNTID 259
+C+GDSGGP+ + +VG+VSWGEGC + GVY +V+RYL WI + D
Sbjct: 186 ACEGDSGGPMVASFHGTWFLVGLVSWGEGCGLLHNYGVYTKVSRYLDWIHGHIRD 240
Score = 41.6 bits (96), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 20/54 (37%), Positives = 33/54 (61%), Gaps = 1/54 (1%)
Query: 87 IVGGQVTYVHQYPWMALLM-YKKRFYCGATLINNLYVLTAAHCVHQGLGIWVTI 139
++ G++T PW +L+ KK+ CGA LI+ +VLTAAHC+ + + V +
Sbjct: 1 LIDGKMTRRGDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCMDESKKLLVRL 54
>pdb|2O8U|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|2O8W|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|3PB1|E Chain E, Crystal Structure Of A Michaelis Complex Between
Plasminogen Activator Inhibitor-1 And Urokinase-Type
Plasminogen Activator
Length = 253
Score = 85.1 bits (209), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 43/109 (39%), Positives = 70/109 (64%), Gaps = 2/109 (1%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEV-PILSNAECKKTAYE-NRITPNMLCAGYPKGEKDSCQG 208
+TG+G ++ L++ V ++S+ EC++ Y + +T MLCA P+ + DSCQG
Sbjct: 137 ITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 196
Query: 209 DSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
D+GGPL + + + G+VSWG GCA ++ PGVY RV+ +L WI+++T
Sbjct: 197 DAGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 16/48 (33%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKR-----FYCGATLINNLYVLTAAHCV 129
I+GG+ T + PW A + + R + CG +LI+ +V++A HC
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCF 48
>pdb|1AUT|C Chain C, Human Activated Protein C
Length = 250
Score = 85.1 bits (209), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 44/115 (38%), Positives = 68/115 (59%), Gaps = 6/115 (5%)
Query: 150 IVTGWGV----QKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKD 204
+VTGWG +K+ +L +++P++ + EC + N ++ NMLCAG +D
Sbjct: 127 LVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEV-MSNMVSENMLCAGILGDRQD 185
Query: 205 SCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNTID 259
+C+GDSGGP+ + +VG+VSWGEGC + GVY +V+RYL WI + D
Sbjct: 186 ACEGDSGGPMVASFHGTWFLVGLVSWGEGCGLLHNYGVYTKVSRYLDWIHGHIRD 240
Score = 42.0 bits (97), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 20/54 (37%), Positives = 33/54 (61%), Gaps = 1/54 (1%)
Query: 87 IVGGQVTYVHQYPWMALLM-YKKRFYCGATLINNLYVLTAAHCVHQGLGIWVTI 139
++ G++T PW +L+ KK+ CGA LI+ +VLTAAHC+ + + V +
Sbjct: 1 LIDGKMTRRGDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCMDESKKLLVRL 54
>pdb|3BSQ|A Chain A, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|B Chain B, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|C Chain C, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
Length = 227
Score = 84.7 bits (208), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 68/223 (30%), Positives = 95/223 (42%), Gaps = 59/223 (26%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC------VHQG---LGIWV 137
I+ G +PW L+ + +CG L+N +VLTAAHC VH G LG
Sbjct: 1 IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHCKMNEYTVHLGSDTLGDRR 60
Query: 138 TIR---GKSFSN----------------------------------------KTGIVTGW 154
R KSF + T V+GW
Sbjct: 61 AQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCEPPGTTCTVSGW 120
Query: 155 GVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSGGP 213
G T L+ V+V ++S +C K Y++ + +MLCAG P +K++C GDSGGP
Sbjct: 121 GTTTSPDVTFPSDLMCVDVKLISPQDCTK-VYKDLLENSMLCAGIPDSKKNACNGDSGGP 179
Query: 214 LHYANETVHHIVGVVSWGE-GCAQENYPGVYARVNRYLTWIKN 255
L + G+VSWG C Q N PGVY +V ++ WI +
Sbjct: 180 LVCRGT----LQGLVSWGTFPCGQPNDPGVYTQVCKFTKWIND 218
>pdb|2QXG|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXG|B Chain B, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXH|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXI|A Chain A, High Resolution Structure Of Human Kallikrein 7 In Complex
With Suc-Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXJ|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-ala-pro-phe-chloromethylketone And Copper
Length = 224
Score = 84.7 bits (208), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 70/226 (30%), Positives = 98/226 (43%), Gaps = 60/226 (26%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC------VHQG---LGIWV 137
I+ G +PW L+ + +CG L+N +VLTAAHC VH G LG
Sbjct: 1 IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHCKMNEYTVHLGSDTLGDRR 60
Query: 138 TIR---GKSFSN----------------------------------------KTGIVTGW 154
R KSF + T V+GW
Sbjct: 61 AQRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCEPPGTTCTVSGW 120
Query: 155 GVQKQGGST-SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSGGP 213
G T L+ V+V ++S +C K Y++ + +MLCAG P +K++C GDSGGP
Sbjct: 121 GTTTSPDVTFPSDLMCVDVKLISPQDCTK-VYKDLLENSMLCAGIPDSKKNACNGDSGGP 179
Query: 214 LHYANETVHHIVGVVSWGE-GCAQENYPGVYARVNRYLTWIKNNTI 258
L + G+VSWG C Q N PGVY +V ++ WI N+T+
Sbjct: 180 LVCRGT----LQGLVSWGTFPCGQPNDPGVYTQVCKFTKWI-NDTM 220
>pdb|1O5A|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1O5B|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5C|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
Length = 253
Score = 84.7 bits (208), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 39/87 (44%), Positives = 60/87 (68%), Gaps = 1/87 (1%)
Query: 172 VPILSNAECKKTAYE-NRITPNMLCAGYPKGEKDSCQGDSGGPLHYANETVHHIVGVVSW 230
V ++S+ EC++ Y + +T MLCA P+ + D+CQGDSGGPL + + + G+VSW
Sbjct: 159 VKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDACQGDSGGPLVCSLQGRMTLTGIVSW 218
Query: 231 GEGCAQENYPGVYARVNRYLTWIKNNT 257
G GCA ++ PGVY RV+ +L WI+++T
Sbjct: 219 GRGCALKDKPGVYTRVSHFLPWIRSHT 245
Score = 37.0 bits (84), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 15/48 (31%), Positives = 27/48 (56%), Gaps = 5/48 (10%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKR-----FYCGATLINNLYVLTAAHCV 129
I+GG+ T + PW A + + R + CG +L++ +V++A HC
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCF 48
>pdb|1BDA|A Chain A, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
pdb|1BDA|B Chain B, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 84.0 bits (206), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 43/100 (43%), Positives = 59/100 (59%), Gaps = 7/100 (7%)
Query: 164 SDTLLEVEVPILSNAECKKTAYENR-ITPNMLCAGYPKG------EKDSCQGDSGGPLHY 216
S+ L E V + ++ C NR +T NMLCAG + D+CQGDSGGPL
Sbjct: 163 SERLKEAHVRLYPSSRCTSQHLLNRTVTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVC 222
Query: 217 ANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNN 256
N+ +VG++SWG GC Q++ PGVY +V YL WI++N
Sbjct: 223 LNDGRMTLVGIISWGLGCGQKDVPGVYTKVTNYLDWIRDN 262
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 22/64 (34%), Positives = 33/64 (51%), Gaps = 9/64 (14%)
Query: 77 TCGA---VNKKTRIVGGQVTYVHQYPWMALLMYK------KRFYCGATLINNLYVLTAAH 127
TCG + RI GG + +PW A + K +RF CG LI++ ++L+AAH
Sbjct: 1 TCGLRQYSQPQFRIKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAH 60
Query: 128 CVHQ 131
C +
Sbjct: 61 CFQE 64
>pdb|1RTF|B Chain B, Complex Of Benzamidine With The Catalytic Domain Of Human
Two Chain Tissue Plasminogen Activator [(Tc)-T-Pa]
pdb|1A5H|A Chain A, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
pdb|1A5H|B Chain B, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
Length = 252
Score = 84.0 bits (206), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 43/100 (43%), Positives = 59/100 (59%), Gaps = 7/100 (7%)
Query: 164 SDTLLEVEVPILSNAECKKTAYENR-ITPNMLCAGYPKG------EKDSCQGDSGGPLHY 216
S+ L E V + ++ C NR +T NMLCAG + D+CQGDSGGPL
Sbjct: 150 SERLKEAHVRLYPSSRCTSQHLLNRTVTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVC 209
Query: 217 ANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNN 256
N+ +VG++SWG GC Q++ PGVY +V YL WI++N
Sbjct: 210 LNDGRMTLVGIISWGLGCGQKDVPGVYTKVTNYLDWIRDN 249
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 18/51 (35%), Positives = 28/51 (54%), Gaps = 6/51 (11%)
Query: 87 IVGGQVTYVHQYPWMALLMYK------KRFYCGATLINNLYVLTAAHCVHQ 131
I GG + +PW A + K +RF CG LI++ ++L+AAHC +
Sbjct: 1 IKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQE 51
>pdb|3GOV|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-1
pdb|4DJZ|B Chain B, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
pdb|4DJZ|D Chain D, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 251
Score = 83.2 bits (204), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 43/112 (38%), Positives = 70/112 (62%), Gaps = 5/112 (4%)
Query: 150 IVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKT--AYENRITPNMLCAGYPKGEKDSCQ 207
IV+GWG Q +TL+E+E+PI+ ++ C+K + ++T +M+CAG +G KD+C
Sbjct: 137 IVSGWGKQFLQ-RFPETLMEIEIPIVDHSTCQKAYAPLKKKVTRDMICAGEKEGGKDACA 195
Query: 208 GDSGGPLHYANETVH--HIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
GDSGGP+ N ++VG VSWG+ C +++ GVY+ ++ WI+ T
Sbjct: 196 GDSGGPMVTLNRERGQWYLVGTVSWGDDCGKKDRYGVYSYIHHNKDWIQRVT 247
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 17/48 (35%), Positives = 30/48 (62%), Gaps = 1/48 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMY-KKRFYCGATLINNLYVLTAAHCVHQGL 133
I G+ PW+A+L + + +CG +L+ + +++TAAHC+HQ L
Sbjct: 1 IFNGRPAQKGTTPWIAMLSHLNGQPFCGGSLLGSSWIVTAAHCLHQSL 48
>pdb|4IGD|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-1
Length = 406
Score = 82.8 bits (203), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 43/112 (38%), Positives = 70/112 (62%), Gaps = 5/112 (4%)
Query: 150 IVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKT--AYENRITPNMLCAGYPKGEKDSCQ 207
IV+GWG Q +TL+E+E+PI+ ++ C+K + ++T +M+CAG +G KD+C
Sbjct: 292 IVSGWGKQFLQ-RFPETLMEIEIPIVDHSTCQKAYAPLKKKVTRDMICAGEKEGGKDACA 350
Query: 208 GDSGGPLHYANETVH--HIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNT 257
GDSGGP+ N ++VG VSWG+ C +++ GVY+ ++ WI+ T
Sbjct: 351 GDSGGPMVTLNRERGQWYLVGTVSWGDDCGKKDRYGVYSYIHHNKDWIQRVT 402
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 17/49 (34%), Positives = 31/49 (63%), Gaps = 1/49 (2%)
Query: 86 RIVGGQVTYVHQYPWMALLMY-KKRFYCGATLINNLYVLTAAHCVHQGL 133
+I G+ PW+A+L + + +CG +L+ + +++TAAHC+HQ L
Sbjct: 155 QIFNGRPAQKGTTPWIAMLSHLNGQPFCGGSLLGSSWIVTAAHCLHQSL 203
>pdb|1GVL|A Chain A, Human Prokallikrein 6 (Hk6) PROZYME PROPROTEASE M
Proneurosin
Length = 223
Score = 81.6 bits (200), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 53/122 (43%), Positives = 67/122 (54%), Gaps = 8/122 (6%)
Query: 140 RGKSFSNKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYP 199
R S + + GWG + G DT+ + ++S EC+ AY +IT NMLCAG
Sbjct: 109 RDCSAQTTSCHILGWG-KTADGDFPDTIQCAYIHLVSREECEH-AYPGQITQNMLCAGDE 166
Query: 200 KGEKDSCQGDSGGPLHYANETVHHIVGVVSWGE-GCAQENYPGVYARVNRYLTWIKNNTI 258
K KDSCQGDSGGPL + H+ G+VSWG C + PGVY V RY WI+ TI
Sbjct: 167 KYGKDSCQGDSGGPLVCGD----HLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQ-KTI 221
Query: 259 DA 260
A
Sbjct: 222 QA 223
Score = 35.4 bits (80), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 16/40 (40%), Positives = 23/40 (57%)
Query: 98 YPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV 137
+P+ A L CG LI+ L+VLTAAHC L +++
Sbjct: 13 HPYQAALYTSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFL 52
>pdb|4D8N|A Chain A, Human Kallikrein 6 Inhibitors With A
Para-Amidobenzylanmine P1 Group Carry A High Binding
Efficiency
pdb|3VFE|A Chain A, Virtual Screening And X-Ray Crystallography For Human
Kallikrein 6 Inhibitors With An Amidinothiophene P1
Group
Length = 223
Score = 81.3 bits (199), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 53/122 (43%), Positives = 67/122 (54%), Gaps = 8/122 (6%)
Query: 140 RGKSFSNKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYP 199
R S + + GWG + G DT+ + ++S EC+ AY +IT NMLCAG
Sbjct: 108 RDCSAQTTSCHILGWG-KTADGDFPDTIQCAYIHLVSREECEH-AYPGQITQNMLCAGDE 165
Query: 200 KGEKDSCQGDSGGPLHYANETVHHIVGVVSWGE-GCAQENYPGVYARVNRYLTWIKNNTI 258
K KDSCQGDSGGPL + H+ G+VSWG C + PGVY V RY WI+ TI
Sbjct: 166 KYGKDSCQGDSGGPLVCGD----HLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQ-KTI 220
Query: 259 DA 260
A
Sbjct: 221 QA 222
Score = 35.4 bits (80), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 16/40 (40%), Positives = 23/40 (57%)
Query: 98 YPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV 137
+P+ A L CG LI+ L+VLTAAHC L +++
Sbjct: 12 HPYQAALYTSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFL 51
>pdb|1A5I|A Chain A, Catalytic Domain Of Vampire Bat (Desmodus Rotundus) Saliva
Plasminogen Activator In Complex With Egr-Cmk
(Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 80.9 bits (198), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 45/114 (39%), Positives = 67/114 (58%), Gaps = 8/114 (7%)
Query: 151 VTGWGVQKQGGST-SDTLLEVEVPILSNAECK-KTAYENRITPNMLCAGYPK-GE----- 202
++G+G K S+ L E V + ++ C K + +T NMLCAG + GE
Sbjct: 149 LSGYGKHKSSSPFYSEQLKEGHVRLYPSSRCAPKFLFNKTVTNNMLCAGDTRSGEIYPNV 208
Query: 203 KDSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNN 256
D+CQGDSGGPL N+ ++G++SWG GC +++ PGVY +V YL WI++N
Sbjct: 209 HDACQGDSGGPLVCMNDNHMTLLGIISWGVGCGEKDVPGVYTKVTNYLGWIRDN 262
>pdb|2F9N|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
Length = 245
Score = 80.9 bits (198), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 52/115 (45%), Positives = 61/115 (53%), Gaps = 12/115 (10%)
Query: 151 VTGWGV--QKQGGSTSDTLLEVEVPILSNAECKKT----AYENR----ITPNMLCAGYPK 200
VTGWG + L +V+VPI+ N C AY I +MLCAG
Sbjct: 127 VTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDMLCAG--N 184
Query: 201 GEKDSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
++DSCQGDSGGPL GVVSWGEGCAQ N PG+Y RV YL WI +
Sbjct: 185 SQRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHH 239
Score = 43.9 bits (102), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 23/57 (40%), Positives = 33/57 (57%), Gaps = 3/57 (5%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRF---YCGATLINNLYVLTAAHCVHQGLGIWVTIR 140
IVGGQ ++PW L + R+ +CG +LI+ +VLTAAHCV + T+R
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLATLR 57
>pdb|1MZA|A Chain A, Crystal Structure Of Human Pro-Granzyme K
pdb|1MZD|A Chain A, Crystal Structure Of Human Pro-Granzyme K
Length = 240
Score = 80.5 bits (197), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 50/113 (44%), Positives = 64/113 (56%), Gaps = 9/113 (7%)
Query: 151 VTGWGVQKQGG-STSDTLLEVEVPILSNAECKKTAYEN---RITPNMLCAGYPKGEKDSC 206
VTGWG SDTL EV V +LS C +Y N IT +M+CAG KG+KDSC
Sbjct: 127 VTGWGATDPDSLRPSDTLREVTVTVLSRKLCNSQSYYNGDPFITKDMVCAGDAKGQKDSC 186
Query: 207 QGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARV-NRYLTWIKNNTI 258
+GD+GGPL + V H +VS G C PG+Y + +Y TWIK+N +
Sbjct: 187 KGDAGGPL--ICKGVFH--AIVSGGHECGVATKPGIYTLLTKKYQTWIKSNLV 235
>pdb|2CGA|A Chain A, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|2CGA|B Chain B, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|1ACB|E Chain E, Crystal And Molecular Structure Of The Bovine
Alpha-Chymotrypsin-Eglin C Complex At 2.0 Angstroms
Resolution
pdb|1CGI|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1CGJ|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1EX3|A Chain A, Crystal Structure Of Bovine Chymotrypsinogen A
(Tetragonal)
pdb|1GL1|A Chain A, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|B Chain B, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|C Chain C, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL0|E Chain E, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-D2v, An Inhibitor From The Insect Locusta
Migratoria
pdb|1K2I|1 Chain 1, Crystal Structure Of Gamma-Chymotrypsin In Complex With 7-
Hydroxycoumarin
pdb|1P2M|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2M|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OXG|A Chain A, Crystal Structure Of A Complex Formed Between Organic
Solvent Treated Bovine Alpha-Chymotrypsin And Its
Autocatalytically Produced Highly Potent 14-Residue
Peptide At 2.2 Resolution
pdb|1T7C|A Chain A, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T7C|C Chain C, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|A Chain A, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|C Chain C, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|A Chain A, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|C Chain C, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|A Chain A, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|C Chain C, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|A Chain A, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|C Chain C, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1CHG|A Chain A, Chymotrypsinogen,2.5 Angstroms Crystal Structure,
Comparison With Alpha-Chymotrypsin,And Implications For
Zymogen Activation
pdb|1GCD|A Chain A, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2Y6T|A Chain A, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|B Chain B, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|C Chain C, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|D Chain D, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|3T62|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|B Chain B, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|C Chain C, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
Length = 245
Score = 80.5 bits (197), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 52/155 (33%), Positives = 77/155 (49%), Gaps = 8/155 (5%)
Query: 105 MYKKRFYCGATLINNLYVL---TAAHCVHQGLGIWVTIRGKSFS-NKTGIVTGWGVQK-Q 159
++K Y T+ N++ +L TAA + + F+ T + TGWG+ +
Sbjct: 88 VFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRYT 147
Query: 160 GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSGGPLHYANE 219
+T D L + +P+LSN CKK + +I M+CAG SC GDSGGPL
Sbjct: 148 NANTPDRLQQASLPLLSNTNCKK-YWGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKN 204
Query: 220 TVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
+VG+VSWG + PGVYARV + W++
Sbjct: 205 GAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ 239
>pdb|3TVJ|B Chain B, Catalytic Fragment Of Masp-2 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 242
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 50/124 (40%), Positives = 70/124 (56%), Gaps = 11/124 (8%)
Query: 145 SNKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYEN------RITPNMLCAGY 198
++ G +GWG+ Q G + L+ V++PI+ + +C AYE +T NMLCAG
Sbjct: 120 TDDIGTASGWGL-TQRGFLARNLMYVDIPIVDHQKCT-AAYEKPPYPRGSVTANMLCAGL 177
Query: 199 PKGEKDSCQGDSGGPLHYAN-ETVHHIV-GVVSWGE-GCAQENYPGVYARVNRYLTWIKN 255
G KDSC+GDSGG L + + ET V G+VSWG C + GVY +V Y+ WI+N
Sbjct: 178 ESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINYIPWIEN 237
Query: 256 NTID 259
D
Sbjct: 238 IISD 241
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 18/45 (40%), Positives = 25/45 (55%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQ 131
I GGQ +PW L++ GA L +N +VLTAAH V++
Sbjct: 1 IYGGQKAKPGDFPWQVLIL-GGTTAAGALLYDN-WVLTAAHAVYE 43
>pdb|1DLK|B Chain B, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
pdb|1DLK|D Chain D, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
Length = 230
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 52/155 (33%), Positives = 77/155 (49%), Gaps = 8/155 (5%)
Query: 105 MYKKRFYCGATLINNLYVL---TAAHCVHQGLGIWVTIRGKSFS-NKTGIVTGWGVQK-Q 159
++K Y T+ N++ +L TAA + + F+ T + TGWG+ +
Sbjct: 73 VFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRYT 132
Query: 160 GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSGGPLHYANE 219
+T D L + +P+LSN CKK + +I M+CAG SC GDSGGPL
Sbjct: 133 NANTPDRLQQASLPLLSNTNCKK-YWGTKIKDAMICAGASG--VSSCMGDSGGPLVCKKN 189
Query: 220 TVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
+VG+VSWG + PGVYARV + W++
Sbjct: 190 GAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ 224
>pdb|1Q3X|A Chain A, Crystal Structure Of The Catalytic Region Of Human Masp-2
pdb|1Q3X|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-2
Length = 328
Score = 79.7 bits (195), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 47/124 (37%), Positives = 68/124 (54%), Gaps = 11/124 (8%)
Query: 145 SNKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYEN------RITPNMLCAGY 198
++ G +GWG+ Q G + L+ V++PI+ + +C AYE +T NMLCAG
Sbjct: 206 TDDIGTASGWGLT-QRGFLARNLMYVDIPIVDHQKCT-AAYEKPPYPRGSVTANMLCAGL 263
Query: 199 PKGEKDSCQGDSGGPLHYANETVHH--IVGVVSWGE-GCAQENYPGVYARVNRYLTWIKN 255
G KDSC+GDSGG L + + + G+VSWG C + GVY +V Y+ WI+N
Sbjct: 264 ESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINYIPWIEN 323
Query: 256 NTID 259
D
Sbjct: 324 IISD 327
Score = 33.9 bits (76), Expect = 0.091, Method: Compositional matrix adjust.
Identities = 24/63 (38%), Positives = 31/63 (49%), Gaps = 3/63 (4%)
Query: 70 LEKCGP-CTCGAVNKKTRIVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC 128
L C P C A RI GGQ +PW L++ GA L +N +VLTAAH
Sbjct: 69 LPVCEPVCGLSARTTGGRIYGGQKAKPGDFPWQVLIL-GGTTAAGALLYDN-WVLTAAHA 126
Query: 129 VHQ 131
V++
Sbjct: 127 VYE 129
>pdb|1ZJK|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-2
Length = 403
Score = 79.7 bits (195), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 47/124 (37%), Positives = 68/124 (54%), Gaps = 11/124 (8%)
Query: 145 SNKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYEN------RITPNMLCAGY 198
++ G +GWG+ Q G + L+ V++PI+ + +C AYE +T NMLCAG
Sbjct: 281 TDDIGTASGWGLT-QRGFLARNLMYVDIPIVDHQKCT-AAYEKPPYPRGSVTANMLCAGL 338
Query: 199 PKGEKDSCQGDSGGPLHYANETVHH--IVGVVSWGE-GCAQENYPGVYARVNRYLTWIKN 255
G KDSC+GDSGG L + + + G+VSWG C + GVY +V Y+ WI+N
Sbjct: 339 ESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINYIPWIEN 398
Query: 256 NTID 259
D
Sbjct: 399 IISD 402
Score = 31.6 bits (70), Expect = 0.44, Method: Compositional matrix adjust.
Identities = 24/64 (37%), Positives = 33/64 (51%), Gaps = 5/64 (7%)
Query: 70 LEKCGPCTCGAVNKKT--RIVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAH 127
L C P CG + T +I GGQ +PW L++ GA L +N +VLTAAH
Sbjct: 144 LPVCEP-VCGLSARTTGGQIYGGQKAKPGDFPWQVLIL-GGTTAAGALLYDN-WVLTAAH 200
Query: 128 CVHQ 131
V++
Sbjct: 201 AVYE 204
>pdb|2BM2|A Chain A, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|B Chain B, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|C Chain C, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|D Chain D, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2FWW|A Chain A, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|B Chain B, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|C Chain C, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|D Chain D, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FXR|A Chain A, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|B Chain B, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|C Chain C, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|D Chain D, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FPZ|A Chain A, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|B Chain B, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|C Chain C, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|D Chain D, Human Tryptase With 2-Amino Benzimidazole
pdb|2FS8|A Chain A, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|B Chain B, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|C Chain C, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|D Chain D, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS9|A Chain A, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|B Chain B, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|C Chain C, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|D Chain D, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2GDD|A Chain A, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|B Chain B, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|C Chain C, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|D Chain D, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2ZA5|A Chain A, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|B Chain B, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|C Chain C, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|D Chain D, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|4A6L|A Chain A, Beta-Tryptase Inhibitor
pdb|4A6L|B Chain B, Beta-Tryptase Inhibitor
pdb|4A6L|C Chain C, Beta-Tryptase Inhibitor
pdb|4A6L|D Chain D, Beta-Tryptase Inhibitor
pdb|3V7T|A Chain A, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|B Chain B, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|C Chain C, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|D Chain D, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
Length = 245
Score = 79.7 bits (195), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 52/115 (45%), Positives = 61/115 (53%), Gaps = 12/115 (10%)
Query: 151 VTGWGV--QKQGGSTSDTLLEVEVPILSNAECKK-------TAYENRIT-PNMLCAGYPK 200
VTGWG + L +V+VPI+ N C T + RI +MLCAG
Sbjct: 127 VTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAG--N 184
Query: 201 GEKDSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
+DSCQGDSGGPL GVVSWGEGCAQ N PG+Y RV YL WI +
Sbjct: 185 TRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHH 239
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 27/46 (58%), Gaps = 3/46 (6%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRF---YCGATLINNLYVLTAAHCV 129
IVGGQ ++PW L + +CG +LI+ +VLTAAHCV
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCV 46
>pdb|2ZEB|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
Length = 243
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 52/115 (45%), Positives = 61/115 (53%), Gaps = 12/115 (10%)
Query: 151 VTGWGV--QKQGGSTSDTLLEVEVPILSNAECKK-------TAYENRIT-PNMLCAGYPK 200
VTGWG + L +V+VPI+ N C T + RI +MLCAG
Sbjct: 127 VTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAG--N 184
Query: 201 GEKDSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
+DSCQGDSGGPL GVVSWGEGCAQ N PG+Y RV YL WI +
Sbjct: 185 TRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHH 239
Score = 38.1 bits (87), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 27/46 (58%), Gaps = 3/46 (6%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRF---YCGATLINNLYVLTAAHCV 129
IVGGQ ++PW L + +CG +LI+ +VLTAAHCV
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCV 46
>pdb|1A0L|A Chain A, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|B Chain B, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|C Chain C, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|D Chain D, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
Length = 244
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 52/115 (45%), Positives = 60/115 (52%), Gaps = 12/115 (10%)
Query: 151 VTGWGVQKQGGSTSDT--LLEVEVPILSNAECKK-------TAYENRIT-PNMLCAGYPK 200
VTGWG L +V+VPI+ N C T + RI +MLCAG
Sbjct: 127 VTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAG--N 184
Query: 201 GEKDSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
+DSCQGDSGGPL GVVSWGEGCAQ N PG+Y RV YL WI +
Sbjct: 185 TRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHH 239
Score = 38.1 bits (87), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 27/46 (58%), Gaps = 3/46 (6%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRF---YCGATLINNLYVLTAAHCV 129
IVGGQ ++PW L + +CG +LI+ +VLTAAHCV
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCV 46
>pdb|2F9O|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9P|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
Length = 245
Score = 79.3 bits (194), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 51/115 (44%), Positives = 61/115 (53%), Gaps = 12/115 (10%)
Query: 151 VTGWGV--QKQGGSTSDTLLEVEVPILSNAECKKT----AYENR----ITPNMLCAGYPK 200
VTGWG + L +V+VPI+ N C AY I +MLCAG
Sbjct: 127 VTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDMLCAG--N 184
Query: 201 GEKDSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
++DSC+GDSGGPL GVVSWGEGCAQ N PG+Y RV YL WI +
Sbjct: 185 SQRDSCKGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHH 239
Score = 43.9 bits (102), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 23/57 (40%), Positives = 33/57 (57%), Gaps = 3/57 (5%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRF---YCGATLINNLYVLTAAHCVHQGLGIWVTIR 140
IVGGQ ++PW L + R+ +CG +LI+ +VLTAAHCV + T+R
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLATLR 57
>pdb|1AZZ|A Chain A, Fiddler Crab Collagenase Complexed To Ecotin
pdb|1AZZ|B Chain B, Fiddler Crab Collagenase Complexed To Ecotin
Length = 226
Score = 79.3 bits (194), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 94/230 (40%), Gaps = 67/230 (29%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC---------------VHQ 131
IVGG + +P A L ++CG +LI+ ++LTAAHC + +
Sbjct: 1 IVGGVEAVPNSWPHQAALFIDDMYFCGGSLISPEWILTAAHCMDGAGFVDVVLGAHNIRE 60
Query: 132 GLGIWVTIRGKSF-----------SNKTGIV----------------------------- 151
VTI+ F SN ++
Sbjct: 61 DEATQVTIQSTDFTVHENYNSFVISNDIAVIRLPVPVTLTAAIATVGLPSTDVGVGTVVT 120
Query: 152 -TGWGVQKQGG-STSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGD 209
TGWG+ SD L +V+VPI+SNA+C A +T +C G K +C GD
Sbjct: 121 PTGWGLPSDSALGISDVLRQVDVPIMSNADCD--AVYGIVTDGNICID-STGGKGTCNGD 177
Query: 210 SGGPLHYANETVHHIVGVVSWG--EGCAQENYPGVYARVNRYLTWIKNNT 257
SGGPL+Y T G+ S+G GC + YP + RV +L WI+ T
Sbjct: 178 SGGPLNYNGLT----YGITSFGAAAGC-EAGYPDAFTRVTYFLDWIQTQT 222
>pdb|4FXG|H Chain H, Complement C4 In Complex With Masp-2
pdb|4FXG|J Chain J, Complement C4 In Complex With Masp-2
Length = 242
Score = 79.3 bits (194), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 49/124 (39%), Positives = 70/124 (56%), Gaps = 11/124 (8%)
Query: 145 SNKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYEN------RITPNMLCAGY 198
++ G +GWG+ Q G + L+ V++PI+ + +C AYE +T NMLCAG
Sbjct: 120 TDDIGTASGWGL-TQRGFLARNLMYVDIPIVDHQKCT-AAYEKPPYPRGSVTANMLCAGL 177
Query: 199 PKGEKDSCQGDSGGPLHYAN-ETVHHIV-GVVSWGE-GCAQENYPGVYARVNRYLTWIKN 255
G KDSC+GD+GG L + + ET V G+VSWG C + GVY +V Y+ WI+N
Sbjct: 178 ESGGKDSCRGDAGGALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVINYIPWIEN 237
Query: 256 NTID 259
D
Sbjct: 238 IISD 241
Score = 29.3 bits (64), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 18/45 (40%), Positives = 25/45 (55%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQ 131
I GGQ +PW L++ GA L +N +VLTAAH V++
Sbjct: 1 IYGGQKAKPGDFPWQVLIL-GGTTAAGALLYDN-WVLTAAHAVYE 43
>pdb|1YM0|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component B: A Novel, Glycosylated Two-chained Trypsin
Length = 238
Score = 79.0 bits (193), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 45/108 (41%), Positives = 62/108 (57%), Gaps = 5/108 (4%)
Query: 152 TGWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKG--EKDSCQG 208
+GWG GG +L V + I +NA C + I +M+CA G ++DSCQG
Sbjct: 127 SGWGTINSGGVCCPAVLRYVTLNITTNAFCDAVYTSDTIYDDMICATDNTGMTDRDSCQG 186
Query: 209 DSGGPLHYANET-VHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
DSGGPL + + + +VG+VSWG GCA YPGVY+RV + WI +
Sbjct: 187 DSGGPLSVKDGSGIFSLVGIVSWGIGCAS-GYPGVYSRVGFHAGWITD 233
Score = 37.0 bits (84), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 16/46 (34%), Positives = 27/46 (58%), Gaps = 2/46 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKR--FYCGATLINNLYVLTAAHCVH 130
IVGG +++PW + K +CG ++IN+ +V+ AAHC+
Sbjct: 1 IVGGIEARPYEFPWQVSVRRKSSDSHFCGGSIINDRWVVCAAHCMQ 46
>pdb|2XRC|A Chain A, Human Complement Factor I
pdb|2XRC|B Chain B, Human Complement Factor I
pdb|2XRC|C Chain C, Human Complement Factor I
pdb|2XRC|D Chain D, Human Complement Factor I
Length = 565
Score = 77.8 bits (190), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 49/110 (44%), Positives = 62/110 (56%), Gaps = 6/110 (5%)
Query: 146 NKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRI-TPNMLCAGYPKGEKD 204
N T IV+GWG +K +L EV ++SN C K Y NR M CAG G D
Sbjct: 446 NDTCIVSGWGREKDNERVF-SLQWGEVKLISN--CSK-FYGNRFYEKEMECAGTYDGSID 501
Query: 205 SCQGDSGGPLHYAN-ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
+C+GDSGGPL + V ++ GVVSWGE C + +PGVY +V Y WI
Sbjct: 502 ACKGDSGGPLVCMDANNVTYVWGVVSWGENCGKPEFPGVYTKVANYFDWI 551
Score = 40.8 bits (94), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 22/71 (30%), Positives = 32/71 (45%), Gaps = 8/71 (11%)
Query: 77 TCGAVNK----KTRIVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQG 132
+CG N+ + RIVGG+ + PW + CG I ++LTAAHC+
Sbjct: 308 SCGVKNRMHIRRKRIVGGKRAQLGDLPWQVAIKDASGITCGGIYIGGCWILTAAHCLRAS 367
Query: 133 ----LGIWVTI 139
IW T+
Sbjct: 368 KTHRYQIWTTV 378
>pdb|1DST|A Chain A, Mutant Of Factor D With Enhanced Catalytic Activity
Length = 228
Score = 77.4 bits (189), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 42/107 (39%), Positives = 57/107 (53%), Gaps = 8/107 (7%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAEC-KKTAYENRITPNMLCAGYPKGEKDSCQGD 209
V GWG+ G D+L V +P+L A C ++T ++ IT ++CA +DSC+GD
Sbjct: 125 VAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCA--ESNRRDSCKGD 182
Query: 210 SGGPLHYANETVHHIVGVVSWGEG-CAQENYPGVYARVNRYLTWIKN 255
SGGPL + GVVSWG C PG+Y RV Y WI +
Sbjct: 183 SGGPLVCGGV----LEGVVSWGSRVCGNRKKPGIYTRVASYAAWIDS 225
Score = 38.5 bits (88), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 16/43 (37%), Positives = 24/43 (55%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCV 129
I+GG+ H P+MA + CG L+ +VL+AAHC+
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCL 43
>pdb|1MKW|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
Length = 308
Score = 77.0 bits (188), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 51/143 (35%), Positives = 69/143 (48%), Gaps = 26/143 (18%)
Query: 124 TAAHCVHQGLGIWVTIRGKSFSNKTGIVTGWGVQKQGGSTS------DTLLEVEVPILSN 177
TAA +H G G VTGWG +++ +TS L V +P++
Sbjct: 174 TAAKLLHAGF--------------KGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVER 219
Query: 178 AECKKTAYENRITPNMLCAGYPKGEK---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGE 232
CK + RIT NM CAGY GE D+C+GDSGGP + + +G+VSWGE
Sbjct: 220 PVCKAST-RIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGE 278
Query: 233 GCAQENYPGVYARVNRYLTWIKN 255
GC ++ G Y V R WI+
Sbjct: 279 GCDRDGKYGFYTHVFRLKKWIQK 301
Score = 44.3 bits (103), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 22/46 (47%), Positives = 29/46 (63%), Gaps = 2/46 (4%)
Query: 86 RIVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
RIV GQ V PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 49 RIVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 94
>pdb|1LTO|A Chain A, Human Alpha1-Tryptase
pdb|1LTO|B Chain B, Human Alpha1-Tryptase
pdb|1LTO|C Chain C, Human Alpha1-Tryptase
pdb|1LTO|D Chain D, Human Alpha1-Tryptase
Length = 245
Score = 77.0 bits (188), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 50/115 (43%), Positives = 60/115 (52%), Gaps = 12/115 (10%)
Query: 151 VTGWGV--QKQGGSTSDTLLEVEVPILSNAECKKT----AYENR----ITPNMLCAGYPK 200
VTGWG + L +V+VPI+ N C AY I +MLCAG
Sbjct: 127 VTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDMLCAG--N 184
Query: 201 GEKDSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
++DSC+GDSGGPL GVVSW EGCAQ N PG+Y RV YL WI +
Sbjct: 185 SQRDSCKGDSGGPLVCKVNGTWLQAGVVSWDEGCAQPNRPGIYTRVTYYLDWIHH 239
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 22/57 (38%), Positives = 33/57 (57%), Gaps = 3/57 (5%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRF---YCGATLINNLYVLTAAHCVHQGLGIWVTIR 140
IVGGQ ++PW L + R+ +CG +LI+ +VLTAAHC+ + T+R
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCLGPDVKDLATLR 57
>pdb|1BBR|K Chain K, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1BBR|N Chain N, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1ETR|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETS|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETT|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1HRT|H Chain H, The Structure Of A Complex Of Bovine Alpha-Thrombin And
Recombinant Hirudin At 2.8 Angstroms Resolution
pdb|1TBR|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBR|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1UCY|K Chain K, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1UCY|N Chain N, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|H Chain H, Thrombin:hirudin 51-65 Complex
pdb|1MKW|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1TOC|B Chain B, Structure Of Serine Proteinase
pdb|1TOC|D Chain D, Structure Of Serine Proteinase
pdb|1TOC|F Chain F, Structure Of Serine Proteinase
pdb|1TOC|H Chain H, Structure Of Serine Proteinase
pdb|1UVT|H Chain H, Bovine Thrombin--Bm14.1248 Complex
pdb|1UVU|H Chain H, Bovine Thrombin--Bm12.1700 Complex
pdb|1YCP|H Chain H, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
pdb|1A0H|B Chain B, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1A0H|E Chain E, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1AVG|H Chain H, Thrombin Inhibitor From Triatoma Pallidipennis
pdb|2A1D|B Chain B, Staphylocoagulase Bound To Bovine Thrombin
pdb|2A1D|F Chain F, Staphylocoagulase Bound To Bovine Thrombin
pdb|2ODY|B Chain B, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|2ODY|D Chain D, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|3PMA|B Chain B, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMA|D Chain D, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMB|B Chain B, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
pdb|3PMB|D Chain D, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
Length = 259
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 51/143 (35%), Positives = 69/143 (48%), Gaps = 26/143 (18%)
Query: 124 TAAHCVHQGLGIWVTIRGKSFSNKTGIVTGWGVQKQGGSTS------DTLLEVEVPILSN 177
TAA +H G G VTGWG +++ +TS L V +P++
Sbjct: 125 TAAKLLHAGF--------------KGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVER 170
Query: 178 AECKKTAYENRITPNMLCAGYPKGEK---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGE 232
CK + RIT NM CAGY GE D+C+GDSGGP + + +G+VSWGE
Sbjct: 171 PVCKAST-RIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGE 229
Query: 233 GCAQENYPGVYARVNRYLTWIKN 255
GC ++ G Y V R WI+
Sbjct: 230 GCDRDGKYGFYTHVFRLKKWIQK 252
Score = 41.6 bits (96), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 21/45 (46%), Positives = 28/45 (62%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV GQ V PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|2JET|C Chain C, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 99
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 39/93 (41%), Positives = 56/93 (60%), Gaps = 3/93 (3%)
Query: 163 TSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSGGPLHYANETVH 222
T + L + +PI+S A+CKK+ + ++IT M CAG DSC GDSGGPL + V
Sbjct: 5 TPEKLQQAALPIVSEADCKKS-WGSKITDVMTCAGASG--VDSCMGDSGGPLVCQKDGVW 61
Query: 223 HIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
+ G+VSWG G + PGVY+RV + W++
Sbjct: 62 TLAGIVSWGSGVCSTSTPGVYSRVTALMPWVQQ 94
>pdb|1ID5|H Chain H, Crystal Structure Of Bovine Thrombin Complex With Protease
Inhibitor Ecotin
Length = 256
Score = 77.0 bits (188), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 51/143 (35%), Positives = 69/143 (48%), Gaps = 26/143 (18%)
Query: 124 TAAHCVHQGLGIWVTIRGKSFSNKTGIVTGWGVQKQGGSTS------DTLLEVEVPILSN 177
TAA +H G G VTGWG +++ +TS L V +P++
Sbjct: 125 TAAKLLHAGF--------------KGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVER 170
Query: 178 AECKKTAYENRITPNMLCAGYPKGEK---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGE 232
CK + RIT NM CAGY GE D+C+GDSGGP + + +G+VSWGE
Sbjct: 171 PVCKAST-RIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGE 229
Query: 233 GCAQENYPGVYARVNRYLTWIKN 255
GC ++ G Y V R WI+
Sbjct: 230 GCDRDGKYGFYTHVFRLKKWIQK 252
Score = 41.6 bits (96), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 21/45 (46%), Positives = 28/45 (62%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV GQ V PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|2BVR|H Chain H, Human Thrombin Complexed With Fragment-based Small
Molecules Occupying The S1 Pocket
Length = 252
Score = 76.6 bits (187), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 47/112 (41%), Positives = 60/112 (53%), Gaps = 7/112 (6%)
Query: 149 GIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEK---DS 205
G VTGWG K+ G S L V +PI+ CK + RIT NM CAGY E D+
Sbjct: 136 GRVTGWGNLKEKGQPS-VLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDEGKRGDA 193
Query: 206 CQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 194 CEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 245
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1VZQ|H Chain H, Complex Of Thrombin With Designed Inhibitor 7165
Length = 250
Score = 76.6 bits (187), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 47/112 (41%), Positives = 60/112 (53%), Gaps = 7/112 (6%)
Query: 149 GIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEK---DS 205
G VTGWG K+ G S L V +PI+ CK + RIT NM CAGY E D+
Sbjct: 136 GRVTGWGNLKETGQPS-VLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDEGKRGDA 193
Query: 206 CQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 194 CEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 245
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1H8D|H Chain H, X-Ray Structure Of The Human Alpha-Thrombin Complex With A
Tripeptide Phosphonate Inhibitor
Length = 260
Score = 76.6 bits (187), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 47/112 (41%), Positives = 60/112 (53%), Gaps = 7/112 (6%)
Query: 149 GIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEK---DS 205
G VTGWG K+ G S L V +PI+ CK + RIT NM CAGY E D+
Sbjct: 136 GRVTGWGNLKETGQPS-VLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDEGKRGDA 193
Query: 206 CQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 194 CEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 245
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1THP|B Chain B, Structure Of Human Alpha-Thrombin Y225p Mutant Bound To
D-Phe-Pro-Arg- Chloromethylketone
pdb|3S7H|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|D Chain D, Structure Of Thrombin Mutant Y225p In The E Form
Length = 259
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 47/118 (39%), Positives = 60/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 136 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ PG Y V R WI+
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKPGFYTHVFRLKKWIQK 252
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1H8I|H Chain H, X-Ray Crystal Structure Of Human Alpha-Thrombin With A
Tripeptide Phosphonate Inhibitor
Length = 253
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 45/112 (40%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 149 GIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEK---DS 205
G VTGWG K+ L V +PI+ CK + RIT NM CAGY E D+
Sbjct: 136 GRVTGWGNLKETWGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDEGKRGDA 194
Query: 206 CQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 195 CEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 246
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|2ZGC|A Chain A, Crystal Structure Of Active Human Granzyme M
pdb|2ZGH|A Chain A, Crystal Structure Of Active Granzyme M Bound To Its
Product
pdb|2ZKS|A Chain A, Structural Insights Into The Proteolytic Machinery Of
Apoptosis- Inducing Granzyme M
Length = 240
Score = 75.9 bits (185), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 61/230 (26%), Positives = 92/230 (40%), Gaps = 61/230 (26%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQ--------------- 131
I+GG+ H P+MA L CG L++ +VLTAAHC+ Q
Sbjct: 1 IIGGREVIPHSRPYMASLQRNGSHLCGGVLVHPKWVLTAAHCLAQRMAQLRLVLGLHTLD 60
Query: 132 --GLGIWV--------------------------------TIRGKSFSNKTGIVT----- 152
GL + TIR + +K +V
Sbjct: 61 SPGLTFHIKAAIQHPRYKPVPALENDLALLQLDGKVKPSRTIRPLALPSKRQVVAAGTRC 120
Query: 153 ---GWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYEN-RITPNMLCAGYPKGEKDSCQG 208
GWG+ QGG S L E+++ +L C + + N ++P+M+C ++ C+G
Sbjct: 121 SMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNGSLSPSMVCLAADSKDQAPCKG 180
Query: 209 DSGGPLHYANETVHHIVGVVSWGEG-CAQENYPGVYARVNRYLTWIKNNT 257
DSGGPL V + GV+S+ C P V V Y++WI+ T
Sbjct: 181 DSGGPLVCGKGRV--LAGVLSFSSRVCTDIFKPPVATAVAPYVSWIRKVT 228
>pdb|2ZGJ|A Chain A, Crystal Structure Of D86n-gzmm Complexed With Its Optimal
Synthesized Substrate
Length = 240
Score = 75.5 bits (184), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 61/230 (26%), Positives = 92/230 (40%), Gaps = 61/230 (26%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQ--------------- 131
I+GG+ H P+MA L CG L++ +VLTAAHC+ Q
Sbjct: 1 IIGGREVIPHSRPYMASLQRNGSHLCGGVLVHPKWVLTAAHCLAQRMAQLRLVLGLHTLD 60
Query: 132 --GLGIWV--------------------------------TIRGKSFSNKTGIVT----- 152
GL + TIR + +K +V
Sbjct: 61 SPGLTFHIKAAIQHPRYKPVPALENNLALLQLDGKVKPSRTIRPLALPSKRQVVAAGTRC 120
Query: 153 ---GWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYEN-RITPNMLCAGYPKGEKDSCQG 208
GWG+ QGG S L E+++ +L C + + N ++P+M+C ++ C+G
Sbjct: 121 SMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNGSLSPSMVCLAADSKDQAPCKG 180
Query: 209 DSGGPLHYANETVHHIVGVVSWGEG-CAQENYPGVYARVNRYLTWIKNNT 257
DSGGPL V + GV+S+ C P V V Y++WI+ T
Sbjct: 181 DSGGPLVCGKGRV--LAGVLSFSSRVCTDIFKPPVATAVAPYVSWIRKVT 228
>pdb|1SGF|G Chain G, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|Z Chain Z, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 237
Score = 75.5 bits (184), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 42/110 (38%), Positives = 64/110 (58%), Gaps = 7/110 (6%)
Query: 148 TGIVTGWG-VQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSC 206
T + +GWG + +D L V + +L N +C K A+ ++T MLCAG G KD+C
Sbjct: 127 TCLASGWGSITPTKFQFTDDLYCVNLKLLPNEDCAK-AHIEKVTDAMLCAGEMDGGKDTC 185
Query: 207 QGDSGGPLHYANETVHHIVGVVSWGEG-CAQENYPGVYARVNRYLTWIKN 255
+GDSGGPL + G+ SWG C + + PGVY ++N++ +WIK+
Sbjct: 186 KGDSGGPLICDGV----LQGITSWGHTPCGEPDMPGVYTKLNKFTSWIKD 231
Score = 38.1 bits (87), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 17/51 (33%), Positives = 26/51 (50%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV 137
IVGG + PW + ++ CG L++ +VLTAAHC +W+
Sbjct: 1 IVGGFKCEKNSQPWHVAVYRYTQYLCGGVLLDPNWVLTAAHCYDDNYKVWL 51
>pdb|1KDQ|B Chain B, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 99
Score = 75.1 bits (183), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 38/93 (40%), Positives = 55/93 (59%), Gaps = 3/93 (3%)
Query: 163 TSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSGGPLHYANETVH 222
T + L + +PI+S A+CKK+ + ++IT M CAG DSC GDSGGPL + V
Sbjct: 5 TPEKLQQAALPIVSEADCKKS-WGSKITDVMTCAG--ASGVDSCMGDSGGPLVCQKDGVW 61
Query: 223 HIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
+ G+VSWG G + P VY+RV + W++
Sbjct: 62 TLAGIVSWGSGVCSTSTPAVYSRVTALMPWVQQ 94
>pdb|1TWX|B Chain B, Crystal Structure Of The Thrombin Mutant D221aD222K
Length = 259
Score = 74.3 bits (181), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 47/118 (39%), Positives = 60/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 136 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGCA++ G Y V R WI+
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCARKGKYGFYTHVFRLKKWIQK 252
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1BTH|H Chain H, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
pdb|1BTH|K Chain K, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 259
Score = 74.3 bits (181), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 47/118 (39%), Positives = 61/118 (51%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQGGSTS------DTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ +T+ L V +PI+ CK + RIT NM CAGY E
Sbjct: 136 GRVTGWGNLKETWTTNVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+CQGDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 195 GKRGDACQGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1SPJ|A Chain A, Structure Of Mature Human Tissue Kallikrein (Human
Kallikrein 1 Or Klk1) At 1.70 Angstrom Resolution With
Vacant Active Site
Length = 238
Score = 74.3 bits (181), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 46/111 (41%), Positives = 63/111 (56%), Gaps = 7/111 (6%)
Query: 147 KTGIVTGWG-VQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDS 205
T + +GWG ++ + S D L V++ IL N ECKK A+ ++T MLC G+ +G KD+
Sbjct: 127 STCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKK-AHVQKVTDFMLCVGHLEGGKDT 185
Query: 206 CQGDSGGPLHYANETVHHIVGVVSWGE-GCAQENYPGVYARVNRYLTWIKN 255
C GDSGGPL + GV SWG C N P V RV Y+ WI++
Sbjct: 186 CVGDSGGPLMCDGV----LQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIED 232
Score = 48.1 bits (113), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 21/51 (41%), Positives = 28/51 (54%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV 137
IVGG H PW A L + F CG L++ +VLTAAHC+ +W+
Sbjct: 1 IVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWL 51
>pdb|1NPM|A Chain A, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
pdb|1NPM|B Chain B, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
Length = 225
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 48/112 (42%), Positives = 65/112 (58%), Gaps = 9/112 (8%)
Query: 150 IVTGWG-VQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
I++GWG V + +TL EV I S +C++ AY +IT M+CAG G D+CQG
Sbjct: 121 IISGWGTVTSPQENFPNTLNCAEVKIYSQNKCER-AYPGKITEGMVCAGSSNGA-DTCQG 178
Query: 209 DSGGPLHYANETVHHIVGVVSWG-EGCAQENYPGVYARVNRYLTWIKNNTID 259
DSGGPL + G+ SWG + C + PGVY ++ RY TWIK T+D
Sbjct: 179 DSGGPLVCDG----MLQGITSWGSDPCGKPEKPGVYTKICRYTTWIK-KTMD 225
Score = 44.3 bits (103), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 25/45 (55%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQ 131
I+ G+ H PW A L +R CG L+ + +VLTAAHC Q
Sbjct: 1 ILEGRECIPHSQPWQAALFQGERLICGGVLVGDRWVLTAAHCKKQ 45
>pdb|1B7X|B Chain B, Structure Of Human Alpha-Thrombin Y225i Mutant Bound To D-
Phe-Pro-Arg-Chloromethylketone
Length = 259
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 136 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKIGFYTHVFRLKKWIQK 252
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|2BDG|A Chain A, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDG|B Chain B, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDH|A Chain A, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|B Chain B, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|C Chain C, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|D Chain D, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDI|A Chain A, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|B Chain B, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|C Chain C, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|D Chain D, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|E Chain E, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|F Chain F, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|G Chain G, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|H Chain H, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|I Chain I, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|J Chain J, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|K Chain K, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|L Chain L, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|M Chain M, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|N Chain N, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|O Chain O, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|P Chain P, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
Length = 223
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 59/224 (26%), Positives = 93/224 (41%), Gaps = 62/224 (27%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQ----GLGIWV----- 137
I+ G+ H PW A L+ + +C L++ +VL+AAHC GLG+
Sbjct: 1 IINGEDCSPHSQPWQAALVMENELFCSGVLVHPQWVLSAAHCFQNSYTIGLGLHSLEADQ 60
Query: 138 ----------------------------------------TIRGKSFSNK------TGIV 151
TIR S +++ + +V
Sbjct: 61 EPGSQMVEASLSVRHPEYNRPLLANDLMLIKLDESVSESDTIRSISIASQCPTAGNSCLV 120
Query: 152 TGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSG 211
+GWG+ G T+L+ + + E Y+ P+M CAG + +KDSC GDSG
Sbjct: 121 SGWGLLANG--RMPTVLQCVNVSVVSEEVCSKLYDPLYHPSMFCAGGGQDQKDSCNGDSG 178
Query: 212 GPLHYANETVHHIVGVVSWGEG-CAQENYPGVYARVNRYLTWIK 254
GPL ++ G+VS+G+ C Q PGVY + ++ WI+
Sbjct: 179 GPLICNG----YLQGLVSFGKAPCGQVGVPGVYTNLCKFTEWIE 218
>pdb|2OLG|A Chain A, Crystal Structure Of The Serine Protease Domain Of
Prophenoloxidase Activating Factor-I In A Zymogen Form
Length = 278
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 45/110 (40%), Positives = 63/110 (57%), Gaps = 7/110 (6%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKT--AYENRITPNMLCAGYPKGEKDSCQG 208
V GWG + + G S ++ VP++ +C KT A R+ + LCAG K KDSC G
Sbjct: 169 VVGWG-RTETGQYSTIKQKLAVPVVHAEQCAKTFGAAGVRVRSSQLCAGGEKA-KDSCGG 226
Query: 209 DSGGPL--HYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNN 256
DSGGPL AN+ + G+VS+G C E +PG+Y +V +Y WI+ N
Sbjct: 227 DSGGPLLAERANQQFF-LEGLVSFGATCGTEGWPGIYTKVGKYRDWIEGN 275
Score = 54.3 bits (129), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 25/60 (41%), Positives = 37/60 (61%), Gaps = 5/60 (8%)
Query: 75 PCTCGAVNKKTRIVGGQVTYVHQYPWMALLMYK-----KRFYCGATLINNLYVLTAAHCV 129
P CG + +I+ G T ++PW A++ YK ++F CG +LINN Y++TAAHCV
Sbjct: 11 PNDCGYQVEADKILNGDDTVPEEFPWTAMIGYKNSSNFEQFACGGSLINNRYIVTAAHCV 70
>pdb|1MH0|A Chain A, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1MH0|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
Length = 287
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 166 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 224
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 225 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 282
Score = 42.4 bits (98), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 28/46 (60%), Gaps = 2/46 (4%)
Query: 86 RIVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
RIV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 75
>pdb|1D9I|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electophilic Inhibitors Having Cyclohexyl Moieties
At P1
Length = 288
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 166 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 224
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 225 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 282
Score = 42.4 bits (98), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 28/46 (60%), Gaps = 2/46 (4%)
Query: 86 RIVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
RIV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 75
>pdb|1D6W|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electrophilic Inhibitors Having Cyclohexyl Moieties
At P1
pdb|1G37|A Chain A, Crystal Structure Of Human Alpha-thrombin Complexed With
Bch-10556 And Exosite-directed Peptide
Length = 287
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 166 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 224
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 225 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 282
Score = 42.4 bits (98), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 28/46 (60%), Gaps = 2/46 (4%)
Query: 86 RIVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
RIV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 75
>pdb|1JWT|A Chain A, Crystal Structure Of Thrombin In Complex With A Novel
Bicyclic Lactam Inhibitor
Length = 305
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 172 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 230
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 231 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 288
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 28/46 (60%), Gaps = 2/46 (4%)
Query: 86 RIVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
RIV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 36 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 81
>pdb|1HAG|E Chain E, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1DOJ|A Chain A, Crystal Structure Of Human Alpha-ThrombinRwj-51438 Complex
At 1.7 A
pdb|1XM1|A Chain A, Nonbasic Thrombin Inhibitor Complex
Length = 295
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 172 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 230
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 231 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 288
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 28/46 (60%), Gaps = 2/46 (4%)
Query: 86 RIVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
RIV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 36 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 81
>pdb|1MTN|C Chain C, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|G Chain G, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|C Chain C, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|H Chain H, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|C Chain C, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|H Chain H, Bovine Chymotrypsin Complexed To Bpti
pdb|1VGC|C Chain C, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|C Chain C, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|C Chain C, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|C Chain C, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|C Chain C, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|C Chain C, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|E Chain E, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|F Chain F, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|C Chain C, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|G Chain G, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|C Chain C, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|G Chain G, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|G Chain G, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|G Chain G, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|G Chain G, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|G Chain G, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|G Chain G, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|G Chain G, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|G Chain G, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|C Chain C, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|G Chain G, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|C Chain C, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|G Chain G, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|C Chain C, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|G Chain G, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|G Chain G, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|C Chain C, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|C Chain C, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|C Chain C, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|C Chain C, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|C Chain C, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
Length = 97
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 38/92 (41%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 163 TSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSGGPLHYANETVH 222
T D L + +P+LSN CKK + +I M+CAG SC GDSGGPL
Sbjct: 3 TPDRLQQASLPLLSNTNCKKY-WGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAW 59
Query: 223 HIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
+VG+VSWG + PGVYARV + W++
Sbjct: 60 TLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ 91
>pdb|1NM6|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
At 1.8a
pdb|1NT1|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
pdb|1TA2|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 1
pdb|1TA6|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 14b
pdb|1SL3|A Chain A, Crystal Structue Of Thrombin In Complex With A Potent P1
Heterocycle- Aryl Based Inhibitor
pdb|1Z71|A Chain A, Thrombin And P2 Pyridine N-oxide Inhibitor Complex
Structure
pdb|1ZRB|A Chain A, Thrombin In Complex With An Azafluorenyl Inhibitor 23b
pdb|1ZGI|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 21
pdb|1ZGV|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 2
pdb|3C1K|A Chain A, Crystal Structure Of Thrombin In Complex With Inhibitor 15
Length = 287
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 165 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 223
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 224 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 281
Score = 42.4 bits (98), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 28/46 (60%), Gaps = 2/46 (4%)
Query: 86 RIVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
RIV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 29 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 74
>pdb|2BDY|A Chain A, Thrombin In Complex With Inhibitor
Length = 289
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 166 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 224
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 225 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 282
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 28/46 (60%), Gaps = 2/46 (4%)
Query: 86 RIVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
RIV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 75
>pdb|1EOJ|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
pdb|1EOL|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
Length = 289
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 168 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 226
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 227 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 284
Score = 42.4 bits (98), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 28/46 (60%), Gaps = 2/46 (4%)
Query: 86 RIVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
RIV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 32 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 77
>pdb|2THF|B Chain B, Structure Of Human Alpha-thrombin Y225f Mutant Bound To
D-phe-pro-arg- Chloromethylketone
Length = 259
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 136 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKFGFYTHVFRLKKWIQK 252
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1AFQ|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|3RU4|E Chain E, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 96
Score = 72.4 bits (176), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 38/92 (41%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 163 TSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSGGPLHYANETVH 222
T D L + +P+LSN CKK + +I M+CAG SC GDSGGPL
Sbjct: 2 TPDRLQQASLPLLSNTNCKKY-WGTKIKDAMICAG--ASGVSSCMGDSGGPLVCKKNGAW 58
Query: 223 HIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
+VG+VSWG + PGVYARV + W++
Sbjct: 59 TLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ 90
>pdb|2A0Q|B Chain B, Structure Of Thrombin In 400 Mm Potassium Chloride
pdb|2A0Q|D Chain D, Structure Of Thrombin In 400 Mm Potassium Chloride
Length = 257
Score = 72.4 bits (176), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 136 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1QUR|H Chain H, Human Alpha-Thrombin In Complex With Bivalent,
Benzamidine-Based Synthetic Inhibitor
pdb|1D3D|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzothiophene Inhibitor 4
pdb|1EB1|H Chain H, Complex Structure Of Human Thrombin With N-Methyl-Arginine
Inhibitor
pdb|1GHV|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1YPE|H Chain H, Thrombin Inhibitor Complex
pdb|1YPG|H Chain H, Thrombin Inhibitor Complex
pdb|1YPJ|H Chain H, Thrombin Inhibitor Complex
pdb|1YPK|H Chain H, Thrombin Inhibitor Complex
pdb|1YPL|H Chain H, X-Ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1008
pdb|1YPM|H Chain H, X-ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1014
pdb|2ANM|H Chain H, Ternary Complex Of An Orally Active Thrombin Inhibitor
With Human Thrombin And A C-Terminal Hirudin Derived
Exo-Sit Inhibitor
pdb|2CF9|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|1GHX|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GHY|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2CF8|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|2CN0|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Inhibitor
pdb|3BIU|H Chain H, Human Thrombin-In Complex With Ub-Thr10
pdb|3BIV|H Chain H, Human Thrombin-In Complex With Ub-Thr11
pdb|2V3H|H Chain H, Thrombin With 3-Cycle No F
pdb|2V3O|H Chain H, Thrombin With 3-Cycle With F
pdb|4AX9|H Chain H, Human Thrombin Complexed With Napsagatran, Ro0466240
pdb|4AYV|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AYY|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AZ2|B Chain B, Human Thrombin - Inhibitor Complex
pdb|1GHW|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-centered Short Hydrogen Bonding Network At The
Active Site
Length = 257
Score = 72.4 bits (176), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 136 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1GJ5|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190ALA190 PROTEASE, Structure-Based Drug Design
pdb|1SB1|H Chain H, Novel Non-Covalent Thrombin Inhibitors Incorporating P1
4,5,6,7- Tetrahydrobenzothiazole Arginine Side Chain
Mimetics
pdb|2PW8|H Chain H, Crystal Structure Of Sulfo-Hirudin Complexed To Thrombin
pdb|3DD2|H Chain H, Crystal Structure Of An Rna Aptamer Bound To Human
Thrombin
pdb|1GJ4|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190/ala190 Protease, Structure-based Drug Design
Length = 258
Score = 72.4 bits (176), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 136 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1DX5|M Chain M, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|N Chain N, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|O Chain O, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|P Chain P, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1E0F|D Chain D, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|F Chain F, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|E Chain E, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
Length = 259
Score = 72.4 bits (176), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 136 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|3JZ1|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E:na+
Form
pdb|3JZ2|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E Form
pdb|3QGN|B Chain B, The Allosteric E-E Equilibrium Is A Key Property Of The
Trypsin Fold
Length = 259
Score = 72.4 bits (176), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 136 GRVTGWGPLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1SFQ|B Chain B, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SFQ|E Chain E, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SG8|B Chain B, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SG8|E Chain E, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SGI|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SGI|E Chain E, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SHH|B Chain B, Slow Form Of Thrombin Bound With Ppack
pdb|1SHH|E Chain E, Slow Form Of Thrombin Bound With Ppack
pdb|2HWL|B Chain B, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|2HWL|D Chain D, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|3BV9|B Chain B, Structure Of Thrombin Bound To The Inhibitor Fm19
Length = 259
Score = 72.4 bits (176), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 136 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1NU9|A Chain A, Staphylocoagulase-prethrombin-2 Complex
pdb|1NU9|D Chain D, Staphylocoagulase-prethrombin-2 Complex
Length = 291
Score = 72.4 bits (176), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 168 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 226
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 227 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 284
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 28/46 (60%), Gaps = 2/46 (4%)
Query: 86 RIVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
RIV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 32 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 77
>pdb|1ABI|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1ABJ|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1DWB|H Chain H, Crystallographic Analysis At 3.0-angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-directed Inhibitors
pdb|1DWC|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWD|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWE|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1FPH|H Chain H, The Interaction Of Thrombin With Fibrinogen: A Structural
Basis For Its Specificity
pdb|1HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of Alpha-
Thrombin
pdb|1IHS|H Chain H, Crystal Structure Of The Complex Of Human Alpha-thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1IHT|H Chain H, Crystal Structure Of The Complex Of Human Alpha-Thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1PPB|H Chain H, The Refined 1.9 Angstroms Crystal Structure Of Human
Alpha-Thrombin: Interaction With D-Phe-Pro-Arg
Chloromethylketone And Significance Of The
Tyr-Pro-Pro-Trp Insertion Segment
pdb|1THR|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1THS|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1TMB|H Chain H, Molecular Basis For The Inhibition Of Human Alpha-thrombin
By The Macrocyclic Peptide Cyclotheonamide A
pdb|2HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of
Alpha-Thrombin
pdb|2HPP|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-Thrombin
pdb|2HPQ|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-thrombin
pdb|3HTC|H Chain H, The Structure Of A Complex Of Recombinant Hirudin And
Human Alpha-Thrombin
pdb|4HTC|H Chain H, The Refined Structure Of The Hirudin-Thrombin Complex
pdb|1HUT|H Chain H, The Structure Of Alpha-Thrombin Inhibited By A 15-Mer
Single-Stranded Dna Aptamer
pdb|1NRN|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRO|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRP|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRQ|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRR|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRS|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1TMT|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1TMU|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1HLT|H Chain H, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HLT|K Chain K, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HAH|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1HAI|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|3HAT|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1FPC|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1HBT|H Chain H, Human Alpha-Thrombin Complexed With A Peptidyl Pyridinium
Methyl Ketone Containing Bivalent Inhibitor
pdb|1HDT|H Chain H, Structure Of A Retro-Binding Peptide Inhibitor Complexed
With Human Alpha-Thrombin
pdb|1HAO|H Chain H, Complex Of Human Alpha-thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (based On Nmr Model Of
Dna)
pdb|1HAP|H Chain H, Complex Of Human Alpha-Thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (Based On X-Ray Model Of
Dna)
pdb|1AHT|H Chain H, Crystal Structure Of Human Alpha-Thrombin Complexed With
Hirugen And P-Amidinophenylpyruvate At 1.6 Angstroms
Resolution
pdb|1DIT|H Chain H, Complex Of A Divalent Inhibitor With Thrombin
pdb|1TOM|H Chain H, Alpha-Thrombin Complexed With Hirugen
pdb|1HXF|H Chain H, Human Thrombin Complex With Hirudin Variant
pdb|1BMM|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-4-[(Aminoiminomethyl)
Amino]-N-[[1-[3-Hydroxy-2-[(2-
Naphthalenylsulfonyl)amino]-1-
Oxopropyl]-2-Pyrrolidinyl] Methyl]butanamide
(Bms-186282)
pdb|1BMN|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-1-(Aminoiminomethyl)-
N-[[1-[n-[(2-Naphthalenylsulfonyl)-L-Seryl]-
Pyrrolidinyl]methyl]-3- Piperidenecarboxamide
(Bms-189090)
pdb|1UMA|H Chain H, Alpha-Thrombin (Hirugen) Complexed With
Na-(N,N-Dimethylcarbamoyl)- Alpha-Azalysine
pdb|1LHD|H Chain H, Human Alpha-thrombin Complexed With
Ac-(d)phe-pro-borolys-oh
pdb|1LHE|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-N-
Butyl-Amidino-Glycine-Oh
pdb|1LHF|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-
Homolys-Oh
pdb|1LHG|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-
Boroornithine-Oh
pdb|1LHC|H Chain H, Human Alpha-Thrombin Complexed With
Ac-(D)phe-Pro-Boroarg-Oh
pdb|1AD8|H Chain H, Complex Of Thrombin With And Inhibitor Containing A Novel
P1 Moiety
pdb|1AI8|H Chain H, Human Alpha-Thrombin Ternary Complex With The Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Borompg
pdb|1AIX|H Chain H, Human Alpha-Thrombin Ternary Complex With Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Boroval
pdb|1AE8|H Chain H, Human Alpha-Thrombin Inhibition By
Eoc-D-Phe-Pro-Azalys-Onp
pdb|1AFE|H Chain H, Human Alpha-Thrombin Inhibition By Cbz-Pro-Azalys-Onp
pdb|1UVS|H Chain H, Bovine Thrombin--Bm51.1011 Complex
pdb|5GDS|H Chain H, Hirunorms Are True Hirudin Mimetics. The Crystal Structure
Of Human Alpha-Thrombin:hirunorm V Complex
pdb|1AY6|H Chain H, Thrombin Inhibitor From Theonalla, Cyclotheanamide-Based
Macrocyclic Tripeptide Motif
pdb|1A46|H Chain H, Thrombin Complexed With Hirugen And A Beta-Strand Mimetic
Inhibitor
pdb|1A4W|H Chain H, Crystal Structures Of Thrombin With Thiazole-Containing
Inhibitors: Probes Of The S1' Binding Site
pdb|1A5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1B5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1TBZ|H Chain H, Human Thrombin With Active Site N-Methyl-D
Phenylalanyl-N-[5-
(Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl]
Butyl]-L- Prolinamide Trifluroacetate And
Exosite-Hirugen
pdb|1A2C|H Chain H, Structure Of Thrombin Inhibited By Aeruginosin298-A From A
Blue-Green Alga
pdb|1A61|H Chain H, Thrombin Complexed With A Beta-Mimetic Thiazole-Containing
Inhibitor
pdb|1A3B|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog1
pdb|1A3E|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog2
pdb|1AWF|H Chain H, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|B Chain B, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|D Chain D, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1BCU|H Chain H, Alpha-Thrombin Complexed With Hirugen And Proflavin
pdb|8KME|2 Chain 2, Crystal Structure Of Human Alpha-thrombin Inhibited With
Sel2770.
pdb|1BA8|B Chain B, Thrombin Inhibitor With A Rigid Tripeptidyl Aldehydes
pdb|1BB0|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1CA8|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|4THN|H Chain H, The Crystal Structure Of Alpha-Thrombin-Hirunorm Iv
Complex Reveals A Novel Specificity Site Recognition
Mode.
pdb|1QBV|H Chain H, Crystal Structure Of Thrombin Complexed With An
Guanidine-Mimetic Inhibitor
pdb|1D4P|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
5- Amidinoindole-4-benzylpiperidine Inhibitor
pdb|7KME|H Chain H, Crystal Structure Of Human Alpha-Thrombin Inhibited With
Sel2711.
pdb|1QHR|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ1|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ6|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ7|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1D3P|B Chain B, Crystal Structure Of Human Aplha-Thrombin In Complex With
Benzo[b]thiophene Inhibitor 3
pdb|1D3Q|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 2
pdb|1D3T|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 1
pdb|1C4U|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4V|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4Y|2 Chain 2, Selective Non-Electrophilic Thrombin Inhibitors
pdb|1DE7|H Chain H, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1DE7|K Chain K, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1G30|B Chain B, Thrombin Inhibitor Complex
pdb|1G32|B Chain B, Thrombin Inhibitor Complex
pdb|1KTS|B Chain B, Thrombin Inhibitor Complex
pdb|1KTT|B Chain B, Thrombin Inhibitor Complex
pdb|1K21|H Chain H, Human Thrombin-Inhibitor Complex
pdb|1K22|H Chain H, Human Thrombin-inhibitor Complex
pdb|1NY2|2 Chain 2, Human Alpha Thrombin Inhibited By Rppgf And Hirugen
pdb|1O2G|H Chain H, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1OYT|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Fluorinated Inhibitor
pdb|1NO9|H Chain H, Design Of Weakly Basic Thrombin Inhibitors Incorporating
Novel P1 Binding Functions: Molecular And X-Ray
Crystallographic Studies.
pdb|1OOK|B Chain B, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Human Alpha-thrombin
pdb|1P8V|C Chain C, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Alpha-thrombin At 2.6a
pdb|1NU7|B Chain B, Staphylocoagulase-Thrombin Complex
pdb|1NU7|F Chain F, Staphylocoagulase-Thrombin Complex
pdb|1NZQ|H Chain H, D-Phe-Pro-Arg-Type Thrombin Inhibitor
pdb|1O0D|H Chain H, Human Thrombin Complexed With A D-Phe-Pro-Arg-Type
Inhibitor And A C- Terminal Hirudin Derived Exo-Site
Inhibitor
pdb|1MU6|B Chain B, Crystal Structure Of Thrombin In Complex With L-378,622
pdb|1MU8|B Chain B, Thrombin-Hirugen_l-378,650
pdb|1MUE|B Chain B, Thrombin-Hirugen-L405,426
pdb|1SR5|C Chain C, Antithrombin-Anhydrothrombin-Heparin Ternary Complex
Structure
pdb|1O5G|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1XMN|B Chain B, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|D Chain D, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|F Chain F, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|H Chain H, Crystal Structure Of Thrombin Bound To Heparin
pdb|1WAY|B Chain B, Active Site Thrombin Inhibitors
pdb|1T4U|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|1T4V|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|2AFQ|B Chain B, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2AFQ|D Chain D, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2A45|B Chain B, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|2A45|E Chain E, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|1W7G|H Chain H, Alpha-Thrombin Complex With Sulfated Hirudin (Residues
54-65) And L- Arginine Template Inhibitor Cs107
pdb|2FES|H Chain H, Orally Active Thrombin Inhibitors
pdb|2C8W|B Chain B, Thrombin Inhibitors
pdb|2C8X|B Chain B, Thrombin Inhibitors
pdb|2C8Y|B Chain B, Thrombin Inhibitors
pdb|2C8Z|B Chain B, Thrombin Inhibitors
pdb|2C90|B Chain B, Thrombin Inhibitors
pdb|2C93|B Chain B, Thrombin Inhibitors
pdb|2FEQ|H Chain H, Orally Active Thrombin Inhibitors
pdb|2BVS|H Chain H, Human Thrombin Complexed With Fragment-Based Small
Molecules Occupying The S1 Pocket
pdb|2BVX|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-P2-Linker
pdb|2BXT|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2BXU|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2A2X|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
Inh12
pdb|2ANK|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
And An Exosite Decapeptide
pdb|2GDE|H Chain H, Thrombin In Complex With Inhibitor
pdb|2H9T|H Chain H, Crystal Structure Of Human Alpha-Thrombin In Complex With
Suramin
pdb|2JH0|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH5|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH6|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|1C1U|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1V|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1W|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5L|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5N|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5O|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1HXE|H Chain H, Serine Protease
pdb|2UUF|B Chain B, Thrombin-Hirugen Binary Complex At 1.26a Resolution
pdb|2UUJ|B Chain B, Thrombin-Hirugen-Gw473178 Ternary Complex At 1.32a
Resolution
pdb|2UUK|B Chain B, Thrombin-Hirugen-Gw420128 Ternary Complex At 1.39a
Resolution
pdb|3BF6|H Chain H, Thrombin:suramin Complex
pdb|2R2M|B Chain B, 2-(2-chloro-6-fluorophenyl)acetamides As Potent Thrombin
Inhibitors
pdb|3EGK|H Chain H, Knoble Inhibitor
pdb|2ZC9|H Chain H, Thrombin In Complex With Inhibitor
pdb|2ZDA|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZDV|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZF0|H Chain H, Exploring Thrombin S1 Pocket
pdb|3E6P|H Chain H, Crystal Structure Of Human Meizothrombin Desf1
pdb|2ZFF|H Chain H, Exploring Thrombin S1-Pocket
pdb|2ZFP|H Chain H, Thrombin Inibition
pdb|2ZGB|H Chain H, Thrombin Inhibition
pdb|2ZGX|H Chain H, Thrombin Inhibition
pdb|2ZFQ|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZFR|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHQ|H Chain H, Thrombin Inhibition
pdb|2ZI2|H Chain H, Thrombin Inhibition
pdb|2ZIQ|H Chain H, Thrombin Inhibition
pdb|2ZG0|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHE|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHF|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHW|H Chain H, Exploring Thrombin S3 Pocket
pdb|3C27|B Chain B, Cyanofluorophenylacetamides As Orally Efficacious Thrombin
Inhibitors
pdb|2ZNK|H Chain H, Thrombin Inhibition
pdb|2ZO3|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3D49|H Chain H, Thrombin Inhibition
pdb|3DA9|B Chain B, Crystal Structure Of Thrombin In Complex With Inhibitor
pdb|3DHK|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3DT0|H Chain H, Understanding Thrombin Inhibition
pdb|3DUX|H Chain H, Understanding Thrombin Inhibition
pdb|3EQ0|H Chain H, Thrombin Inhibitor
pdb|3F68|H Chain H, Thrombin Inhibition
pdb|3PMH|B Chain B, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib
Interaction With Two Distinct Alpha-Thrombin Sites
pdb|3P6Z|B Chain B, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P6Z|H Chain H, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3LDX|H Chain H, Discovery And Clinical Evaluation Of Rwj-671818, A
Thrombin Inhibitor With An Oxyguanidine P1 Motif
pdb|3P70|B Chain B, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|D Chain D, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|F Chain F, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|H Chain H, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3TU7|H Chain H, Human Alpha-Thrombin Complexed With
N-(Methylsulfonyl)-D-Phenylalanyl-
N-((1-Carbamimidoyl-4-Piperidinyl)methyl)-L-Prolinamide
(Bms-189664)
pdb|3QLP|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And A Modified Thrombin Binding Aptamer (Mtba)
pdb|3P17|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3B23|B Chain B, Crystal Structure Of Thrombin-Variegin Complex: Insights
Of A Novel Mechanism Of Inhibition And Design Of Tunable
Thrombin Inhibitors
pdb|3QTO|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QTV|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QX5|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QWC|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3U69|H Chain H, Unliganded Wild-Type Human Thrombin
pdb|3U8T|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Cys
pdb|3RLW|H Chain H, Human Thrombin In Complex With Mi328
pdb|3RLY|H Chain H, Human Thrombin In Complex With Mi329
pdb|3RM0|H Chain H, Human Thrombin In Complex With Mi354
pdb|3RM2|H Chain H, Human Thrombin In Complex With Mi003
pdb|3RML|H Chain H, Human Thrombin In Complex With Mi331
pdb|3RMM|H Chain H, Human Thrombin In Complex With Mi332
pdb|3RMN|H Chain H, Human Thrombin In Complex With Mi341
pdb|3RMO|H Chain H, Human Thrombin In Complex With Mi004
pdb|3U8O|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-D-Thr
pdb|3U8R|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Ile
pdb|3SHA|H Chain H, Human Thrombin In Complex With Ubthr97
pdb|3SHC|H Chain H, Human Thrombin In Complex With Ubthr101
pdb|3SI3|H Chain H, Human Thrombin In Complex With Ubthr103
pdb|3SI4|H Chain H, Human Thrombin In Complex With Ubthr104
pdb|3SV2|H Chain H, Human Thrombin In Complex With Ubthr105
pdb|4E7R|H Chain H, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4E7R|G Chain G, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4DIH|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Sodium Ions
pdb|4DII|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Potassium Ions
pdb|3T5F|H Chain H, Human Thrombin In Complex With Mi340
pdb|3UTU|H Chain H, High Affinity Inhibitor Of Human Thrombin
pdb|3U98|H Chain H, Human Thrombin In Complex With Mi001
pdb|3U9A|H Chain H, Human Thrombin In Complex With Mi330
pdb|4E05|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|4E06|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|3UWJ|H Chain H, Human Thrombin In Complex With Mi353
pdb|4BAH|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAK|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAM|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAN|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAO|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAQ|B Chain B, Thrombin In Complex With Inhibitor
Length = 259
Score = 72.4 bits (176), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 136 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|2XWA|A Chain A, Crystal Structure Of Complement Factor D Mutant R202a
pdb|2XWA|B Chain B, Crystal Structure Of Complement Factor D Mutant R202a
Length = 228
Score = 72.4 bits (176), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 40/107 (37%), Positives = 56/107 (52%), Gaps = 8/107 (7%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAEC-KKTAYENRITPNMLCAGYPKGEKDSCQGD 209
V GWG+ G D+L V +P+L A C ++T ++ IT ++CA +DSC+GD
Sbjct: 125 VAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCA--ESNRRDSCKGD 182
Query: 210 SGGPLHYANETVHHIVGVVSWGEG-CAQENYPGVYARVNRYLTWIKN 255
SGGPL + GVV+ G C PG+Y RV Y WI +
Sbjct: 183 SGGPLVCGGV----LEGVVTSGSAVCGNRKKPGIYTRVASYAAWIDS 225
Score = 38.9 bits (89), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 16/43 (37%), Positives = 24/43 (55%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCV 129
I+GG+ H P+MA + CG L+ +VL+AAHC+
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCL 43
>pdb|2GP9|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A Self-
Inhibited Conformation
pdb|3BEI|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A
Self_inhibited Conformation
pdb|3BEF|B Chain B, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3BEF|E Chain E, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3QDZ|B Chain B, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4.
pdb|3QDZ|D Chain D, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4
Length = 259
Score = 72.4 bits (176), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 136 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|3NXP|A Chain A, Crystal Structure Of Human Prethrombin-1
Length = 424
Score = 72.4 bits (176), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 301 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 359
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 360 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 417
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 28/46 (60%), Gaps = 2/46 (4%)
Query: 86 RIVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
RIV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 165 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 210
>pdb|1M9U|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|B Chain B, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|C Chain C, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
Length = 241
Score = 72.4 bits (176), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 17/186 (9%)
Query: 83 KKTRIVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWVTI--- 139
+++ G Q V Y M++ A+ N++ +L A + G I +
Sbjct: 62 QQSDTSGTQTANVDSY-----TMHENYGAGTASYSNDIAILHLATSISLGGNIQAAVLPA 116
Query: 140 -RGKSFSNKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYE---NRITPNMLC 195
++ T +++GWG + D L + +P+++ A+C I N +C
Sbjct: 117 NNNNDYAGTTCVISGWGRTDGTNNLPDILQKSSIPVITTAQCTAAMVGVGGANIWDNHIC 176
Query: 196 AGYPKGEKDSCQGDSGGPLHYANETVHHIVGVVSW----GEGCAQENYPGVYARVNRYLT 251
P G +C GDSGGPL+ + +VGV SW G G +YP VY RV+ YL
Sbjct: 177 VQDPAGNTGACNGDSGGPLNCPDGGTR-VVGVTSWVVSSGLGACLPDYPSVYTRVSAYLG 235
Query: 252 WIKNNT 257
WI +N+
Sbjct: 236 WIGDNS 241
>pdb|3R3G|B Chain B, Structure Of Human Thrombin With Residues 145-150 Of
Murine Thrombin
Length = 259
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 45/118 (38%), Positives = 61/118 (51%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQGGSTS------DTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG ++ +T+ L V +PI+ CK + RIT NM CAGY E
Sbjct: 136 GRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|4D9Q|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9Q|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 72.0 bits (175), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 41/107 (38%), Positives = 55/107 (51%), Gaps = 8/107 (7%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAEC-KKTAYENRITPNMLCAGYPKGEKDSCQGD 209
V GWG+ G D L V +P+L A C ++T ++ IT M+CA +DSC+GD
Sbjct: 125 VAGWGIVSHAGRRPDRLQHVLLPVLDRATCNRRTHHDGAITQRMMCA--ESNRRDSCKGD 182
Query: 210 SGGPLHYANETVHHIVGVVSWGEG-CAQENYPGVYARVNRYLTWIKN 255
SGGPL + GVV+ G C PG+Y RV Y WI +
Sbjct: 183 SGGPLVCGGV----LEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDS 225
Score = 38.9 bits (89), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 16/43 (37%), Positives = 24/43 (55%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCV 129
I+GG+ H P+MA + CG L+ +VL+AAHC+
Sbjct: 1 ILGGREAEAHARPYMASVQVNGEHLCGGVLVAEQWVLSAAHCL 43
>pdb|1WBG|B Chain B, Active Site Thrombin Inhibitors
Length = 259
Score = 72.0 bits (175), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 58/118 (49%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 136 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC + G Y V R WI+
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCRDDGKYGFYTHVFRLKKWIQK 252
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1FDP|A Chain A, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|B Chain B, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|C Chain C, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|D Chain D, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
Length = 235
Score = 71.6 bits (174), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 40/107 (37%), Positives = 56/107 (52%), Gaps = 8/107 (7%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAEC-KKTAYENRITPNMLCAGYPKGEKDSCQGD 209
V GWG+ G D+L V +P+L A C ++T ++ IT ++CA +DSC+GD
Sbjct: 132 VAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCA--ESNRRDSCKGD 189
Query: 210 SGGPLHYANETVHHIVGVVSWGEG-CAQENYPGVYARVNRYLTWIKN 255
SGGPL + GVV+ G C PG+Y RV Y WI +
Sbjct: 190 SGGPLVCGGV----LEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDS 232
Score = 41.6 bits (96), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 18/50 (36%), Positives = 27/50 (54%)
Query: 80 AVNKKTRIVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCV 129
A + RI+GG+ H P+MA + CG L+ +VL+AAHC+
Sbjct: 1 AAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCL 50
>pdb|3GIC|B Chain B, Structure Of Thrombin Mutant Delta(146-149e) In The Free
Form
Length = 250
Score = 71.6 bits (174), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 46/112 (41%), Positives = 58/112 (51%), Gaps = 9/112 (8%)
Query: 149 GIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEK---DS 205
G VTGWG K S L V +PI+ CK + RIT NM CAGY E D+
Sbjct: 136 GRVTGWGNLKGQPSV---LQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDEGKRGDA 191
Query: 206 CQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 192 CEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 243
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|3K65|B Chain B, Crystal Structure Of Prethombin-2FRAGMENT-2 Complex
Length = 308
Score = 71.6 bits (174), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 45/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 185 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 243
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GD+GGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 244 GKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 301
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 28/46 (60%), Gaps = 2/46 (4%)
Query: 86 RIVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
RIV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 49 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 94
>pdb|1DSU|A Chain A, Human Factor D, Complement Activating Enzyme
pdb|1DSU|B Chain B, Human Factor D, Complement Activating Enzyme
pdb|1DFP|A Chain A, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DFP|B Chain B, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DIC|A Chain A, Structure Of 3,4-Dichloroisocoumarin-Inhibited Factor D
pdb|1BIO|A Chain A, Human Complement Factor D In Complex With Isatoic
Anhydride Inhibitor
pdb|1HFD|A Chain A, Human Complement Factor D In A P21 Crystal Form
pdb|4D9R|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9R|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 71.6 bits (174), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 40/107 (37%), Positives = 56/107 (52%), Gaps = 8/107 (7%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAEC-KKTAYENRITPNMLCAGYPKGEKDSCQGD 209
V GWG+ G D+L V +P+L A C ++T ++ IT ++CA +DSC+GD
Sbjct: 125 VAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCA--ESNRRDSCKGD 182
Query: 210 SGGPLHYANETVHHIVGVVSWGEG-CAQENYPGVYARVNRYLTWIKN 255
SGGPL + GVV+ G C PG+Y RV Y WI +
Sbjct: 183 SGGPLVCGGV----LEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDS 225
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 16/43 (37%), Positives = 24/43 (55%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCV 129
I+GG+ H P+MA + CG L+ +VL+AAHC+
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCL 43
>pdb|1DM4|B Chain B, Ser195ala Mutant Of Human Thrombin Complexed With
Fibrinopeptide A (7- 16)
pdb|1JMO|H Chain H, Crystal Structure Of The Heparin Cofactor Ii-S195a
Thrombin Complex
Length = 260
Score = 71.6 bits (174), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 45/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 137 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 195
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GD+GGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 196 GKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 253
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 28/46 (60%), Gaps = 2/46 (4%)
Query: 86 RIVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
RIV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 46
>pdb|1EAI|A Chain A, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1EAI|B Chain B, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1C1M|A Chain A, Porcine Elastase Under Xenon Pressure (8 Bar)
pdb|1HV7|A Chain A, Porcine Pancreatic Elastase Complexed With Gw311616a
pdb|1FZZ|A Chain A, The Crystal Structure Of The Complex Of Non-Peptidic
Inhibitor Ono-6818 And Porcine Pancreatic Elastase.
pdb|1GWA|A Chain A, Triiodide Derivative Of Porcine Pancreas Elastase
pdb|1L0Z|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Dry Paraffin
Oil
pdb|1L1G|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Glycerol
pdb|1LKA|A Chain A, Porcine Pancreatic ElastaseCA-Complex
pdb|1LKB|A Chain A, Porcine Pancreatic Elastase/na-complex
pdb|1MMJ|N Chain N, Porcine Pancreatic Elastase Complexed With A Potent
Peptidyl Inhibitor, Fr136706
pdb|1MCV|A Chain A, Crystal Structure Analysis Of A Hybrid Squash Inhibitor In
Complex With Porcine Pancreatic Elastase
pdb|1UO6|A Chain A, Porcine Pancreatic ElastaseXE-Complex
pdb|1UVO|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(crystal A)
pdb|1UVP|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(Crystal B)
pdb|2A7C|A Chain A, On The Routine Use Of Soft X-rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2A7J|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2BLO|A Chain A, Elastase Before A High Dose X-Ray "burn"
pdb|2BLQ|A Chain A, Elastase After A High Dose X-Ray "burn"
pdb|2D26|C Chain C, Active Site Distortion Is Sufficient For Proteinase
Inhibit Second Crystal Structure Of Covalent
Serpin-Proteinase Complex
pdb|2CV3|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With A Macroclyclic Peptide Inhibitor
pdb|2DE8|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With A
Unique Conformation Induced By Tris
pdb|2DE9|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With Tris After Soaking A Tris-Free Solution
pdb|2G4T|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastase (na)
pdb|2G4U|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastaase
(ca)
pdb|2OQU|A Chain A, High Pressure Cryocooling Of Capillary Sample
Cryoprotection And Diffraction Phasing At Long
Wavelengths
pdb|1QNJ|A Chain A, The Structure Of Native Porcine Pancreatic Elastase At
Atomic Resolution (1.1 A)
pdb|2IOT|A Chain A, Clavulanic Acid Bound To Elastase
pdb|2V0B|A Chain A, Sad Structure Solution Porcine Pancreatic Elastase From A
Selenate Derivative
pdb|2V35|A Chain A, Porcine Pancreatic Elastase In Complex With Inhibitor Jm54
pdb|3HGP|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By High
Resolution Crystallography
pdb|3HGN|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By Neutron
Crystallography
pdb|3UOU|A Chain A, Crystal Structure Of The Kunitz-Type Protease Inhibitor
Shpi-1 Lys13leu Mutant In Complex With Pancreatic
Elastase
Length = 240
Score = 71.6 bits (174), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 40/108 (37%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPN-MLCAGYPKGEKDSCQGD 209
+TGWG+ + G + TL + +P + A C ++Y N M+CAG G + CQGD
Sbjct: 129 ITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCAG-GDGVRSGCQGD 187
Query: 210 SGGPLHYANETVHHIVGVVSWGE--GCAQENYPGVYARVNRYLTWIKN 255
SGGPLH + + GV S+ GC P V+ RV+ Y++WI N
Sbjct: 188 SGGPLHCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINN 235
Score = 36.2 bits (82), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 35/76 (46%), Gaps = 4/76 (5%)
Query: 87 IVGGQVTYVHQYPWMALLMYKK----RFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGK 142
+VGG + +P L Y+ CG TLI +V+TAAHCV + L V +
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTFRVVVGEH 60
Query: 143 SFSNKTGIVTGWGVQK 158
+ + G GVQK
Sbjct: 61 NLNQNDGTEQYVGVQK 76
>pdb|2EST|E Chain E, Crystallographic Study Of The Binding Of A Trifluoroacetyl
Dipeptide Anilide Inhibitor With Elastase
pdb|4EST|E Chain E, Crystal Structure Of The Covalent Complex Formed By A
Peptidyl Alpha, Alpha-Difluoro-Beta-Keto Amide With
Porcine Pancreatic Elastase At 1.78-Angstroms Resolution
pdb|5EST|E Chain E, Crystallographic Analysis Of The Inhibition Of Porcine
Pancreatic Elastase By A Peptidyl Boronic Acid:
Structure Of A Reaction Intermediate
pdb|7EST|E Chain E, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|8EST|E Chain E, Reaction Of Porcine Pancreatic Elastase With 7-substituted
3-alkoxy-4-chloroisocoumarins: Design Of Potent
Inhibitors Using The Crystal Structure Of The Complex
Formed With 4- Chloro-3-ethoxy-7-guanidino-isocoumarin
pdb|1ELA|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELC|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELB|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELD|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1ELE|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1NES|E Chain E, Structure Of The Product Complex Of Acetyl-ala-pro-ala
With Porcine Pancreatic Elastase At 1.65 Angstroms
Resolution
pdb|1BMA|A Chain A, Benzyl Methyl Aminimide Inhibitor Complexed To Porcine
Pancreatic Elastase
pdb|1FLE|E Chain E, Crystal Structure Of Elafin Complexed With Porcine
Pancreatic Elastase
pdb|1B0E|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With Mdl
101,146
pdb|1QGF|A Chain A, Porcine Pancreatic Elastase Complexed With (3r, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One
pdb|1QIX|B Chain B, Porcine Pancreatic Elastase Complexed With Human
Beta-casomorphin-7
pdb|1QR3|E Chain E, Structure Of Porcine Pancreatic Elastase In Complex With
Fr901277, A Novel Macrocyclic Inhibitor Of Elastases At
1.6 Angstrom Resolution
pdb|1E34|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2- One Soaked In Ph 9 Buffer For One Minute
pdb|1E35|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One Soaked In Ph 9 Buffer For Two
Minutes
pdb|1E36|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One
pdb|1E37|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 1 Minute
pdb|1E38|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 2 Minutes
pdb|1HAZ|B Chain B, Snapshots Of Serine Protease Catalysis: (c) Acyl-enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-casomorphin-7 Jumped To Ph 9 For 1 Minute
pdb|1H9L|B Chain B, Porcine Pancreatic Elastase Complexed With
Acetyl-Val-Glu-Pro-Ile-Cooh
pdb|1OKX|A Chain A, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|1OKX|B Chain B, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|2FO9|A Chain A, Structure Of Porcine Pancreatic Elastase In 95% Acetone
pdb|2FOA|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010 %
BENZENE
pdb|2FOB|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010
CYCLOHEXANE
pdb|2FOC|A Chain A, Structure Of Porcine Pancreatic Elastase In 55%
Dimethylformamide
pdb|2FOD|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Ethanol
pdb|2FOE|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Hexane
pdb|2FOF|A Chain A, Structure Of Porcine Pancreatic Elastase In 80%
Isopropanol
pdb|2FOG|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2FOH|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2BD4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin- 7 And Lys-Ser At Ph 5.0
pdb|2BD5|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Lys- Ser At Ph 5 And Immersed In
Ph 9 Buffer For 30 Seconds
pdb|2BD9|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 28 Seconds (2nd Ph Jump)
pdb|2BDC|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile At
Ph 5.0
pdb|2H1U|A Chain A, Porcine Pancreatic Elastase Complexed With Metpheleuglu At
Ph 5.0
pdb|1BTU|A Chain A, Porcine Pancreatic Elastase Complexed With (3s, 4r)-1-
Toluenesulphonyl-3-Ethyl-Azetidin-2-One-4-Carboxylic
Acid
pdb|1EAS|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 3.
Design, Synthesis, X-Ray Crystallographic Analysis, And
Structure-Activity Relationships For A Series Of Orally
Active 3-Amino-6-Phenylpyridin- 2-One Trifluoromethyl
Ketones
pdb|1EAT|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 5.
Design, Synthesis, And X-Ray Crystallography Of A Series
Of Orally Active 5- Amino-Pyrimidin-6-One-Containing
Trifluoromethylketones
pdb|1EAU|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 6.
Design Of A Potent, Intratracheally Active,
Pyridone-Based Trifluoromethyl Ketone
pdb|1ELF|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ELG|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ESA|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|1EST|A Chain A, The Atomic Structure Of Crystalline Porcine Pancreatic
Elastase At 2.5 Angstroms Resolution. Comparisons With
The Structure Of Alpha- Chymotrypsin
pdb|1INC|A Chain A, Crystal Structures Of The Complex Of Porcine Pancreatic
Elastase With Two Valine-Derived Benzoxazinone
Inhibitors
pdb|1JIM|A Chain A, Stereospecific Reaction Of 3-Methoxy-4-Chloro-7-
Aminoisocoumarin With Crystalline Porcine Pancreatic
Elastase
pdb|1LVY|A Chain A, Porcine Elastase
pdb|3EST|A Chain A, Structure Of Native Porcine Pancreatic Elastase At 1.65
Angstroms Resolution
pdb|6EST|A Chain A, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|9EST|A Chain A, Structural Study Of Porcine Pancreatic Elastase Complexed
With 7- Amino-3-(2-Bromoethoxy)-4-Chloroisocoumarin As A
Nonreactivatable Doubly Covalent Enzyme-Inhibitor
Complex
pdb|1GVK|B Chain B, Porcine Pancreatic Elastase Acyl Enzyme At 0.95 A
Resolution
pdb|3E3T|A Chain A, Structure Of Porcine Pancreatic Elastase With The Magic
Triangle I3c
pdb|3MNB|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. First Stage Of
Radiation Damage
pdb|3MNC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Second Stage Of
Radiation Damage
pdb|3MNS|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Third Stage Of
Radiation Damage
pdb|3MNX|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fourth Stage Of
Radiation Damage
pdb|3MO3|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fifth Stage Of
Radiation Damage
pdb|3MO6|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Sixth Stage Of
Radiation Damage
pdb|3MO9|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Seventh Stage Of
Radiation Damage
pdb|3MOC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Eighth Stage Of
Radiation Damage
pdb|3MTY|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. First Step Of Radiation
Damage
pdb|3MU0|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU1|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3MU4|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. First Step Of Radiation
Damage
pdb|3MU5|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU8|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3ODD|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Second Step Of Radiation
Damage
pdb|3ODF|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Second Step Of Radiation
Damage
pdb|2BB4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Asp- Phe At Ph 5.0
pdb|2BD2|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0
pdb|2BD3|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Lys- Ala-nh2 At Ph 5.0
pdb|2BD7|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
pdb|2BD8|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 30 Seconds
pdb|2BDA|A Chain A, Porcine Pancreatic Elastase Complexed With N-Acetyl-Npi
And Ala-Ala At Ph 5.0
pdb|2BDB|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile And
Ala-ala At Ph 5.0
pdb|1ESB|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|4GVU|A Chain A, Lyngbyastatin 7-porcine Pancreatic Elastase Co-crystal
Structure
Length = 240
Score = 71.6 bits (174), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 40/108 (37%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPN-MLCAGYPKGEKDSCQGD 209
+TGWG+ + G + TL + +P + A C ++Y N M+CAG G + CQGD
Sbjct: 129 ITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCAG-GDGVRSGCQGD 187
Query: 210 SGGPLHYANETVHHIVGVVSWGE--GCAQENYPGVYARVNRYLTWIKN 255
SGGPLH + + GV S+ GC P V+ RV+ Y++WI N
Sbjct: 188 SGGPLHCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINN 235
Score = 36.2 bits (82), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 35/76 (46%), Gaps = 4/76 (5%)
Query: 87 IVGGQVTYVHQYPWMALLMYKK----RFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGK 142
+VGG + +P L Y+ CG TLI +V+TAAHCV + L V +
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTFRVVVGEH 60
Query: 143 SFSNKTGIVTGWGVQK 158
+ + G GVQK
Sbjct: 61 NLNQNNGTEQYVGVQK 76
>pdb|3SQE|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The
Alternative Form
pdb|3SQH|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The The
Open Form
Length = 290
Score = 71.6 bits (174), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 45/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 167 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 225
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GD+GGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 226 GKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 283
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 20/46 (43%), Positives = 28/46 (60%), Gaps = 2/46 (4%)
Query: 86 RIVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
RIV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 31 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 76
>pdb|1HAX|B Chain B, Snapshots Of Serine Protease Catalysis: (A) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 At Ph 5
pdb|1HAY|B Chain B, Snapshots Of Serine Protease Catalysis: (B) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 10 Seconds
pdb|1HB0|B Chain B, Snapshots Of Serine Protease Catalysis: (D) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 2 Minutes
Length = 240
Score = 71.6 bits (174), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 40/108 (37%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPN-MLCAGYPKGEKDSCQGD 209
+TGWG+ + G + TL + +P + A C ++Y N M+CAG G + CQGD
Sbjct: 129 ITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCAG-GDGVRSGCQGD 187
Query: 210 SGGPLHYANETVHHIVGVVSWGE--GCAQENYPGVYARVNRYLTWIKN 255
SGGPLH + + GV S+ GC P V+ RV+ Y++WI N
Sbjct: 188 SGGPLHCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINN 235
Score = 36.2 bits (82), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 35/76 (46%), Gaps = 4/76 (5%)
Query: 87 IVGGQVTYVHQYPWMALLMYKK----RFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGK 142
+VGG + +P L Y+ CG TLI +V+TAAHCV + L V +
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCVDRELTFRVVVGEH 60
Query: 143 SFSNKTGIVTGWGVQK 158
+ + G GVQK
Sbjct: 61 NLNQNNGTEQYVGVQK 76
>pdb|1JOU|B Chain B, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|D Chain D, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|F Chain F, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1TB6|H Chain H, 2.5a Crystal Structure Of The
Antithrombin-Thrombin-Heparin Ternary Complex
pdb|2B5T|B Chain B, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|2B5T|D Chain D, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|3B9F|H Chain H, 1.6 A Structure Of The Pci-Thrombin-Heparin Complex
pdb|3GIS|B Chain B, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|D Chain D, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|F Chain F, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3LU9|B Chain B, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|3LU9|E Chain E, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|4DT7|B Chain B, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DT7|D Chain D, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DY7|B Chain B, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
pdb|4DY7|E Chain E, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
Length = 259
Score = 71.6 bits (174), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 45/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 136 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GD+GGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 195 GKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1RD3|B Chain B, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
pdb|1RD3|D Chain D, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
Length = 259
Score = 70.9 bits (172), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 45/118 (38%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 136 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWG+GC ++ G Y V R WI+
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGKGCDRDGKYGFYTHVFRLKKWIQK 252
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1ORF|A Chain A, The Oligomeric Structure Of Human Granzyme A Reveals The
Molecular Determinants Of Substrate Specificity
Length = 234
Score = 70.9 bits (172), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 62/189 (32%), Positives = 89/189 (47%), Gaps = 22/189 (11%)
Query: 81 VNKKTRIVGGQVTYVHQYPWMALLMYKKRF----YCGATLINNLYVLTAAHCVHQGLGIW 136
+NK+++++ G + + P +++ KK F Y AT +L +L + +
Sbjct: 44 LNKRSQVILGAHSITREEPTKQIMLVKKEFPYPCYDPATREGDLKLLQLTE--KAKINKY 101
Query: 137 VTI-----RGKSFSNKTGI-VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENR-- 188
VTI +G T V GWG S SDTL EVE+ I+ C + N
Sbjct: 102 VTILHLPKKGDDVKPGTMCQVAGWGRTHNSASWSDTLREVEITIIDRKVCNDRNHYNFNP 161
Query: 189 -ITPNMLCAGYPKGEKDSCQGDSGGPLHYANETVHHIVGVVSWG--EGCAQENYPGVYAR 245
I NM+CAG +G +DSC GDSG PL E V GV S+G C PGVY
Sbjct: 162 VIGMNMVCAGSLRGGRDSCNGDSGSPL--LCEGVFR--GVTSFGLENKCGDPRGPGVYIL 217
Query: 246 VN-RYLTWI 253
++ ++L WI
Sbjct: 218 LSKKHLNWI 226
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 18/42 (42%), Positives = 23/42 (54%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC 128
I+GG H P+M LL ++ C LI +VLTAAHC
Sbjct: 1 IIGGNEVTPHSRPYMVLLSLDRKTICAGALIAKDWVLTAAHC 42
>pdb|1Z8I|B Chain B, Crystal Structure Of The Thrombin Mutant G193a Bound To
Ppack
Length = 259
Score = 70.9 bits (172), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 45/118 (38%), Positives = 58/118 (49%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 136 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+ DSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 195 GKRGDACEADSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|2XW9|A Chain A, Crystal Structure Of Complement Factor D Mutant S183a
pdb|2XWB|I Chain I, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|J Chain J, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 228
Score = 70.5 bits (171), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 39/107 (36%), Positives = 56/107 (52%), Gaps = 8/107 (7%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAEC-KKTAYENRITPNMLCAGYPKGEKDSCQGD 209
V GWG+ G D+L V +P+L A C ++T ++ IT ++CA +DSC+GD
Sbjct: 125 VAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCA--ESNRRDSCKGD 182
Query: 210 SGGPLHYANETVHHIVGVVSWGEG-CAQENYPGVYARVNRYLTWIKN 255
+GGPL + GVV+ G C PG+Y RV Y WI +
Sbjct: 183 AGGPLVCGGV----LEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDS 225
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 16/43 (37%), Positives = 24/43 (55%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCV 129
I+GG+ H P+MA + CG L+ +VL+AAHC+
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCL 43
>pdb|2XXL|A Chain A, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
pdb|2XXL|B Chain B, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
Length = 408
Score = 70.5 bits (171), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 50/131 (38%), Positives = 70/131 (53%), Gaps = 12/131 (9%)
Query: 133 LGIWVTIRGKSFSNKTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPN 192
L I ++ K+ T VTGWG + GS+SD LL+ VP+ + C + AY + +
Sbjct: 244 LPITDELKEKAEQISTYFVTGWGT-TENGSSSDVLLQANVPLQPRSACSQ-AYRRAVPLS 301
Query: 193 MLCAGYPKGE-KDSCQGDSGGPL----HYANETVHHIV--GVVSWG-EGCAQENYPGVYA 244
LC G G+ +DSC+GDSGGPL Y E +V G+VS G C Q + PG+Y
Sbjct: 302 QLCVG--GGDLQDSCKGDSGGPLQAPAQYLGEYAPKMVEFGIVSQGVVTCGQISLPGLYT 359
Query: 245 RVNRYLTWIKN 255
V Y+ WI +
Sbjct: 360 NVGEYVQWITD 370
Score = 53.9 bits (128), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 34/100 (34%), Positives = 46/100 (46%), Gaps = 10/100 (10%)
Query: 40 DYTSWFQELISGFVTNQEESTPPEP-----VKPVDLEKCGPCTCGAVNKKTRIVGGQVTY 94
DY S+ Q+ + G P K + L K CG + R+ G
Sbjct: 68 DYASYLQKALCGEFNGVRHFCCPSANIQHNSKVMSLFKDENFDCGNFLSQ-RVSNGYEVK 126
Query: 95 VHQYPWMALLMYKK----RFYCGATLINNLYVLTAAHCVH 130
+ PWMALL Y++ RF CG +I+ Y+LTAAHCVH
Sbjct: 127 LSSRPWMALLRYQQFGESRFLCGGAMISERYILTAAHCVH 166
>pdb|2OD3|B Chain B, Human Thrombin Chimera With Human Residues 184a, 186,
186a, 186b, 186c And 222 Replaced By Murine Thrombin
Equivalents
Length = 259
Score = 70.5 bits (171), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 44/118 (37%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAG+ +
Sbjct: 136 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGFKVND 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 195 TKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRKGKYGFYTHVFRLKKWIQK 252
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|2OCV|B Chain B, Structural Basis Of Na+ Activation Mimicry In Murine
Thrombin
Length = 259
Score = 70.1 bits (170), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 43/117 (36%), Positives = 61/117 (52%), Gaps = 12/117 (10%)
Query: 149 GIVTGWGVQKQGGSTS------DTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG ++ +T+ L V +PI+ CK + RIT NM CAG+ +
Sbjct: 136 GRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKAST-RIRITDNMFCAGFKVND 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 195 TKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRKGKYGFYTHVFRLKAWIQ 251
Score = 38.1 bits (87), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 16/33 (48%), Positives = 23/33 (69%), Gaps = 2/33 (6%)
Query: 99 PWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 13 PWQVMLFRKSPQELLCGASLISDRWVLTAAHCI 45
>pdb|1Z8J|B Chain B, Crystal Structure Of The Thrombin Mutant G193p Bound To
Ppack
Length = 259
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 45/118 (38%), Positives = 58/118 (49%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 136 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+ DSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 195 GKRGDACEPDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1VR1|H Chain H, Specifity For Plasminogen Activator Inhibitor-1
Length = 261
Score = 69.3 bits (168), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 45/118 (38%), Positives = 58/118 (49%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CA Y E
Sbjct: 140 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAYYKPDE 198
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 199 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 256
Score = 42.4 bits (98), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 21/49 (42%), Positives = 29/49 (59%), Gaps = 6/49 (12%)
Query: 87 IVGGQVTYVHQYPWMALLMYK------KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K +RF CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFAKHRRSPGERFLCGASLISDRWVLTAAHCL 49
>pdb|2PSX|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin
pdb|2PSY|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin And Zinc
Length = 227
Score = 69.3 bits (168), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 45/113 (39%), Positives = 65/113 (57%), Gaps = 9/113 (7%)
Query: 150 IVTGWGVQKQGGSTSDTLLE-VEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+V+GWG K +L+ + + +LS C+ AY +I M CAG K +DSCQG
Sbjct: 120 LVSGWGTTKSPQVHFPKVLQCLNISVLSQKRCED-AYPRQIDDTMFCAG-DKAGRDSCQG 177
Query: 209 DSGGPLHYANETVHHIVGVVSWGE-GCAQENYPGVYARVNRYLTWIKNNTIDA 260
DSGGP+ N ++ G+VSWG+ CA+ N PGVY + ++ WI+ TI A
Sbjct: 178 DSGGPV-VCNGSLQ---GLVSWGDYPCARPNRPGVYTNLCKFTKWIQ-ETIQA 225
>pdb|2PUX|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par3
pdb|2PV9|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par4
Length = 258
Score = 68.9 bits (167), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 42/117 (35%), Positives = 61/117 (52%), Gaps = 12/117 (10%)
Query: 149 GIVTGWGVQKQGGSTS------DTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG ++ +T+ L V +PI+ CK + RIT NM CAG+ +
Sbjct: 136 GRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKAST-RIRITDNMFCAGFKVND 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
D+C+GD+GGP + + +G+VSWGEGC ++ G Y V R WI+
Sbjct: 195 TKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRKGKYGFYTHVFRLKRWIQ 251
Score = 38.1 bits (87), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 16/33 (48%), Positives = 23/33 (69%), Gaps = 2/33 (6%)
Query: 99 PWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 13 PWQVMLFRKSPQELLCGASLISDRWVLTAAHCI 45
>pdb|1OP8|A Chain A, Crystal Structure Of Human Granzyme A
pdb|1OP8|B Chain B, Crystal Structure Of Human Granzyme A
pdb|1OP8|C Chain C, Crystal Structure Of Human Granzyme A
pdb|1OP8|D Chain D, Crystal Structure Of Human Granzyme A
pdb|1OP8|E Chain E, Crystal Structure Of Human Granzyme A
pdb|1OP8|F Chain F, Crystal Structure Of Human Granzyme A
Length = 234
Score = 68.9 bits (167), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 61/189 (32%), Positives = 88/189 (46%), Gaps = 22/189 (11%)
Query: 81 VNKKTRIVGGQVTYVHQYPWMALLMYKKRF----YCGATLINNLYVLTAAHCVHQGLGIW 136
+NK+++++ G + + P +++ KK F Y AT +L +L + +
Sbjct: 44 LNKRSQVILGAHSITREEPTKQIMLVKKEFPYPCYDPATREGDLKLLQLTE--KAKINKY 101
Query: 137 VTI-----RGKSFSNKTGI-VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENR-- 188
VTI +G T V GWG S SDTL EV + I+ C + N
Sbjct: 102 VTILHLPKKGDDVKPGTMCQVAGWGRTHNSASWSDTLREVNITIIDRKVCNDRNHYNFNP 161
Query: 189 -ITPNMLCAGYPKGEKDSCQGDSGGPLHYANETVHHIVGVVSWG--EGCAQENYPGVYAR 245
I NM+CAG +G +DSC GDSG PL E V GV S+G C PGVY
Sbjct: 162 VIGMNMVCAGSLRGGRDSCNGDSGSPL--LCEGVFR--GVTSFGLENKCGDPRGPGVYIL 217
Query: 246 VN-RYLTWI 253
++ ++L WI
Sbjct: 218 LSKKHLNWI 226
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 18/42 (42%), Positives = 23/42 (54%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC 128
I+GG H P+M LL ++ C LI +VLTAAHC
Sbjct: 1 IIGGNEVTPHSRPYMVLLSLDRKTICAGALIAKDWVLTAAHC 42
>pdb|2B9L|A Chain A, Crystal Structure Of Prophenoloxidase Activating Factor-Ii
From The Beetle Holotrichia Diomphalia
Length = 394
Score = 68.2 bits (165), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 46/154 (29%), Positives = 76/154 (49%), Gaps = 17/154 (11%)
Query: 115 TLINNLYVLTAAHCVHQGLGIWVTI---RGKSFSNKTGIVTGWGVQKQGGST---SDTLL 168
T++N++ +L + Q I + + F + +GWG +K+ GS S+ L
Sbjct: 227 TVVNDVALLLLDRPLVQADNIGTICLPQQSQIFDSTECFASGWG-KKEFGSRHRYSNILK 285
Query: 169 EVEVPILSNAECKKTAYENRI------TPNMLCAGYPKGEKDSCQGDSGGPLHY---ANE 219
++++P + +C+ R+ +CAG +G KD+C GD G PL N
Sbjct: 286 KIQLPTVDRDKCQADLRNTRLGLKFVLDQTFVCAGGEQG-KDTCTGDGGSPLFCPDPRNP 344
Query: 220 TVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
+ + +G+V+WG GC EN PGVYA V + WI
Sbjct: 345 SRYMQMGIVAWGIGCGDENVPGVYANVAHFRNWI 378
>pdb|1ELV|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Complement C1s Protease
Length = 333
Score = 68.2 bits (165), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 71/267 (26%), Positives = 96/267 (35%), Gaps = 90/267 (33%)
Query: 69 DLEKCGPCTCGA----VNKKTRIVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLT 124
+L KC P CG +K RI+GG + +PW + G LIN +VLT
Sbjct: 62 ELPKCVP-VCGVPREPFEEKQRIIGGSDADIKNFPWQVFF---DNPWAGGALINEYWVLT 117
Query: 125 AAHCV---------------------------------HQGLGIWVTIRGKS-FSNKTGI 150
AAH V H G + G++ F N +
Sbjct: 118 AAHVVEGNREPTMYVGSTSVQTSRLAKSKMLTPEHVFIHPGWKLLAVPEGRTNFDNDIAL 177
Query: 151 VTGWGVQKQG---------GSTSD------------------------TLLEVEVPILSN 177
V K G G++SD L +P+
Sbjct: 178 VRLKDPVKMGPTVSPICLPGTSSDYNLMDGDLGLISGWGRTEKRDRAVRLKAARLPVAPL 237
Query: 178 AECKKTAYENR--------ITPNMLCAGYPKGEKDSCQGDSGGPLHYA---NETVHHIVG 226
+CK+ E TPNM+CAG KG DSC+GDSGG ++T + G
Sbjct: 238 RKCKEVKVEKPTADAEAYVFTPNMICAGGEKG-MDSCKGDSGGAFAVQDPNDKTKFYAAG 296
Query: 227 VVSWGEGCAQENYPGVYARVNRYLTWI 253
+VSWG C G+Y RV Y+ WI
Sbjct: 297 LVSWGPQCGTY---GLYTRVKNYVDWI 320
>pdb|4GAW|A Chain A, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|B Chain B, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|C Chain C, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|D Chain D, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|E Chain E, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|F Chain F, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|G Chain G, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|H Chain H, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|I Chain I, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|J Chain J, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|K Chain K, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|L Chain L, Crystal Structure Of Active Human Granzyme H
Length = 226
Score = 67.4 bits (163), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 61/231 (26%), Positives = 90/231 (38%), Gaps = 70/231 (30%)
Query: 87 IVGGQVTYVHQYPWMALLMY---KKRFYCGATLINNLYVLTAAHCVHQGLGIWVTIRG-- 141
I+GG H P+MA + + K R CG L+ +VLTAAHC QG I VT+
Sbjct: 1 IIGGHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHC--QGSSINVTLGAHN 58
Query: 142 ------------------------KSFSNKTGI--------------------------- 150
K+FSN +
Sbjct: 59 IKEQERTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKWTTAVRPLRLPSSKAQVKP 118
Query: 151 -----VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDS 205
V GWG + + TL EV + + + +C++ + N +C G PK +
Sbjct: 119 GQLCSVAGWGYVSMS-TLATTLQEVLLTVQKDCQCERLFHGNYSRATEICVGDPKKTQTG 177
Query: 206 CQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNN 256
+GDSGGPL + G++S+G + PGVY +V+ +L WIK
Sbjct: 178 FKGDSGGPLVCKDVA----QGILSYGN--KKGTPPGVYIKVSHFLPWIKRT 222
>pdb|3TJU|A Chain A, Crystal Structure Of Human Granzyme H With An Inhibitor
pdb|3TJV|A Chain A, Crystal Structure Of Human Granzyme H With A Peptidyl
Substrate
pdb|3TK9|A Chain A, Crystal Structure Of Human Granzyme H
Length = 226
Score = 67.4 bits (163), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 61/230 (26%), Positives = 90/230 (39%), Gaps = 70/230 (30%)
Query: 87 IVGGQVTYVHQYPWMALLMY---KKRFYCGATLINNLYVLTAAHCVHQGLGIWVTIRG-- 141
I+GG H P+MA + + K R CG L+ +VLTAAHC QG I VT+
Sbjct: 1 IIGGHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHC--QGSSINVTLGAHN 58
Query: 142 ------------------------KSFSNKTGI--------------------------- 150
K+FSN +
Sbjct: 59 IKEQERTQQFIPVKRPIPHPAYNPKNFSNNIMLLQLERKAKWTTAVRPLRLPSSKAQVKP 118
Query: 151 -----VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDS 205
V GWG + + TL EV + + + +C++ + N +C G PK +
Sbjct: 119 GQLCSVAGWGYVSMS-TLATTLQEVLLTVQKDCQCERLFHGNYSRATEICVGDPKKTQTG 177
Query: 206 CQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
+GDSGGPL + G++S+G + PGVY +V+ +L WIK
Sbjct: 178 FKGDSGGPLVCKDVA----QGILSYGN--KKGTPPGVYIKVSHFLPWIKR 221
>pdb|1BBR|E Chain E, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|E Chain E, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|G Chain G, Thrombin:hirudin 51-65 Complex
pdb|1YCP|M Chain M, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 109
Score = 67.4 bits (163), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 38/95 (40%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 166 TLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEK---DSCQGDSGGPLHYAN--ET 220
L V +P++ CK + RIT NM CAGY GE D+C+GDSGGP +
Sbjct: 9 VLQVVNLPLVERPVCKAST-RIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNN 67
Query: 221 VHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
+ +G+VSWGEGC ++ G Y V R WI+
Sbjct: 68 RWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 102
>pdb|2KAI|B Chain B, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|B Chain B, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|Y Chain Y, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|B Chain B, Kallikrein Complexed With Hirustasin
pdb|1HIA|Y Chain Y, Kallikrein Complexed With Hirustasin
Length = 152
Score = 67.0 bits (162), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 41/110 (37%), Positives = 58/110 (52%), Gaps = 9/110 (8%)
Query: 151 VTGWGVQKQGGST---SDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQ 207
+GWG + G D + V++ +L N C A+ +++T +MLCAGY G KD+C
Sbjct: 43 ASGWGSIEPGPDDFEFPDEIQCVQLTLLQNTFCAD-AHPDKVTESMLCAGYLPGGKDTCM 101
Query: 208 GDSGGPLHYANETVHHIVGVVSWGEG-CAQENYPGVYARVNRYLTWIKNN 256
GDSGGPL N G+ SWG C N P +Y ++ YL WI +
Sbjct: 102 GDSGGPL-ICNGMWQ---GITSWGHTPCGSANKPSIYTKLIFYLDWIDDT 147
>pdb|1ELT|A Chain A, Structure Of Native Pancreatic Elastase From North
Atlantic Salmon At 1.61 Angstroms Resolution
Length = 236
Score = 66.6 bits (161), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 36/107 (33%), Positives = 57/107 (53%), Gaps = 5/107 (4%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTA-YENRITPNMLCAGYPKGEKDSCQGD 209
+TGWG GG SD+L + +P + +A C + + + + M+CAG G C GD
Sbjct: 129 ITGWGKTSTGGPLSDSLKQAWLPSVDHATCSSSGWWGSTVKTTMVCAG--GGANSGCNGD 186
Query: 210 SGGPLHYANETVHHIVGVVSW--GEGCAQENYPGVYARVNRYLTWIK 254
SGGPL+ +++ GV S+ GC P V+ RV+ Y++W+
Sbjct: 187 SGGPLNCQVNGSYYVHGVTSFVSSSGCNASKKPTVFTRVSAYISWMN 233
>pdb|2PGB|B Chain B, Inhibitor-Free Human Thrombin Mutant C191a-C220a
pdb|2PGQ|B Chain B, Human Thrombin Mutant C191a-C220a In Complex With The
Inhibitor Ppack
Length = 259
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 44/118 (37%), Positives = 57/118 (48%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 136 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+ +GDSGGP + + +G+VSWGEG ++ G Y V R WI+
Sbjct: 195 GKRGDAAEGDSGGPFVMKSPFNNRWYQMGIVSWGEGADRDGKYGFYTHVFRLKKWIQK 252
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|2PKS|C Chain C, Thrombin In Complex With Inhibitor
pdb|3PO1|C Chain C, Thrombin In Complex With Benzothiazole Guanidine
Length = 102
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 38/95 (40%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 166 TLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEK---DSCQGDSGGPLHYAN--ET 220
L V +PI+ CK + RIT NM CAGY E D+C+GDSGGP +
Sbjct: 5 VLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNN 63
Query: 221 VHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
+ +G+VSWGEGC ++ G Y V R WI+
Sbjct: 64 RWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 98
>pdb|2HNT|F Chain F, Crystallographic Structure Of Human Gamma-Thrombin
pdb|1BHX|F Chain F, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|C Chain C, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
Length = 105
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 38/95 (40%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 166 TLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEK---DSCQGDSGGPLHYAN--ET 220
L V +PI+ CK + RIT NM CAGY E D+C+GDSGGP +
Sbjct: 5 VLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNN 63
Query: 221 VHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
+ +G+VSWGEGC ++ G Y V R WI+
Sbjct: 64 RWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 98
>pdb|1EQ9|A Chain A, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
pdb|1EQ9|B Chain B, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
Length = 222
Score = 65.9 bits (159), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 39/106 (36%), Positives = 62/106 (58%), Gaps = 8/106 (7%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
+TGWG + GG+T + L E+E+ + +C++ + R+ + +C +GE +C GDS
Sbjct: 122 LTGWGSTRLGGNTPNALQEIELIVHPQKQCERDQW--RVIDSHICTLTKRGEG-ACHGDS 178
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNN 256
GGPL AN +G+VS+G CA P VY RV+ +++WI N
Sbjct: 179 GGPL-VANGAQ---IGIVSFGSPCAL-GEPDVYTRVSSFVSWINAN 219
>pdb|1TQ0|B Chain B, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ0|D Chain D, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ7|B Chain B, Crystal Structure Of The Anticoagulant Thrombin Mutant
W215aE217A Bound To Ppack
Length = 257
Score = 65.5 bits (158), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 44/118 (37%), Positives = 57/118 (48%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 136 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VS G GC ++ G Y V R WI+
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCDRDGKYGFYTHVFRLKKWIQK 252
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|3EE0|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF HUMAN
Thrombin (Space Group P2(1)2(1)2(1))
pdb|3HKJ|B Chain B, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
pdb|3HKJ|E Chain E, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
Length = 259
Score = 65.1 bits (157), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 44/118 (37%), Positives = 57/118 (48%), Gaps = 12/118 (10%)
Query: 149 GIVTGWGVQKQ------GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG K+ G L V +PI+ CK + RIT NM CAGY E
Sbjct: 136 GRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST-RIRITDNMFCAGYKPDE 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
D+C+GDSGGP + + +G+VS G GC ++ G Y V R WI+
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCDRDGKYGFYTHVFRLKKWIQK 252
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1HYL|A Chain A, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|1HYL|B Chain B, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|2HLC|A Chain A, Hl Collagenase Structure At 1.7a Resolution
pdb|2HLC|B Chain B, Hl Collagenase Structure At 1.7a Resolution
Length = 230
Score = 65.1 bits (157), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 60/233 (25%), Positives = 92/233 (39%), Gaps = 69/233 (29%)
Query: 87 IVGGQVTYVHQYPWMA----LLMYKKRFYCGATLINNLYVLTAAHCVHQG------LGIW 136
I+ G Y +P+ A L ++R +CG +LI+N ++LTAAHCVH LG
Sbjct: 1 IINGYEAYTGLFPYQAGLDITLQDQRRVWCGGSLIDNKWILTAAHCVHDAVSVVVYLGSA 60
Query: 137 VTIRGKS--------------------------------------------------FSN 146
V G++ F N
Sbjct: 61 VQYEGEAVVNSERIISHSMFNPDTYLNDVALIKIPHVEYTDNIQPIRLPSGEELNNKFEN 120
Query: 147 KTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSC 206
V+GWG Q + + L ++ N C + I + +C G K C
Sbjct: 121 IWATVSGWG---QSNTDTVILQYTYNLVIDNDRCAQEYPPGIIVESTICGDTSDG-KSPC 176
Query: 207 QGDSGGPLHYANETVHHIVGVVSW--GEGCAQENYPGVYARVNRYLTWIKNNT 257
GDSGGP +++ + ++GVVS+ G GC + P ++RV Y+ WI+ NT
Sbjct: 177 FGDSGGPFVLSDKNL--LIGVVSFVSGAGC-ESGKPVGFSRVTSYMDWIQQNT 226
>pdb|1TON|A Chain A, Rat Submaxillary Gland Serine Protease, Tonin. Structure
Solution And Refinement At 1.8 Angstroms Resolution
Length = 235
Score = 64.7 bits (156), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 41/109 (37%), Positives = 61/109 (55%), Gaps = 7/109 (6%)
Query: 148 TGIVTGWG-VQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSC 206
T + +GWG S L V + +LSN +C +T Y++ +T MLCAG +G KD+C
Sbjct: 125 TCLASGWGSTNPSEMVVSHDLQCVNIHLLSNEKCIET-YKDNVTDVMLCAGEMEGGKDTC 183
Query: 207 QGDSGGPLHYANETVHHIVGVVSWGEG-CAQENYPGVYARVNRYLTWIK 254
GDSGGPL + G+ S G CA+ P +YA++ ++ +WIK
Sbjct: 184 AGDSGGPLICDGV----LQGITSGGATPCAKPKTPAIYAKLIKFTSWIK 228
Score = 32.7 bits (73), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 16/42 (38%), Positives = 23/42 (54%), Gaps = 2/42 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC 128
IVGG + PW ++ + CG LI+ +V+TAAHC
Sbjct: 1 IVGGYKCEKNSQPWQVAVI--NEYLCGGVLIDPSWVITAAHC 40
>pdb|2ZCH|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|2ZCK|P Chain P, Crystal Structure Of A Ternary Complex Between Psa, A
Substrat-Acyl Intermediate And An Activating Antibody
pdb|2ZCL|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|3QUM|P Chain P, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
pdb|3QUM|Q Chain Q, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
Length = 237
Score = 64.7 bits (156), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 41/113 (36%), Positives = 60/113 (53%), Gaps = 7/113 (6%)
Query: 148 TGIVTGWG-VQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSC 206
T +GWG ++ + T L V++ ++SN C + + ++T MLCAG G K +C
Sbjct: 127 TCYASGWGSIEPEEFLTPKKLQCVDLHVISNDVCAQV-HPQKVTKFMLCAGRWTGGKSTC 185
Query: 207 QGDSGGPLHYANETVHHIVGVVSWG-EGCAQENYPGVYARVNRYLTWIKNNTI 258
GDSGGPL N + G+ SWG E CA P +Y +V Y WIK+ +
Sbjct: 186 SGDSGGPL-VCNGVLQ---GITSWGSEPCALPERPSLYTKVVHYRKWIKDTIV 234
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 19/43 (44%), Positives = 25/43 (58%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCV 129
IVGG H PW L+ + R CG L++ +VLTAAHC+
Sbjct: 1 IVGGWECEKHSQPWQVLVASRGRAVCGGVLVHPQWVLTAAHCI 43
>pdb|4GSO|A Chain A, Structure Of Jararacussin-I
Length = 232
Score = 63.5 bits (153), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 60/226 (26%), Positives = 87/226 (38%), Gaps = 61/226 (26%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAH------------------- 127
++GG ++++P++A L Y ++CG TLIN +V+TAAH
Sbjct: 1 VLGGDECDINEHPFLAFL-YSHGYFCGLTLINQEWVVTAAHCDSTNFQMQLGVHSKKVLN 59
Query: 128 -------------CVHQGLG------IWVTIRGKSFSNKTGI-----------------V 151
C ++ + I + K SN I +
Sbjct: 60 EDEQTRNPKEKFICPNKNMSEVLDKDIMLIKLDKPISNSKHIAPLSLPSNPPSVGSVCRI 119
Query: 152 TGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSG 211
GWG T + L + E + AY LCAG +G KD+C GDSG
Sbjct: 120 MGWGSITIPNETYPDVPYCANINLVDYEVCQGAYNGLPAKTTLCAGVLEGGKDTCVGDSG 179
Query: 212 GPLHYANETVHHIVGVVSWG-EGCAQENYPGVYARVNRYLTWIKNN 256
GPL + G+VS+G C Q PG+Y V Y WI+ N
Sbjct: 180 GPLICNGQ----FQGIVSYGAHSCGQGPKPGIYTNVFDYTDWIQRN 221
>pdb|2QY0|B Chain B, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
pdb|2QY0|D Chain D, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
Length = 242
Score = 63.5 bits (153), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 40/112 (35%), Positives = 62/112 (55%), Gaps = 10/112 (8%)
Query: 149 GIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAY-ENRI---TPNMLCAGYPKGEKD 204
G V+G+GV ++ + L V +P+ + C+ +NR+ + NM CAG+P ++D
Sbjct: 128 GYVSGFGVMEE--KIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQD 185
Query: 205 SCQGDSGGPLHYANETVHHIV--GVVSWGEGCAQENYPGVYARVNRYLTWIK 254
+CQGDSGG + V G+VSWG GC++ G Y +V Y+ WIK
Sbjct: 186 ACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSRGY--GFYTKVLNYVDWIK 235
Score = 30.8 bits (68), Expect = 0.89, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 23/44 (52%), Gaps = 2/44 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVH 130
I+GGQ + +PW R G L+ + ++LTAAH ++
Sbjct: 1 IIGGQKAKMGNFPWQVFTNIHGR--GGGALLGDRWILTAAHTLY 42
>pdb|2AIP|A Chain A, Crystal Structure Of Native Protein C Activator From The
Venom Of Copperhead Snake Agkistrodon Contortrix
Contortrix
pdb|2AIQ|A Chain A, Crystal Structure Of Benzamidine-Inhibited Protein C
Activator From The Venom Of Copperhead Snake Agkistrodon
Contortrix Contortrix
Length = 231
Score = 63.2 bits (152), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 58/223 (26%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFSN 146
++GG ++++ ++AL+ Y CG TLIN +VLTA HC + I++ + N
Sbjct: 1 VIGGDECNINEHRFLALV-YANGSLCGGTLINQEWVLTARHCDRGNMRIYLGMHNLKVLN 59
Query: 147 KTGIVTG-----WGVQKQGGSTSD---TLLEVEVPILSNAE----------------CKK 182
K + + + + + D L+ + P+ ++A C+
Sbjct: 60 KDALRRFPKEKYFCLNTRNDTIWDKDIMLIRLNRPVRNSAHIAPLSLPSNPPSVGSVCRI 119
Query: 183 TAYENRITPN------------------------------MLCAGYPKGEKDSCQGDSGG 212
+ +PN LCAG +G KD+C+GDSGG
Sbjct: 120 MGWGTITSPNATLPDVPHCANINILDYAVCQAAYKGLAATTLCAGILEGGKDTCKGDSGG 179
Query: 213 PLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
PL N I+ V G CAQ PG+Y +V Y WI++
Sbjct: 180 PL-ICNGQFQGILSV--GGNPCAQPRKPGIYTKVFDYTDWIQS 219
>pdb|4H4F|A Chain A, Crystal Structure Of Human Chymotrypsin C (ctrc) Bound To
Inhibitor Eglin C From Hirudo Medicinalis
Length = 249
Score = 63.2 bits (152), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 40/107 (37%), Positives = 56/107 (52%), Gaps = 5/107 (4%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYEN-RITPNMLCAGYPKGEKDSCQGD 209
VTGWG G +D L + P++ +A C + + R+ M+CAG G +C GD
Sbjct: 128 VTGWGRLWTNGPIADKLQQGLQPVVDHATCSRIDWWGFRVKKTMVCAG-GDGVISACNGD 186
Query: 210 SGGPLHYANET-VHHIVGVVSWG--EGCAQENYPGVYARVNRYLTWI 253
SGGPL+ E + G+VS+G GC P VY RV+ Y+ WI
Sbjct: 187 SGGPLNCQLENGSWEVFGIVSFGSRRGCNTRKKPVVYTRVSAYIDWI 233
Score = 44.7 bits (104), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 22/47 (46%), Positives = 28/47 (59%), Gaps = 4/47 (8%)
Query: 87 IVGGQVTYVHQYPWMALLMYKK----RFYCGATLINNLYVLTAAHCV 129
+VGG+ H +PW L Y K R CG TLI + +VLTAAHC+
Sbjct: 1 VVGGEDARPHSWPWQISLQYLKNDTWRHTCGGTLIASNFVLTAAHCI 47
>pdb|1PYT|D Chain D, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 251
Score = 63.2 bits (152), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 63/239 (26%), Positives = 91/239 (38%), Gaps = 67/239 (28%)
Query: 82 NKKTRIVGGQVTYVHQYPWMALLMYKK----RFYCGATLI-------------------- 117
N R+VGG+ H +PW L Y + R CG TLI
Sbjct: 9 NLSARVVGGEDAIPHSWPWQISLQYLRDNTWRHTCGGTLITPNHVLTAAHCISNTLTYRV 68
Query: 118 ----NNLYVLTAAHCVHQGLG-IWVTIRGKSFSNKTGI---------------------- 150
NNL V A ++ G+ I+V + SF + I
Sbjct: 69 ALGKNNLEVEDEAGSLYVGVDTIFVHEKWNSFLVRNDIALIKLAETVELGDTIQVACLPS 128
Query: 151 ------------VTGWGVQKQGGSTSDTLLEVEVPILSNAEC-KKTAYENRITPNMLCAG 197
VTGWG G + L + P++ A C ++ + + M+CAG
Sbjct: 129 EGSLLPQDYPCFVTGWGRLYTNGPIAAELQQGLQPVVDYATCSQRDWWGTTVKETMVCAG 188
Query: 198 YPKGEKDSCQGDSGGPLHYANETVHHIVGVVSWGEG--CAQENYPGVYARVNRYLTWIK 254
G +C GDSGGPL+ + + G+VS+G G C P V+ RV+ Y+ WI
Sbjct: 189 -GDGVISACNGDSGGPLNCQADGQWDVRGIVSFGSGLSCNTFKKPTVFTRVSAYIDWIN 246
>pdb|1GPZ|A Chain A, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
pdb|1GPZ|B Chain B, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
Length = 399
Score = 63.2 bits (152), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 40/112 (35%), Positives = 62/112 (55%), Gaps = 10/112 (8%)
Query: 149 GIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAY-ENRI---TPNMLCAGYPKGEKD 204
G V+G+GV ++ + L V +P+ + C+ +NR+ + NM CAG+P ++D
Sbjct: 285 GYVSGFGVMEE--KIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQD 342
Query: 205 SCQGDSGGPLHYANETVHHIV--GVVSWGEGCAQENYPGVYARVNRYLTWIK 254
+CQGDSGG + V G+VSWG GC++ G Y +V Y+ WIK
Sbjct: 343 ACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSRGY--GFYTKVLNYVDWIK 392
Score = 33.5 bits (75), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 19/65 (29%), Positives = 33/65 (50%), Gaps = 7/65 (10%)
Query: 70 LEKCGPCTCGA----VNKKTRIVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTA 125
+ +C P CG V ++ +I+GGQ + +PW R G L+ + ++LTA
Sbjct: 138 IPRCLP-VCGKPVNPVEQRQQIIGGQKAKMGNFPWQVFTNIHGR--GGGALLGDRWILTA 194
Query: 126 AHCVH 130
AH ++
Sbjct: 195 AHTLY 199
>pdb|1BRU|P Chain P, Structure Of Porcine Pancreatic Elastase Complexed With
The Elastase Inhibitor Gr143783
Length = 241
Score = 63.2 bits (152), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 39/109 (35%), Positives = 60/109 (55%), Gaps = 5/109 (4%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAY-ENRITPNMLCAGYPKGEKDSCQGD 209
VTGWG + G++ D L + ++ ++ A C K + + + NM+CAG G SC GD
Sbjct: 129 VTGWGRLQTNGASPDILQQGQLLVVDYATCSKPGWWGSTVKTNMICAG-GDGIISSCNGD 187
Query: 210 SGGPLHYANETVH-HIVGVVSWGE--GCAQENYPGVYARVNRYLTWIKN 255
SGGPL+ + G+VS+G GC + P V+ RV+ Y+ WI +
Sbjct: 188 SGGPLNCQGANGQWQVHGIVSFGSSLGCNYYHKPSVFTRVSNYIDWINS 236
>pdb|1MD8|A Chain A, Monomeric Structure Of The Active Catalytic Domain Of
Complement Protease C1r
Length = 329
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 40/112 (35%), Positives = 62/112 (55%), Gaps = 10/112 (8%)
Query: 149 GIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKK-TAYENRI---TPNMLCAGYPKGEKD 204
G V+G+GV ++ + L V +P+ + C+ +NR+ + NM CAG+P ++D
Sbjct: 217 GYVSGFGVMEE--KIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQD 274
Query: 205 SCQGDSGGPLHYANETVHHIV--GVVSWGEGCAQENYPGVYARVNRYLTWIK 254
+CQGDSGG + V G+VSWG GC++ G Y +V Y+ WIK
Sbjct: 275 ACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSRGY--GFYTKVLNYVDWIK 324
Score = 35.4 bits (80), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 20/65 (30%), Positives = 33/65 (50%), Gaps = 7/65 (10%)
Query: 70 LEKCGPCTCGA----VNKKTRIVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTA 125
+ +C P CG V ++ RI+GGQ + +PW R G L+ + ++LTA
Sbjct: 70 IPRCLP-VCGKPVNPVEQRQRIIGGQKAKMGNFPWQVFTNIHGR--GGGALLGDRWILTA 126
Query: 126 AHCVH 130
AH ++
Sbjct: 127 AHTLY 131
>pdb|3EDX|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|D Chain D, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|F Chain F, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3HK3|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(ONE Molecule In The Asymmetric Unit)
pdb|3HK6|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HK6|D Chain D, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HKI|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
pdb|3HKI|E Chain E, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
Length = 258
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 41/117 (35%), Positives = 59/117 (50%), Gaps = 12/117 (10%)
Query: 149 GIVTGWGVQKQGGSTS------DTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGE 202
G VTGWG ++ +T+ L V +PI+ CK + RIT NM CAG+ +
Sbjct: 136 GRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKAST-RIRITDNMFCAGFKVND 194
Query: 203 K---DSCQGDSGGPLHYAN--ETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
D+C+GDSGGP + + +G+VS G GC ++ G Y V R WI+
Sbjct: 195 TKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCDRKGKYGFYTHVFRLKRWIQ 251
Score = 38.1 bits (87), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 16/33 (48%), Positives = 23/33 (69%), Gaps = 2/33 (6%)
Query: 99 PWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 13 PWQVMLFRKSPQELLCGASLISDRWVLTAAHCI 45
>pdb|4E7N|A Chain A, Crystal Structure Of Ahv_tl-I, A Glycosylated Snake-Venom
Thrombin- Like Enzyme From Agkistrodon Halys
Length = 238
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 39/109 (35%), Positives = 56/109 (51%), Gaps = 8/109 (7%)
Query: 151 VTGWG-VQKQGGSTSDTLLEVEVPILSNAECKKT--AYENRITPNMLCAGYPKGEKDSCQ 207
+ GWG + G+ D V + +L C+ +E T LCAG +G KD+C+
Sbjct: 122 IMGWGRISPTEGTYPDVPHCVNINLLEYEMCRAPYPEFELPATSRTLCAGILEGGKDTCK 181
Query: 208 GDSGGPLHYANETVHHIVGVVSWGEG-CAQENYPGVYARVNRYLTWIKN 255
GDSGGPL + G+ SWG+ CAQ + P Y +V +L WI+N
Sbjct: 182 GDSGGPLICNGQ----FQGIASWGDDPCAQPHKPAAYTKVFDHLDWIEN 226
Score = 42.0 bits (97), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 22/63 (34%), Positives = 36/63 (57%), Gaps = 2/63 (3%)
Query: 87 IVGGQVTYVHQYPWM-ALLMYKKR-FYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSF 144
I+GG ++++ ++ AL + R +CG TLIN +VLTAAHC + I + + K
Sbjct: 1 IIGGDECNINEHRFLVALYTSRSRTLFCGGTLINQEWVLTAAHCDRKNFRIKLGMHSKKV 60
Query: 145 SNK 147
N+
Sbjct: 61 PNE 63
>pdb|1MD7|A Chain A, Monomeric Structure Of The Zymogen Of Complement Protease
C1r
Length = 328
Score = 62.0 bits (149), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 39/112 (34%), Positives = 62/112 (55%), Gaps = 10/112 (8%)
Query: 149 GIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKK-TAYENRI---TPNMLCAGYPKGEKD 204
G V+G+GV ++ + L V +P+ + C+ +NR+ + NM CAG+P ++D
Sbjct: 217 GYVSGFGVMEE--KIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQD 274
Query: 205 SCQGDSGGPLHYANETVHHIV--GVVSWGEGCAQENYPGVYARVNRYLTWIK 254
+CQGD+GG + V G+VSWG GC++ G Y +V Y+ WIK
Sbjct: 275 ACQGDAGGVFAVRDPNTDRWVATGIVSWGIGCSRGY--GFYTKVLNYVDWIK 324
Score = 35.4 bits (80), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 20/65 (30%), Positives = 33/65 (50%), Gaps = 7/65 (10%)
Query: 70 LEKCGPCTCGA----VNKKTRIVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTA 125
+ +C P CG V ++ RI+GGQ + +PW R G L+ + ++LTA
Sbjct: 70 IPRCLP-VCGKPVNPVEQRQRIIGGQKAKMGNFPWQVFTNIHGR--GGGALLGDRWILTA 126
Query: 126 AHCVH 130
AH ++
Sbjct: 127 AHTLY 131
>pdb|1FI8|A Chain A, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
pdb|1FI8|B Chain B, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
Length = 228
Score = 61.6 bits (148), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 37/105 (35%), Positives = 55/105 (52%), Gaps = 6/105 (5%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
V GWG G SDTL EVE+ + + +C+ N +CAG PK ++ S +GDS
Sbjct: 125 VAGWGKLGPMGKYSDTLQEVELTVQEDQKCESYLKNYFDKANEICAGDPKIKRASFRGDS 184
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GGPL G+VS+G+ + P + +V+ +L+WIK
Sbjct: 185 GGPLVCKKVA----AGIVSYGQN--DGSTPRAFTKVSTFLSWIKK 223
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 24/57 (42%), Positives = 28/57 (49%), Gaps = 6/57 (10%)
Query: 87 IVGGQVTYVHQYPWMALLM----YKKRFYCGATLINNLYVLTAAHCVHQGLGIWVTI 139
I+GG H P+MA L Y CG LI +VLTAAHC G I VT+
Sbjct: 1 IIGGHEAKPHSRPYMAYLQIMDEYSGSKKCGGFLIREDFVLTAAHC--SGSKIQVTL 55
>pdb|1FQ3|A Chain A, Crystal Structure Of Human Granzyme B
pdb|1FQ3|B Chain B, Crystal Structure Of Human Granzyme B
Length = 227
Score = 61.2 bits (147), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 64/230 (27%), Positives = 88/230 (38%), Gaps = 69/230 (30%)
Query: 87 IVGGQVTYVHQYPWMALLMY---KKRFYCGATLINNLYVLTAAHCVHQGLGIWVTIRG-- 141
I+GG H P+MA LM K CG LI + +VLTAAHC G I VT+
Sbjct: 1 IIGGHEAKPHSRPYMAYLMIWDQKSLKRCGGFLIQDDFVLTAAHC--WGSSINVTLGAHN 58
Query: 142 ------------------------KSFSN------------------------------- 146
K+FSN
Sbjct: 59 IKEQEPTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKRTRAVQPLRLPSNKAQVKP 118
Query: 147 -KTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDS 205
+T V GWG G S TL EV++ + + +C+ + LC G P+ +K S
Sbjct: 119 GQTCSVAGWGQTAPLGKHSHTLQEVKMTVQEDRKCESDLRHYYDSTIELCVGDPEIKKTS 178
Query: 206 CQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
+GDSGGPL N+ G+VS+G P +V+ ++ WIK
Sbjct: 179 FKGDSGGPL-VCNKVAQ---GIVSYGRNNGMP--PRACTKVSSFVHWIKK 222
>pdb|1IAU|A Chain A, Human Granzyme B In Complex With Ac-Iepd-Cho
Length = 227
Score = 61.2 bits (147), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 64/230 (27%), Positives = 88/230 (38%), Gaps = 69/230 (30%)
Query: 87 IVGGQVTYVHQYPWMALLMY---KKRFYCGATLINNLYVLTAAHCVHQGLGIWVTIRG-- 141
I+GG H P+MA LM K CG LI + +VLTAAHC G I VT+
Sbjct: 1 IIGGHEAKPHSRPYMAYLMIWDQKSLKRCGGFLIRDDFVLTAAHC--WGSSINVTLGAHN 58
Query: 142 ------------------------KSFSN------------------------------- 146
K+FSN
Sbjct: 59 IKEQEPTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKRTRAVQPLRLPSNKAQVKP 118
Query: 147 -KTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDS 205
+T V GWG G S TL EV++ + + +C+ + LC G P+ +K S
Sbjct: 119 GQTCSVAGWGQTAPLGKHSHTLQEVKMTVQEDRKCESDLRHYYDSTIELCVGDPEIKKTS 178
Query: 206 CQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
+GDSGGPL N+ G+VS+G P +V+ ++ WIK
Sbjct: 179 FKGDSGGPL-VCNKVAQ---GIVSYGRNNGMP--PRACTKVSSFVHWIKK 222
>pdb|1BQY|A Chain A, Plasminogen Activator (tsv-pa) From Snake Venom
pdb|1BQY|B Chain B, Plasminogen Activator (tsv-pa) From Snake Venom
Length = 234
Score = 60.8 bits (146), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 40/86 (46%), Positives = 49/86 (56%), Gaps = 7/86 (8%)
Query: 172 VPILSNAECKKTAYENRITPNM-LCAGYPKGEKDSCQGDSGGPLHYANETVHHIVGVVSW 230
+ IL +A C+ TAY R N LCAG +G +D+C DSGGPL N G+VSW
Sbjct: 142 INILDHAVCR-TAYSWRQVANTTLCAGILQGGRDTCHFDSGGPL-ICNGIFQ---GIVSW 196
Query: 231 -GEGCAQENYPGVYARVNRYLTWIKN 255
G C Q PGVY +V YL WIK+
Sbjct: 197 GGHPCGQPGEPGVYTKVFDYLDWIKS 222
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 18/61 (29%), Positives = 30/61 (49%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFSN 146
+ GG ++++ + +L F CG TLIN +V+TAAHC + + K N
Sbjct: 1 VFGGDECNINEHRSLVVLFNSNGFLCGGTLINQDWVVTAAHCDSNNFQLLFGVHSKKILN 60
Query: 147 K 147
+
Sbjct: 61 E 61
>pdb|1SGF|A Chain A, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|X Chain X, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 240
Score = 60.1 bits (144), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 38/109 (34%), Positives = 57/109 (52%), Gaps = 7/109 (6%)
Query: 148 TGIVTGWGVQKQ-GGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSC 206
T + +GWG D L V + +L N +C K A+E ++T MLCAG G +C
Sbjct: 130 TCLASGWGSTTPIKFKYPDDLQCVNLKLLPNEDCDK-AHEMKVTDAMLCAGEMDGGSYTC 188
Query: 207 QGDSGGPLHYANETVHHIVGVVSWG-EGCAQENYPGVYARVNRYLTWIK 254
+ DSGGPL + G+ SWG E C + P VY ++ ++ +WI+
Sbjct: 189 EHDSGGPLICDG----ILQGITSWGPEPCGEPTEPSVYTKLIKFSSWIR 233
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 26/50 (52%)
Query: 88 VGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV 137
V QV + PW + ++ CG L++ +VLTAAHC + +W+
Sbjct: 5 VQSQVDCENSQPWHVAVYRFNKYQCGGVLLDRNWVLTAAHCYNDKYQVWL 54
>pdb|1SI5|H Chain H, Protease-Like Domain From 2-Chain Hepatocyte Growth Factor
Length = 240
Score = 59.7 bits (143), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 42/117 (35%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 141 GKSFSNKTGI-VTGWGVQKQGGSTSDTLLEV-EVPILSNAECKKTAYENRITPNM--LCA 196
G + KT V GWG G D LL V + I+ N +C + + ++T N +CA
Sbjct: 109 GSTIPEKTSCSVYGWGYT--GLINYDGLLRVAHLYIMGNEKCSQ-HHRGKVTLNESEICA 165
Query: 197 GYPKGEKDSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
G K C+GD GGPL + ++GV+ G GCA N PG++ RV Y WI
Sbjct: 166 GAEKIGSGPCEGDYGGPLVCEQHKMRMVLGVIVPGRGCAIPNRPGIFVRVAYYAKWI 222
Score = 33.1 bits (74), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 13/29 (44%), Positives = 17/29 (58%)
Query: 100 WMALLMYKKRFYCGATLINNLYVLTAAHC 128
WM L Y+ + CG +LI +VLTA C
Sbjct: 13 WMVSLRYRNKHICGGSLIKESWVLTARQC 41
>pdb|1SHY|A Chain A, The Crystal Structure Of Hgf Beta-Chain In Complex With
The Sema Domain Of The Met Receptor
Length = 234
Score = 59.7 bits (143), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 42/117 (35%), Positives = 58/117 (49%), Gaps = 7/117 (5%)
Query: 141 GKSFSNKTGI-VTGWGVQKQGGSTSDTLLEV-EVPILSNAECKKTAYENRITPNM--LCA 196
G + KT V GWG G D LL V + I+ N +C + + ++T N +CA
Sbjct: 109 GSTIPEKTSCSVYGWGYT--GLINYDGLLRVAHLYIMGNEKCSQ-HHRGKVTLNESEICA 165
Query: 197 GYPKGEKDSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
G K C+GD GGPL + ++GV+ G GCA N PG++ RV Y WI
Sbjct: 166 GAEKIGSGPCEGDYGGPLVCEQHKMRMVLGVIVPGRGCAIPNRPGIFVRVAYYAKWI 222
Score = 33.1 bits (74), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 13/29 (44%), Positives = 17/29 (58%)
Query: 100 WMALLMYKKRFYCGATLINNLYVLTAAHC 128
WM L Y+ + CG +LI +VLTA C
Sbjct: 13 WMVSLRYRNKHICGGSLIKESWVLTARQC 41
>pdb|1EUF|A Chain A, Bovine Duodenase(New Serine Protease), Crystal Structure
Length = 227
Score = 59.3 bits (142), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 37/103 (35%), Positives = 53/103 (51%), Gaps = 7/103 (6%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
V GWG ++D L EV++ + S +C ++N I +CAG P K+S GDS
Sbjct: 124 VAGWGRLGVNMPSTDKLQEVDLEVQSEEKCI-ARFKNYIPFTQICAGDPSKRKNSFSGDS 182
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
GGPL N G+VS+G P VY R++ +L+WI
Sbjct: 183 GGPL-VCNGVAQ---GIVSYGRN--DGTTPDVYTRISSFLSWI 219
Score = 44.7 bits (104), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 24/56 (42%), Positives = 32/56 (57%), Gaps = 5/56 (8%)
Query: 87 IVGGQVTYVHQYPWMALLMYK---KRFYCGATLINNLYVLTAAHCVHQGLGIWVTI 139
I+GG H P+MA L++K K CG L+ +VLTAAHC+ G I VT+
Sbjct: 1 IIGGHEAKPHSRPYMAFLLFKTSGKSHICGGFLVREDFVLTAAHCL--GSSINVTL 54
>pdb|3S9A|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Closed-Form)
pdb|3S9B|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V (Open-Form)
pdb|3S9C|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V In Complex
With The Fragment (Residues 1533-1546) Of Human Factor V
pdb|3SBK|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Ppack-Bound Form)
Length = 234
Score = 58.5 bits (140), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 62/225 (27%), Positives = 86/225 (38%), Gaps = 59/225 (26%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKR--FYCGATLINNLYVLTAAHCVHQGLGIWVTI----- 139
+VGG ++++P++ L +C LIN +VLTAAHC + + I + +
Sbjct: 1 VVGGDECNINEHPFLVALYTSASSTIHCAGALINREWVLTAAHCDRRNIRIKLGMHSKNI 60
Query: 140 ----------RGKSFSNKTGIVTGW-----------------------------GVQKQ- 159
RGK F T G GV +
Sbjct: 61 RNEDEQIRVPRGKYFCLNTKFPNGLDKDIMLIRLRRPVTYSTHIAPVSLPSRSRGVGSRC 120
Query: 160 ---GGSTSDTLLEVEVPILSNAECKKTAYENRITP------NMLCAGYPKGEKDSCQGDS 210
G T +VP +N K + + P LCAG KG +D+C GDS
Sbjct: 121 RIMGWGKISTTTYPDVPHCTNIFIVKHKWCEPLYPWVPADSRTLCAGILKGGRDTCHGDS 180
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GGPL N +H IV S E C Q P VY +V Y WI++
Sbjct: 181 GGPL-ICNGEMHGIVAGGS--EPCGQHLKPAVYTKVFDYNNWIQS 222
>pdb|2RDL|A Chain A, Hamster Chymase 2
pdb|2RDL|B Chain B, Hamster Chymase 2
Length = 226
Score = 56.6 bits (135), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 54/177 (30%), Positives = 81/177 (45%), Gaps = 17/177 (9%)
Query: 85 TRIVGGQVTYVHQYPWMALLMYKKRF----YCGATLINNLYVLTAAHCVHQGLGI-WVTI 139
T ++G V + W L + +K+F Y ++N++ +L + LG+ + I
Sbjct: 52 TVLLGAHNKKVKEDTWQKLEV-EKQFPHPKYDDRLVLNDIMLLKLKEKANLTLGVGTLPI 110
Query: 140 RGKSFSNKTGIV---TGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCA 196
KS S G V GWG SDTL EV++ IL CK +E+ LC
Sbjct: 111 SAKSNSIPPGRVCRAVGWGRTNVNEPPSDTLQEVKMRILDPQACKH--FEDFHQEPQLCV 168
Query: 197 GYPKGEKDSCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
G PK ++ +GDSGGPL A G+ S+ A+ P V+ R++ Y WI
Sbjct: 169 GNPKKIRNVYKGDSGGPLLCAGIA----QGIASYVLRNAKP--PSVFTRISHYRPWI 219
>pdb|1AO5|A Chain A, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
pdb|1AO5|B Chain B, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
Length = 237
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 36/111 (32%), Positives = 55/111 (49%), Gaps = 7/111 (6%)
Query: 150 IVTGWG-VQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQG 208
+ +GWG + D L V + +L N C K Y ++T MLCAG G KD+C+
Sbjct: 129 LASGWGSITPTRWQKPDDLQCVFITLLPNENCAKV-YLQKVTDVMLCAGEMGGGKDTCRD 187
Query: 209 DSGGPLHYANETVHHIVGVVSWGE-GCAQENYPGVYARVNRYLTWIKNNTI 258
DSGGPL + G S+G C + P +Y + ++ +WIK+ +
Sbjct: 188 DSGGPLICDG----ILQGTTSYGPVPCGKPGVPAIYTNLIKFNSWIKDTMM 234
Score = 40.8 bits (94), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 18/51 (35%), Positives = 27/51 (52%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV 137
+VGG + PW + Y+K CG L++ +VLTAAHC +W+
Sbjct: 1 VVGGFNCEKNSQPWQVAVYYQKEHICGGVLLDRNWVLTAAHCYVDQYEVWL 51
>pdb|1OP2|A Chain A, Crystal Structure Of Aav-Sp-Ii, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 55.1 bits (131), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 59/229 (25%), Positives = 91/229 (39%), Gaps = 65/229 (28%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFSN 146
++GG ++++ ++ F+CG TLIN +V+TAAHC + + + K N
Sbjct: 1 VIGGNECDINEHRFLVAFFNTTGFFCGGTLINPEWVVTAAHCDSTNFQMQLGVHSKKVLN 60
Query: 147 --------KTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAE-----------------CK 181
K + + L++++ PI SN++ C+
Sbjct: 61 EDEQTRNPKEKFICPNKNNNEVLDKDIMLIKLDKPI-SNSKHIAPLSLPSSPPSVGSVCR 119
Query: 182 KTAYENRITP--------------NML----C-AGYP--------------KGEKDSCQG 208
+ ITP N+L C AGYP +G KD+C G
Sbjct: 120 IMGW-GSITPVKETFPDVPYCANINLLDHAVCQAGYPELLAEYRTLCAGIVQGGKDTCGG 178
Query: 209 DSGGPLHYANETVHHIVGVVSWG-EGCAQENYPGVYARVNRYLTWIKNN 256
DSGGPL + G+VS+G C Q PG+Y V Y WI+ N
Sbjct: 179 DSGGPLICNGQ----FQGIVSYGAHPCGQGPKPGIYTNVFDYTDWIQRN 223
>pdb|1OP0|A Chain A, Crystal Structure Of Aav-sp-i, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 54.7 bits (130), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 59/229 (25%), Positives = 91/229 (39%), Gaps = 65/229 (28%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFSN 146
++GG ++++ ++ F+CG TLIN +V+TAAHC + + + K N
Sbjct: 1 VIGGNECDINEHRFLVAFFNTTGFFCGGTLINPEWVVTAAHCDSTDFQMQLGVHSKKVLN 60
Query: 147 --------KTGIVTGWGVQKQGGSTSDTLLEVEVPILSNAE-----------------CK 181
K + + L++++ PI SN++ C+
Sbjct: 61 EDEQTRNPKEKFICPNKNNNEVLDKDIMLIKLDKPI-SNSKHIAPLSLPSSPPSVGSVCR 119
Query: 182 KTAYENRITP--------------NML----C-AGYP--------------KGEKDSCQG 208
+ ITP N+L C AGYP +G KD+C G
Sbjct: 120 IMGW-GSITPVKETFPDVPYCANINLLDHAVCQAGYPELLAEYRTLCAGIVQGGKDTCGG 178
Query: 209 DSGGPLHYANETVHHIVGVVSWG-EGCAQENYPGVYARVNRYLTWIKNN 256
DSGGPL + G+VS+G C Q PG+Y V Y WI+ N
Sbjct: 179 DSGGPLICNGQ----FQGIVSYGAHPCGQGPKPGIYTNVFDYTDWIQRN 223
>pdb|1PYT|C Chain C, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 253
Score = 54.3 bits (129), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 37/113 (32%), Positives = 54/113 (47%), Gaps = 9/113 (7%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYEN-RITPNMLCAGYPKGEKDSCQGD 209
++GWG GG D L E +P++ C + + + M+CAG + C GD
Sbjct: 142 ISGWGRLYTGGPLPDKLQEALLPVVDYEHCSQYDWWGITVKKTMVCAG--GDTRSGCDGD 199
Query: 210 SGGPLHY----ANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKNNTI 258
SGGPL+ + VH + VS GC P V+ RV+ ++ WI N TI
Sbjct: 200 SGGPLNCPAADGSWQVHGVTSFVS-AFGCNTIKKPTVFTRVSAFIDWI-NETI 250
Score = 33.9 bits (76), Expect = 0.089, Method: Compositional matrix adjust.
Identities = 16/50 (32%), Positives = 26/50 (52%), Gaps = 4/50 (8%)
Query: 84 KTRIVGGQVTYVHQYPWMALLMYKK----RFYCGATLINNLYVLTAAHCV 129
+R+V G+ + + W L Y+K CG +LI +V+TA HC+
Sbjct: 9 SSRVVNGEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCI 58
>pdb|1FY3|A Chain A, [g175q]hbp, A Mutant Of Human Heparin Binding Protein
(cap37)
Length = 225
Score = 53.9 bits (128), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 57/227 (25%), Positives = 80/227 (35%), Gaps = 74/227 (32%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVH-QGLGIWVTIRG---- 141
IVGG+ Q+P++A + + R +CG LI+ +V+TAA C Q G+ + G
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGRHFCGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDL 60
Query: 142 --------KSFS---------------------------NKTGIVT-------------- 152
++FS N T VT
Sbjct: 61 RRRERQSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILPLPLQNATVEAG 120
Query: 153 ------GWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSC 206
GWG Q+ GG S V V + +C+ PN +C G C
Sbjct: 121 TRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCR---------PNNVCTGVLTRRGGIC 171
Query: 207 QGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
GD G PL E + H V S G C + P + RV + WI
Sbjct: 172 NGDQGTPL--VCEGLAHGVASFSLGP-CGRG--PDFFTRVALFRDWI 213
>pdb|3N7O|A Chain A, X-Ray Structure Of Human Chymase In Complex With Small
Molecule Inhibitor
Length = 226
Score = 53.9 bits (128), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 8/103 (7%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
V GWG SDTL EV++ ++ C + + + LC G P+ K + +GDS
Sbjct: 125 VAGWGRTGVLKPGSDTLQEVKLRLMDPQAC--SHFRDFDHNLQLCVGNPRKTKSAFKGDS 182
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
GGPL A G+VS+G A+ P V+ R++ Y WI
Sbjct: 183 GGPLLCAGAA----QGIVSYGRSDAKP--PAVFTRISHYQPWI 219
Score = 35.4 bits (80), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 23/57 (40%), Positives = 28/57 (49%), Gaps = 6/57 (10%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKR----FYCGATLINNLYVLTAAHCVHQGLGIWVTI 139
I+GG H P+MA L +CG LI +VLTAAHC G I VT+
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCA--GRSITVTL 55
>pdb|1PJP|A Chain A, The 2.2 A Crystal Structure Of Human Chymase In Complex
With Succinyl- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|1T31|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|2HVX|A Chain A, Discovery Of Potent, Orally Active, Nonpeptide Inhibitors
Of Human Mast Cell Chymase By Using Structure-Based Drug
Design
pdb|3S0N|A Chain A, Crystal Structure Of Human Chymase With Benzimidazolone
Inhibitor
Length = 226
Score = 53.9 bits (128), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 8/103 (7%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
V GWG SDTL EV++ ++ C + + + LC G P+ K + +GDS
Sbjct: 125 VAGWGRTGVLKPGSDTLQEVKLRLMDPQAC--SHFRDFDHNLQLCVGNPRKTKSAFKGDS 182
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
GGPL A G+VS+G A+ P V+ R++ Y WI
Sbjct: 183 GGPLLCAGAA----QGIVSYGRSDAKP--PAVFTRISHYQPWI 219
>pdb|1A7S|A Chain A, Atomic Resolution Structure Of Hbp
pdb|1AE5|A Chain A, Human Heparin Binding Protein
Length = 225
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 57/227 (25%), Positives = 80/227 (35%), Gaps = 74/227 (32%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVH-QGLGIWVTIRG---- 141
IVGG+ Q+P++A + + R +CG LI+ +V+TAA C Q G+ + G
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGRHFCGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDL 60
Query: 142 --------KSFS---------------------------NKTGIVT-------------- 152
++FS N T VT
Sbjct: 61 RRRERQSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILPLPLQNATVEAG 120
Query: 153 ------GWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSC 206
GWG Q+ GG S V V + +C+ PN +C G C
Sbjct: 121 TRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCR---------PNNVCTGVLTRRGGIC 171
Query: 207 QGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
GD G PL E + H V S G C + P + RV + WI
Sbjct: 172 NGDGGTPL--VCEGLAHGVASFSLGP-CGRG--PDFFTRVALFRDWI 213
>pdb|1KLT|A Chain A, Crystal Structure Of Pmsf-Treated Human Chymase At 1.9
Angstroms Resolution
Length = 226
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 8/103 (7%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
V GWG SDTL EV++ ++ C + + + LC G P+ K + +GDS
Sbjct: 125 VAGWGRTGVLKPGSDTLQEVKLRLMDPQAC--SHFRDFDHNLQLCVGNPRKTKSAFKGDS 182
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
GGPL A G+VS+G A+ P V+ R++ Y WI
Sbjct: 183 GGPLLCAGVA----QGIVSYGRSDAKP--PAVFTRISHYRPWI 219
Score = 36.6 bits (83), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 23/57 (40%), Positives = 29/57 (50%), Gaps = 6/57 (10%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKR----FYCGATLINNLYVLTAAHCVHQGLGIWVTI 139
I+GG + H P+MA L +CG LI +VLTAAHC G I VT+
Sbjct: 1 IIGGTESKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCA--GRSITVTL 55
>pdb|2ASU|B Chain B, Crystal Structure Of The Beta-Chain Of HgflMSP
Length = 234
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 31/104 (29%), Positives = 53/104 (50%), Gaps = 4/104 (3%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEV-PILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGD 209
+ GWG K G+ +DT+L V + ++SN EC + R+ + +C +C+GD
Sbjct: 121 IAGWGETK--GTGNDTVLNVALLNVISNQECN-IKHRGRVRESEMCTEGLLAPVGACEGD 177
Query: 210 SGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
GGPL + G++ CA+ +P V+ RV+ ++ WI
Sbjct: 178 YGGPLACFTHNSWVLEGIIIPNRVCARSRWPAVFTRVSVFVDWI 221
>pdb|4AFQ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFQ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFS|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFZ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFZ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AG1|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|B Chain B, Human Chymase - Fynomer Complex
Length = 226
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 8/103 (7%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
V GWG SDTL EV++ ++ C + + + LC G P+ K + +GDS
Sbjct: 125 VAGWGRTGVLKPGSDTLQEVKLRLMDPQAC--SHFRDFDHNLQLCVGNPRKTKSAFKGDS 182
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
GGPL A G+VS+G A+ P V+ R++ Y WI
Sbjct: 183 GGPLLCAGVA----QGIVSYGRSDAKP--PAVFTRISHYRPWI 219
Score = 35.4 bits (80), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 23/57 (40%), Positives = 28/57 (49%), Gaps = 6/57 (10%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKR----FYCGATLINNLYVLTAAHCVHQGLGIWVTI 139
I+GG H P+MA L +CG LI +VLTAAHC G I VT+
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCA--GRSITVTL 55
>pdb|1NN6|A Chain A, Human Pro-Chymase
Length = 228
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 8/103 (7%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
V GWG SDTL EV++ ++ C + + + LC G P+ K + +GDS
Sbjct: 127 VAGWGRTGVLKPGSDTLQEVKLRLMDPQAC--SHFRDFDHNLQLCVGNPRKTKSAFKGDS 184
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
GGPL A G+VS+G A+ P V+ R++ Y WI
Sbjct: 185 GGPLLCAGVA----QGIVSYGRSDAKP--PAVFTRISHYRPWI 221
Score = 35.4 bits (80), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 23/57 (40%), Positives = 28/57 (49%), Gaps = 6/57 (10%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKR----FYCGATLINNLYVLTAAHCVHQGLGIWVTI 139
I+GG H P+MA L +CG LI +VLTAAHC G I VT+
Sbjct: 3 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCA--GRSITVTL 57
>pdb|1KYN|B Chain B, Cathepsin-G
pdb|1KYN|A Chain A, Cathepsin-G
Length = 235
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 59/230 (25%), Positives = 94/230 (40%), Gaps = 73/230 (31%)
Query: 87 IVGGQVTYVHQYPWMALLMYKK---RFYCGATLINNLYVLTA-------------AHCVH 130
I+GG+ + H P+MA L + + CG L+ +VLTA AH +
Sbjct: 1 IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGSNINVTLGAHNIQ 60
Query: 131 ------QGLGIWVTIRGKSFSNKT------------------------------GI---- 150
Q + IR ++ +T G+
Sbjct: 61 RRENTQQHITARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPVALPRAQEGLRPGT 120
Query: 151 ---VTGWG-VQKQGGSTSDTLLEVEVPILSNAECKKT--AYENRITPNMLCAGYPKGEKD 204
V GWG V + G+ DTL EV++ + + +C + +Y+ R +C G + K
Sbjct: 121 LCTVAGWGRVSMRRGT--DTLREVQLRVQRDRQCLRIFGSYDPR---RQICVGDRRERKA 175
Query: 205 SCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
+ +GDSGGPL N H G+VS+G+ P V+ RV+ +L WI+
Sbjct: 176 AFKGDSGGPL-LCNNVAH---GIVSYGKSSGVP--PEVFTRVSSFLPWIR 219
>pdb|1AU8|A Chain A, Human Cathepsin G
pdb|1T32|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|1CGH|A Chain A, Human Cathepsin G
Length = 224
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 59/230 (25%), Positives = 94/230 (40%), Gaps = 73/230 (31%)
Query: 87 IVGGQVTYVHQYPWMALLMYKK---RFYCGATLINNLYVLTA-------------AHCVH 130
I+GG+ + H P+MA L + + CG L+ +VLTA AH +
Sbjct: 1 IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGSNINVTLGAHNIQ 60
Query: 131 ------QGLGIWVTIRGKSFSNKT------------------------------GI---- 150
Q + IR ++ +T G+
Sbjct: 61 RRENTQQHITARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPVALPRAQEGLRPGT 120
Query: 151 ---VTGWG-VQKQGGSTSDTLLEVEVPILSNAECKKT--AYENRITPNMLCAGYPKGEKD 204
V GWG V + G+ DTL EV++ + + +C + +Y+ R +C G + K
Sbjct: 121 LCTVAGWGRVSMRRGT--DTLREVQLRVQRDRQCLRIFGSYDPR---RQICVGDRRERKA 175
Query: 205 SCQGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIK 254
+ +GDSGGPL N H G+VS+G+ P V+ RV+ +L WI+
Sbjct: 176 AFKGDSGGPL-LCNNVAH---GIVSYGKSSGVP--PEVFTRVSSFLPWIR 219
>pdb|3S69|A Chain A, Crystal Structure Of Saxthrombin
Length = 234
Score = 51.6 bits (122), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 33/85 (38%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 172 VPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDSGGPLHYANETVHHIVGVVSWG 231
+ +L +A C+ E LCAG +G KD+C GDSGGPL + G+VS+G
Sbjct: 142 INLLDDAVCQAGYPELLTEYRTLCAGILEGGKDTCGGDSGGPLICNGQ----FQGIVSFG 197
Query: 232 EG-CAQENYPGVYARVNRYLTWIKN 255
C Q PGVY +V Y WI++
Sbjct: 198 AHPCGQGLKPGVYTKVFDYNHWIQS 222
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 17/61 (27%), Positives = 31/61 (50%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFSN 146
++GG ++++ + F+C TLIN +VLTAAHC + + + + K N
Sbjct: 1 VIGGDECNINEHRSLVAFFNSTGFFCSGTLINEEWVLTAAHCDNTNFQMKLGVHSKKVLN 60
Query: 147 K 147
+
Sbjct: 61 E 61
>pdb|3RP2|A Chain A, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
pdb|3RP2|B Chain B, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
Length = 224
Score = 51.2 bits (121), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 38/103 (36%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 152 TGWGVQKQGGSTSDTLLEVEVPILSNAEC-KKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
GWG TS TL EVE+ I+ C YE + +C G P + + GDS
Sbjct: 126 AGWGKTGVRDPTSYTLREVELRIMDEKACVDYRYYEYKF---QVCVGSPTTLRAAFMGDS 182
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
GGPL A V H G+VS+G A+ P ++ RV+ Y+ WI
Sbjct: 183 GGPLLCAG--VAH--GIVSYGHPDAKP--PAIFTRVSTYVPWI 219
>pdb|3G01|A Chain A, Structure Of Grc Mutant E192rE193G
pdb|3G01|B Chain B, Structure Of Grc Mutant E192rE193G
Length = 227
Score = 50.8 bits (120), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 6/105 (5%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
V GWG G TL EV++ + + C+ + N +C G K + S +GDS
Sbjct: 125 VAGWGKVTPDGEFPKTLHEVKLTVQKDQVCESQFQSSYNRANEICVGDSKIKGASFRGDS 184
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GGPL G+VS+G+ + P V+ RV +++WIK
Sbjct: 185 GGPLVCKRAA----AGIVSYGQ--TDGSAPQVFTRVLSFVSWIKK 223
Score = 41.6 bits (96), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 22/57 (38%), Positives = 33/57 (57%), Gaps = 6/57 (10%)
Query: 87 IVGGQVTYVHQYPWMA----LLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWVTI 139
I+GG H P+MA L + K+ +CG L+ + +VLTAAHC +G + VT+
Sbjct: 1 IIGGNEISPHSRPYMAYYEFLKVGGKKMFCGGFLVRDKFVLTAAHC--KGRSMTVTL 55
>pdb|1FON|A Chain A, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
pdb|1FON|B Chain B, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
Length = 240
Score = 50.8 bits (120), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 33/108 (30%), Positives = 50/108 (46%), Gaps = 8/108 (7%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYEN-RITPNMLCAGYPKGEKDSCQGD 209
++GWG GG D L + +P + C + + + M+CAG + C GD
Sbjct: 129 ISGWGRLYTGGPLPDKLQQALLPTVDYEHCSQWDWWGITVKKTMVCAG--GDTRSGCNGD 186
Query: 210 SGGPLHY----ANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
SGGPL+ + VH + VS GC P V+ RV+ ++ WI
Sbjct: 187 SGGPLNCPAADGSWQVHGVTSFVS-AFGCNTIKKPTVFTRVSAFIDWI 233
Score = 28.5 bits (62), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 22/44 (50%), Gaps = 4/44 (9%)
Query: 90 GQVTYVHQYPWMALLMYKK----RFYCGATLINNLYVLTAAHCV 129
G+ + + W L Y+K CG +LI +V+TA HC+
Sbjct: 2 GEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCI 45
>pdb|4F4O|C Chain C, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|F Chain F, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|I Chain I, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|L Chain L, Structure Of The Haptoglobin-Haemoglobin Complex
Length = 347
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/130 (26%), Positives = 57/130 (43%), Gaps = 22/130 (16%)
Query: 149 GIVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITP----------------- 191
G V+GWG + + ++ L V +P+ +C + YE P
Sbjct: 220 GYVSGWG-RNANLNFTEHLKYVMLPVADQEKCVQ-YYEGSTVPEKKTPKSPVGVQPILNE 277
Query: 192 NMLCAGYPKGEKDSCQGDSGGPL--HYANETVHHIVGVVSWGEGCAQENYPGVYARVNRY 249
+ CAG K ++D+C GD+G H ++ + G++S+ + C Y GVY RV
Sbjct: 278 HTFCAGLSKYQEDTCYGDAGSAFAVHDKDDDTWYAAGILSFDKSCRTAEY-GVYVRVTSI 336
Query: 250 LTWIKNNTID 259
L WI+ D
Sbjct: 337 LDWIQTTIAD 346
Score = 37.4 bits (85), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 18/52 (34%), Positives = 28/52 (53%)
Query: 81 VNKKTRIVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQG 132
V++ RI+GG + +PW A ++ GATLIN ++LT A + G
Sbjct: 97 VDQVQRIMGGSLDAKGSFPWQAKMISHHNLTSGATLINEQWLLTTAKNLRLG 148
>pdb|1FY1|A Chain A, [r23s,F25e]hbp, A Mutant Of Human Heparin Binding Protein
(Cap37)
Length = 225
Score = 48.9 bits (115), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 56/227 (24%), Positives = 78/227 (34%), Gaps = 74/227 (32%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVH-QGLGIWVTIRG---- 141
IVGG+ Q+P++A + + CG LI+ +V+TAA C Q G+ + G
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGSHECGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDL 60
Query: 142 --------KSFS---------------------------NKTGIVT-------------- 152
++FS N T VT
Sbjct: 61 RRRERQSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILPLPLQNATVEAG 120
Query: 153 ------GWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSC 206
GWG Q+ GG S V V + +C+ PN +C G C
Sbjct: 121 TRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCR---------PNNVCTGVLTRRGGIC 171
Query: 207 QGDSGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWI 253
GD G PL E + H V S G C + P + RV + WI
Sbjct: 172 NGDGGTPL--VCEGLAHGVASFSLGP-CGRG--PDFFTRVALFRDWI 213
>pdb|1GVZ|A Chain A, Prostate Specific Antigen (Psa) From Stallion Seminal
Plasma
Length = 237
Score = 48.1 bits (113), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 38/109 (34%), Positives = 53/109 (48%), Gaps = 7/109 (6%)
Query: 148 TGIVTGWG-VQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSC 206
T +GWG + S TL VE+ + SN +C + AY ++T +LCA + C
Sbjct: 127 TCYTSGWGLISTFTNRGSGTLQCVELRLQSNEKCAR-AYPEKMTEFVLCATHRDDSGSIC 185
Query: 207 QGDSGGPLHYANETVHHIVGVVSWG-EGCAQENYPGVYARVNRYLTWIK 254
GDSGG L + V G+ SWG CA N V+ +V + WIK
Sbjct: 186 LGDSGGAL--ICDGVFQ--GITSWGYSECADFNDNFVFTKVMPHKKWIK 230
Score = 44.7 bits (104), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 19/51 (37%), Positives = 28/51 (54%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWV 137
I+GG H PW + ++ F CG L++ +VLTAAHC+ IW+
Sbjct: 1 IIGGWECEKHSKPWQVAVYHQGHFQCGGVLVHPQWVLTAAHCMSDDYQIWL 51
>pdb|3FZZ|A Chain A, Structure Of Grc
pdb|3FZZ|B Chain B, Structure Of Grc
Length = 227
Score = 47.8 bits (112), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 32/105 (30%), Positives = 49/105 (46%), Gaps = 6/105 (5%)
Query: 151 VTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGDS 210
V GWG G TL EV++ + + C+ + N +C G K + S + DS
Sbjct: 125 VAGWGKVTPDGEFPKTLHEVKLTVQKDQVCESQFQSSYNRANEICVGDSKIKGASFEEDS 184
Query: 211 GGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
GGPL G+VS+G+ + P V+ RV +++WIK
Sbjct: 185 GGPLVCKRAA----AGIVSYGQ--TDGSAPQVFTRVLSFVSWIKK 223
Score = 41.6 bits (96), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 22/57 (38%), Positives = 33/57 (57%), Gaps = 6/57 (10%)
Query: 87 IVGGQVTYVHQYPWMA----LLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWVTI 139
I+GG H P+MA L + K+ +CG L+ + +VLTAAHC +G + VT+
Sbjct: 1 IIGGNEISPHSRPYMAYYEFLKVGGKKMFCGGFLVRDKFVLTAAHC--KGRSMTVTL 55
>pdb|1FUJ|A Chain A, Pr3 (Myeloblastin)
pdb|1FUJ|B Chain B, Pr3 (Myeloblastin)
pdb|1FUJ|C Chain C, Pr3 (Myeloblastin)
pdb|1FUJ|D Chain D, Pr3 (Myeloblastin)
Length = 221
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 30/106 (28%), Positives = 48/106 (45%), Gaps = 13/106 (12%)
Query: 150 IVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGD 209
+ GWG + L E+ V +++ C+ P+ +C P+ + C GD
Sbjct: 126 LAMGWGRVGAHDPPAQVLQELNVTVVT-FFCR---------PHNICTFVPRRKAGICFGD 175
Query: 210 SGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
SGGPL + + I V W GCA +P + RV Y+ WI++
Sbjct: 176 SGGPL-ICDGIIQGIDSFVIW--GCATRLFPDFFTRVALYVDWIRS 218
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 21/46 (45%), Positives = 27/46 (58%), Gaps = 3/46 (6%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKR---FYCGATLINNLYVLTAAHCV 129
IVGG H P+MA L + +CG TLI+ +VLTAAHC+
Sbjct: 1 IVGGHEAQPHSRPYMASLQMRGNPGSHFCGGTLIHPSFVLTAAHCL 46
>pdb|2KAI|A Chain A, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|A Chain A, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|X Chain X, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|A Chain A, Kallikrein Complexed With Hirustasin
pdb|1HIA|X Chain X, Kallikrein Complexed With Hirustasin
Length = 80
Score = 44.7 bits (104), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 21/62 (33%), Positives = 33/62 (53%), Gaps = 1/62 (1%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFSN 146
I+GG+ + +PW + + F CG L+N +VLTAAHC + +W+ R F N
Sbjct: 1 IIGGRECEKNSHPWQVAIYHYSSFQCGGVLVNPKWVLTAAHCKNDNYEVWLG-RHNLFEN 59
Query: 147 KT 148
+
Sbjct: 60 EN 61
>pdb|1HNE|E Chain E, Structure Of Human Neutrophil Elastase In Complex With A
Peptide Chloromethyl Ketone Inhibitor At 1.84-Angstroms
Resolution
Length = 218
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 19/42 (45%), Positives = 27/42 (64%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC 128
IVGG+ H +P+M L + +CGATLI +V++AAHC
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHC 42
Score = 41.6 bits (96), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 28/106 (26%), Positives = 48/106 (45%), Gaps = 13/106 (12%)
Query: 150 IVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGD 209
+ GWG+ + + L E+ V ++++ C+++ +C + C GD
Sbjct: 123 LAMGWGLLGRNRGIASVLQELNVTVVTSL-CRRSN---------VCTLVRGRQAGVCFGD 172
Query: 210 SGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
SG PL N +H I V GCA YP +A V +++ WI +
Sbjct: 173 SGSPL-VCNGLIHGIASFVR--GGCASGLYPDAFAPVAQFVNWIDS 215
>pdb|2WIN|I Chain I, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|J Chain J, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|K Chain K, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|L Chain L, C3 Convertase (C3bbb) Stabilized By Scin
Length = 507
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 20/45 (44%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 189 ITPNMLCAG--YPKGEKDSCQGDSGGPLHYANETVHHIVGVVSWG 231
+TP LC G P + ++C+GDSGGPL + VGV+SWG
Sbjct: 417 VTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQVGVISWG 461
Score = 28.9 bits (63), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 25/87 (28%), Positives = 35/87 (40%), Gaps = 23/87 (26%)
Query: 93 TYVHQYPWMALLMY----KKRFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFSNKT 148
T H+ PW A + K C +++ +VLTAAHC T+ K S K
Sbjct: 229 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHC--------FTVDDKEHSIKV 280
Query: 149 GIVTGWGVQKQGGSTSDTLLEVEVPIL 175
+ GG D LE+EV +
Sbjct: 281 SV---------GGEKRD--LEIEVVLF 296
>pdb|1DLE|A Chain A, Factor B Serine Protease Domain
pdb|1DLE|B Chain B, Factor B Serine Protease Domain
Length = 298
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 20/45 (44%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 189 ITPNMLCAG--YPKGEKDSCQGDSGGPLHYANETVHHIVGVVSWG 231
+TP LC G P + ++C+GDSGGPL + VGV+SWG
Sbjct: 210 VTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQVGVISWG 254
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 25/87 (28%), Positives = 35/87 (40%), Gaps = 23/87 (26%)
Query: 93 TYVHQYPWMALLMY----KKRFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFSNKT 148
T H+ PW A + K C +++ +VLTAAHC T+ K S K
Sbjct: 22 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHC--------FTVDDKEHSIKV 73
Query: 149 GIVTGWGVQKQGGSTSDTLLEVEVPIL 175
+ GG D LE+EV +
Sbjct: 74 SV---------GGEKRD--LEIEVVLF 89
>pdb|1PPF|E Chain E, X-Ray Crystal Structure Of The Complex Of Human Leukocyte
Elastase (Pmn Elastase) And The Third Domain Of The
Turkey Ovomucoid Inhibitor
Length = 218
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 19/42 (45%), Positives = 27/42 (64%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC 128
IVGG+ H +P+M L + +CGATLI +V++AAHC
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHC 42
Score = 41.6 bits (96), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 28/106 (26%), Positives = 48/106 (45%), Gaps = 13/106 (12%)
Query: 150 IVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGD 209
+ GWG+ + + L E+ V +++ + C+++ +C + C GD
Sbjct: 123 LAMGWGLLGRNRGIASVLQELNVTVVT-SLCRRSN---------VCTLVRGRQAGVCFGD 172
Query: 210 SGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
SG PL N +H I V GCA YP +A V +++ WI +
Sbjct: 173 SGSPL-VCNGLIHGIASFVR--GGCASGLYPDAFAPVAQFVNWIDS 215
>pdb|1RRK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
pdb|1RS0|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With Di-Isopropyl-Phosphate (Dip)
pdb|1RTK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With 4-Guanidinobenzoic Acid
Length = 497
Score = 42.4 bits (98), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 20/45 (44%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 189 ITPNMLCAG--YPKGEKDSCQGDSGGPLHYANETVHHIVGVVSWG 231
+TP LC G P + ++C+GDSGGPL + VGV+SWG
Sbjct: 409 VTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQVGVISWG 453
Score = 28.9 bits (63), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 25/87 (28%), Positives = 35/87 (40%), Gaps = 23/87 (26%)
Query: 93 TYVHQYPWMALLMY----KKRFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFSNKT 148
T H+ PW A + K C +++ +VLTAAHC T+ K S K
Sbjct: 221 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHC--------FTVDDKEHSIKV 272
Query: 149 GIVTGWGVQKQGGSTSDTLLEVEVPIL 175
+ GG D LE+EV +
Sbjct: 273 SV---------GGEKRD--LEIEVVLF 288
>pdb|1PPG|E Chain E, The Refined 2.3 Angstroms Crystal Structure Of Human
Leukocyte Elastase In A Complex With A Valine
Chloromethyl Ketone Inhibitor
pdb|1H1B|A Chain A, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|1H1B|B Chain B, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|2Z7F|E Chain E, Crystal Structure Of The Complex Of Human Neutrophil
Elastase With 12SLPI
pdb|3Q76|A Chain A, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q76|B Chain B, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q77|A Chain A, Structure Of Human Neutrophil Elastase In Complex With A
Dihydropyrimidone Inhibitor
Length = 218
Score = 42.4 bits (98), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 19/42 (45%), Positives = 27/42 (64%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC 128
IVGG+ H +P+M L + +CGATLI +V++AAHC
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHC 42
Score = 41.6 bits (96), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 28/106 (26%), Positives = 48/106 (45%), Gaps = 13/106 (12%)
Query: 150 IVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGD 209
+ GWG+ + + L E+ V +++ + C+++ +C + C GD
Sbjct: 123 LAMGWGLLGRNRGIASVLQELNVTVVT-SLCRRSN---------VCTLVRGRQAGVCFGD 172
Query: 210 SGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
SG PL N +H I V GCA YP +A V +++ WI +
Sbjct: 173 SGSPL-VCNGLIHGIASFVR--GGCASGLYPDAFAPVAQFVNWIDS 215
>pdb|2RG3|A Chain A, Covalent Complex Structure Of Elastase
Length = 218
Score = 42.4 bits (98), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 19/42 (45%), Positives = 27/42 (64%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC 128
IVGG+ H +P+M L + +CGATLI +V++AAHC
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHC 42
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 27/106 (25%), Positives = 47/106 (44%), Gaps = 13/106 (12%)
Query: 150 IVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGD 209
+ GWG+ + + L E+ V ++++ C+++ +C + C GD
Sbjct: 123 LAMGWGLLGRNRGIASVLQELNVTVVTSL-CRRSN---------VCTLVRGRQAGVCFGD 172
Query: 210 SGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
G PL N +H I V GCA YP +A V +++ WI +
Sbjct: 173 XGSPL-VCNGLIHGIASFVR--GGCASGLYPDAFAPVAQFVNWIDS 215
>pdb|3HRZ|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|I Chain I, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|2XWJ|I Chain I, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|J Chain J, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|K Chain K, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|L Chain L, Crystal Structure Of Complement C3b In Complex With Factor
B
Length = 741
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 20/45 (44%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 189 ITPNMLCAG--YPKGEKDSCQGDSGGPLHYANETVHHIVGVVSWG 231
+TP LC G P + ++C+GDSGGPL + VGV+SWG
Sbjct: 651 VTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQVGVISWG 695
Score = 28.9 bits (63), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 25/87 (28%), Positives = 35/87 (40%), Gaps = 23/87 (26%)
Query: 93 TYVHQYPWMALLMY----KKRFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFSNKT 148
T H+ PW A + K C +++ +VLTAAHC T+ K S K
Sbjct: 463 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHC--------FTVDDKEHSIKV 514
Query: 149 GIVTGWGVQKQGGSTSDTLLEVEVPIL 175
+ GG D LE+EV +
Sbjct: 515 SV---------GGEKRD--LEIEVVLF 530
>pdb|2OK5|A Chain A, Human Complement Factor B
Length = 752
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 20/45 (44%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 189 ITPNMLCAG--YPKGEKDSCQGDSGGPLHYANETVHHIVGVVSWG 231
+TP LC G P + ++C+GDSGGPL + VGV+SWG
Sbjct: 661 VTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQVGVISWG 705
Score = 28.9 bits (63), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 25/87 (28%), Positives = 35/87 (40%), Gaps = 23/87 (26%)
Query: 93 TYVHQYPWMALLMY----KKRFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFSNKT 148
T H+ PW A + K C +++ +VLTAAHC T+ K S K
Sbjct: 473 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHC--------FTVDDKEHSIKV 524
Query: 149 GIVTGWGVQKQGGSTSDTLLEVEVPIL 175
+ GG D LE+EV +
Sbjct: 525 SV---------GGEKRD--LEIEVVLF 540
>pdb|2XWB|F Chain F, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|H Chain H, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 732
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 20/45 (44%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 189 ITPNMLCAG--YPKGEKDSCQGDSGGPLHYANETVHHIVGVVSWG 231
+TP LC G P + ++C+GDSGGPL + VGV+SWG
Sbjct: 642 VTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKRSRFIQVGVISWG 686
Score = 28.9 bits (63), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 25/87 (28%), Positives = 35/87 (40%), Gaps = 23/87 (26%)
Query: 93 TYVHQYPWMALLMY----KKRFYCGATLINNLYVLTAAHCVHQGLGIWVTIRGKSFSNKT 148
T H+ PW A + K C +++ +VLTAAHC T+ K S K
Sbjct: 454 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHC--------FTVDDKEHSIKV 505
Query: 149 GIVTGWGVQKQGGSTSDTLLEVEVPIL 175
+ GG D LE+EV +
Sbjct: 506 SV---------GGEKRD--LEIEVVLF 521
>pdb|1B0F|A Chain A, Crystal Structure Of Human Neutrophil Elastase With Mdl
101, 146
Length = 218
Score = 41.6 bits (96), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 28/106 (26%), Positives = 48/106 (45%), Gaps = 13/106 (12%)
Query: 150 IVTGWGVQKQGGSTSDTLLEVEVPILSNAECKKTAYENRITPNMLCAGYPKGEKDSCQGD 209
+ GWG+ + + L E+ V ++++ C+++ +C + C GD
Sbjct: 123 LAMGWGLLGRNRGIASVLQELNVTVVTSL-CRRSN---------VCTLVRGRQAGVCFGD 172
Query: 210 SGGPLHYANETVHHIVGVVSWGEGCAQENYPGVYARVNRYLTWIKN 255
SG PL N +H I V GCA YP +A V +++ WI +
Sbjct: 173 SGSPL-VCNGLIHGIASFVR--GGCASGLYPDAFAPVAQFVNWIDS 215
Score = 41.2 bits (95), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 19/42 (45%), Positives = 26/42 (61%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC 128
IVGG+ H +P+M L +CGATLI +V++AAHC
Sbjct: 1 IVGGRRARPHAWPFMVSLQLAGGHFCGATLIAPNFVMSAAHC 42
>pdb|1BBR|H Chain H, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|H Chain H, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|F Chain F, Thrombin:hirudin 51-65 Complex
pdb|1YCP|K Chain K, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 150
Score = 41.6 bits (96), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 21/45 (46%), Positives = 28/45 (62%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV GQ V PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|2HNT|C Chain C, Crystallographic Structure Of Human Gamma-Thrombin
Length = 70
Score = 39.7 bits (91), Expect = 0.002, Method: Composition-based stats.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1BHX|B Chain B, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|B Chain B, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
pdb|2PKS|B Chain B, Thrombin In Complex With Inhibitor
pdb|3PO1|B Chain B, Thrombin In Complex With Benzothiazole Guanidine
Length = 147
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 19/45 (42%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 87 IVGGQVTYVHQYPWMALLMYK--KRFYCGATLINNLYVLTAAHCV 129
IV G + PW +L K + CGA+LI++ +VLTAAHC+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCL 45
>pdb|1MTN|B Chain B, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|F Chain F, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|B Chain B, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|G Chain G, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|B Chain B, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|G Chain G, Bovine Chymotrypsin Complexed To Bpti
pdb|1AFQ|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|1VGC|B Chain B, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|B Chain B, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|B Chain B, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|B Chain B, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|B Chain B, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|B Chain B, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|C Chain C, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|D Chain D, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|B Chain B, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|F Chain F, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|B Chain B, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|F Chain F, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|F Chain F, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|F Chain F, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|F Chain F, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|F Chain F, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|F Chain F, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|F Chain F, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|F Chain F, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|B Chain B, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|F Chain F, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|B Chain B, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|F Chain F, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|B Chain B, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|F Chain F, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|F Chain F, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|B Chain B, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|B Chain B, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|B Chain B, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|B Chain B, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|B Chain B, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
pdb|3RU4|D Chain D, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 131
Score = 38.5 bits (88), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 19/43 (44%), Positives = 25/43 (58%), Gaps = 1/43 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRF-YCGATLINNLYVLTAAHC 128
IV G+ +PW L K F +CG +LIN +V+TAAHC
Sbjct: 1 IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHC 43
>pdb|3H7O|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
pdb|3H7O|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
Length = 228
Score = 37.7 bits (86), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 18/44 (40%), Positives = 28/44 (63%), Gaps = 3/44 (6%)
Query: 89 GGQVTYVHQYPW-MALLMY--KKRFYCGATLINNLYVLTAAHCV 129
GG+ T + Q PW +A+ Y ++ CG +++ +VLTAAHCV
Sbjct: 2 GGEKTDIKQVPWTVAVRTYPGEESLTCGGAILSQWFVLTAAHCV 45
>pdb|1KDQ|A Chain A, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 131
Score = 37.4 bits (85), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 18/43 (41%), Positives = 25/43 (58%), Gaps = 1/43 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRF-YCGATLINNLYVLTAAHC 128
IV G+ +PW L K F +CG +LI+ +V+TAAHC
Sbjct: 1 IVNGEDAIPGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHC 43
>pdb|3H7T|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
pdb|3H7T|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
Length = 235
Score = 37.0 bits (84), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 13/43 (30%), Positives = 28/43 (65%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHCV 129
I+GG+ + + + PW ++ ++ +CG +++ +V+TAA CV
Sbjct: 1 IIGGKKSDITKEPWAVGVLVDEKPFCGGSILTANFVITAAQCV 43
>pdb|2ODP|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
pdb|2ODQ|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
Length = 509
Score = 35.4 bits (80), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 19/65 (29%), Positives = 29/65 (44%), Gaps = 5/65 (7%)
Query: 68 VDLEKCGPCTCGAVNKKTRIVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAH 127
+D+ K CG N + + + PW + K + C LI++ +VLTAAH
Sbjct: 210 LDVSKLTDTICGVGN-----MSANASDQERTPWHVTIKPKSQETCRGALISDQWVLTAAH 264
Query: 128 CVHQG 132
C G
Sbjct: 265 CFRDG 269
Score = 33.1 bits (74), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 16/43 (37%), Positives = 23/43 (53%), Gaps = 1/43 (2%)
Query: 189 ITPNMLCAGYPKGEKDSCQGDSGGPLHYANETVHHIVGVVSWG 231
+T LC+G + E C+G+SGG + VG+VSWG
Sbjct: 416 VTDQFLCSGTQEDES-PCKGESGGAVFLERRFRFFQVGLVSWG 457
>pdb|2I6Q|A Chain A, Complement Component C2a
pdb|2I6S|A Chain A, Complement Component C2a
Length = 517
Score = 35.0 bits (79), Expect = 0.037, Method: Compositional matrix adjust.
Identities = 19/65 (29%), Positives = 29/65 (44%), Gaps = 5/65 (7%)
Query: 68 VDLEKCGPCTCGAVNKKTRIVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAH 127
+D+ K CG N + + + PW + K + C LI++ +VLTAAH
Sbjct: 218 LDVSKLTDTICGVGN-----MSANASDQERTPWHVTIKPKSQETCRGALISDQWVLTAAH 272
Query: 128 CVHQG 132
C G
Sbjct: 273 CFRDG 277
Score = 33.1 bits (74), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 16/43 (37%), Positives = 23/43 (53%), Gaps = 1/43 (2%)
Query: 189 ITPNMLCAGYPKGEKDSCQGDSGGPLHYANETVHHIVGVVSWG 231
+T LC+G + E C+G+SGG + VG+VSWG
Sbjct: 424 VTDQFLCSGTQEDES-PCKGESGGAVFLERRFRFFQVGLVSWG 465
>pdb|2JET|B Chain B, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 128
Score = 34.7 bits (78), Expect = 0.051, Method: Compositional matrix adjust.
Identities = 15/32 (46%), Positives = 21/32 (65%), Gaps = 1/32 (3%)
Query: 98 YPWMALLMYKKRF-YCGATLINNLYVLTAAHC 128
+PW L K F +CG +LI+ +V+TAAHC
Sbjct: 9 WPWQVSLQDKTGFHFCGGSLISEDWVVTAAHC 40
>pdb|1AKS|A Chain A, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
pdb|1UHB|A Chain A, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 125
Score = 33.5 bits (75), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 17/42 (40%), Positives = 24/42 (57%), Gaps = 1/42 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC 128
IVGG + P+ L F CG +LIN+ +V++AAHC
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHC 41
>pdb|1EPT|A Chain A, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
Length = 43
Score = 32.3 bits (72), Expect = 0.25, Method: Compositional matrix adjust.
Identities = 17/42 (40%), Positives = 24/42 (57%), Gaps = 1/42 (2%)
Query: 87 IVGGQVTYVHQYPWMALLMYKKRFYCGATLINNLYVLTAAHC 128
IVGG + P+ L F CG +LIN+ +V++AAHC
Sbjct: 1 IVGGYTCAANSIPYQVSLNSGSHF-CGGSLINSQWVVSAAHC 41
>pdb|3F1S|B Chain B, Crystal Structure Of Protein Z Complexed With Protein
Z-Dependent Inhibitor
Length = 283
Score = 32.0 bits (71), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 30/122 (24%), Positives = 49/122 (40%), Gaps = 27/122 (22%)
Query: 69 DLEKCGP---CTCGAVNKKTRIVGGQVTYVHQYPWMALLMYKK-RFYCGATLINNLYVLT 124
D ++C P C CG + + R Q PW L + + +CG +I +VLT
Sbjct: 37 DHKQCVPHDQCACGVLTSEKRAPDLQ-----DLPWQVKLTNSEGKDFCGGVIIRENFVLT 91
Query: 125 AAHC--VHQGLGIWVTIRGKSFSNKTG----------IVTGWGVQKQGGSTSDTLLEVEV 172
A C +H+ + + K++ N+T + G +LLE+E
Sbjct: 92 TAKCSLLHRNITV------KTYFNRTSQDPLMIKITHVHVHMRYDADAGENDLSLLELEW 145
Query: 173 PI 174
PI
Sbjct: 146 PI 147
>pdb|3H5C|B Chain B, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex
Length = 317
Score = 31.2 bits (69), Expect = 0.59, Method: Compositional matrix adjust.
Identities = 30/122 (24%), Positives = 49/122 (40%), Gaps = 27/122 (22%)
Query: 69 DLEKCGP---CTCGAVNKKTRIVGGQVTYVHQYPWMALLMYKK-RFYCGATLINNLYVLT 124
D ++C P C CG + + R Q PW L + + +CG +I +VLT
Sbjct: 78 DHKQCVPHDQCACGVLTSEKRAPDLQ-----DLPWQVKLTNSEGKDFCGGVIIRENFVLT 132
Query: 125 AAHC--VHQGLGIWVTIRGKSFSNKTG----------IVTGWGVQKQGGSTSDTLLEVEV 172
A C +H+ + + K++ N+T + G +LLE+E
Sbjct: 133 TAKCSLLHRNITV------KTYFNRTSQDPLMIKITHVHVHMRYDADAGENDLSLLELEW 186
Query: 173 PI 174
PI
Sbjct: 187 PI 188
>pdb|1VKW|A Chain A, Crystal Structure Of A Putative Nitroreductase (tm1586)
From Thermotoga Maritima Msb8 At 2.00 A Resolution
Length = 218
Score = 27.7 bits (60), Expect = 6.2, Method: Compositional matrix adjust.
Identities = 15/51 (29%), Positives = 22/51 (43%)
Query: 49 ISGFVTNQEESTPPEPVKPVDLEKCGPCTCGAVNKKTRIVGGQVTYVHQYP 99
I+ F+ N E PPE VK V+ P K + GG++ + P
Sbjct: 130 ITSFLENDLEELPPEIVKIVEXTILAPSALNRQPWKIKYTGGELCISSERP 180
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.317 0.136 0.436
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 9,242,339
Number of Sequences: 62578
Number of extensions: 408754
Number of successful extensions: 1857
Number of sequences better than 100.0: 355
Number of HSP's better than 100.0 without gapping: 347
Number of HSP's successfully gapped in prelim test: 8
Number of HSP's that attempted gapping in prelim test: 640
Number of HSP's gapped (non-prelim): 700
length of query: 260
length of database: 14,973,337
effective HSP length: 97
effective length of query: 163
effective length of database: 8,903,271
effective search space: 1451233173
effective search space used: 1451233173
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.6 bits)
S2: 50 (23.9 bits)